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Abstract  
Enteropathogenic Escherichia coli (EPEC) virulence depends on a Type-3 Secretion 
System (T3SS) that transfers many ‘effector’ proteins into human gastrointestinal cells. 
The components for the effector-delivery apparatus (T3SS and translocator proteins), 
virulence-critical surface protein (Intimin) and seven effectors (EspG, EspF, Map, 
EspH, EspZ, Tir, EspB; latter also a translocator) are encoded on the Locus of 
Enterocyte Effacement (LEE) pathogenicity island. The EspA translocator protein 
extends the T3SS and is tipped with EspB and EspD which insert into the plasma 
membrane enabling effector delivery into the host cytoplasm. Two LEE effectors, Tir 
and EspZ, have virulence-critical functions with both inserted into the plasma 
membrane and linked, for Tir, as a receptor for EPEC (via Intimin) and, for EspZ, to 
prevent a cytotoxic response. It is controversial how Tir becomes inserted into 
membranes and how EspZ prevent cytotoxicity. Previous work predicted that Tir 
insertion depends on LEE effector activities. Here, we demonstrate LEE sufficiency for 
Tir insertion and rule out roles for Intimin and classical LEE (EspG, Map, EspF, EspH, 
EspZ) effectors. Surprisingly, our data implicated roles for the EspA and EspD 
translocators in stable Tir-intimin interactions and revealed a new EspZ protective 
mechanism i.e. prevention of cytotoxicity triggered as a consequence of Tir-Intimin 
interaction. Furthermore, we provide bioinformatic and experimental support that an 
unusual Edwardsiella tarda LEE-like region encodes a functional effector-delivery 
system. The swapping of protein homologues between E. tarda and EPEC has also 
provided an opportunity to gain insights on the structure/function of ~20 
T3SS/translocon components and virulence-critical Tir, Intimin and EspZ proteins.  
 
 
 
 
 
 
 
 
 
 
ii 
  
Acknowledgements 
Firstly, I would like to express my sincere gratitude to my supervisor Professor Brendan 
Kenny for giving me the opportunity to be part of his laboratory and for his guidance 
and support throughout this PhD project. Much of this work has resulted from an 
invaluable help received by him and my colleagues. Thus, I would like to say thank you 
for Oliver Amin and Aseel Al-layla for your help, patience and friendship over the past 
four years.  
 
Much of my appreciation goes to my family Mum, Wife and Kids for the unwavering 
support, love and encouragement throughout this process. Special thanks to my Dad 
who wanted to see me achieve my goal. Also, I would like to thank Jeremy lab group 
for support me over past few of years. Finally, thank my friends who supported me 
while going through this experience. 
I would also like to show my appreciation towards the Institute for Cell and Molecular 
Biosciences - Newcastle University (ICAMB) for a great research opportunity, full of 
experiences and support when needed.  
 
 
 
 
  
 
 
 
 
 
 
  
 
  
  
 
 
iii 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
  
Table of Contents 
                
Abstract........................................................................................................................ i  
Acknowledgements..................................................................................................... ii  
Table of contents ....................................................................................................... vi  
List of figures ............................................................................................................ viii  
List of tables............................................................................................................... xii  
Abbreviations ............................................................................................................ xiii 
Chapter 1: Introduction……………………………………………………………...…….1 
1.1 Pathogenic Bacteria .................................................................................... 1 
1.1.1 Escherichia coli and enteropathogenic E. coli (EPEC) .............................. 1 
1.1.2 Interactions of EPEC with epithelial cells ................................................... 3 
1.2 Locus of Enterocyte Effacement (LEE) ...................................................... 3 
1.3    The EPEC type III secretion system (T3SS) ................................................ 4 
 1.4   EPEC LEE and non-LEE effector proteins .................................................. 6 
 1.5   EPEC LEE effector proteins ......................................................................... 7 
1.5.1 Translocated intimin receptor (Tir) ........................................................... 7 
1.5.2 EspZ ...................................................................................................... 11 
1.5.3 EspF ...................................................................................................... 12 
      1.5.4   Map ........................................................................................................ 13 
      1.5.5   EspH ....................................................................................................... 14 
1.5.6 EspG ...................................................................................................... 15 
   1.6   Intimin ............................................................................................................ 15 
1.7 Non-LEE encoded effectors ......................................................................... 17 
1.8 EPEC chaperones ......................................................................................... 18 
1.9 EPEC proteins secretion and regulation ..................................................... 20 
  1.10 Bacterial protein pore-forming and insertion ............................................. 21 
1.11 Manipulation of host cell functions by EPEC effector proteins ................ 23 
v 
  
       1.11.1 EPEC effector proteins induce watery diarrhoea ................................... 23 
       1.11.2 EPEC effectors regulate host cell survival ............................................. 24 
       1.11.3 EPEC effectors manipulate inflammatory signalling pathways .............. 27 
1.12  Project aims .................................................................................................. 29 
2.1 Cell culture ..................................................................................................... 31 
     2.1.1 Mammalian cell culture ............................................................................. 31 
     2.1.2 Bacterial strains and mammalian cells ...................................................... 31 
Chapter 2:  Materials and Methods 
2.2 Molecular biology .......................................................................................... 34 
     2.2.1 Polymerase chain reaction (PCR) and agarose gel electrophoresis ......... 34 
     2.2.2 Plasmid extraction ..................................................................................... 37 
     2.2.3 DNA sequencing ....................................................................................... 37 
     2.2.4 Preparation of electrocompetent cells ....................................................... 37 
     2.2.5 Electroporation of bacterial cells ............................................................... 38 
     2.2.6 Transformation of bacteria using heat-shock procedure ............................ 38 
     2.2.7 Construction of EPEC gene knockout mutants ......................................... 40 
     2.2.8 Plasmid construction ................................................................................. 41 
2.3 Bacterial infection ......................................................................................... 43 
     2.3.1 Hela cells infection .................................................................................... 43 
     2.3.2 Isolation of cellular protein fractions .......................................................... 43 
     2.3.3 Western Blot analysis ............................................................................... 44 
     2.3.4 Immunofluorescence microscopy .............................................................. 45 
     2.3.5 Lactate dehydrogenase (LDH) cytotoxicity assay ..................................... 46 
Chapter 3:  Interrogating roles for EPEC T3SS secretion substrates in Tir 
modification to T” form and membrane insertion processes 
3.1 Introduction .................................................................................................... 48 
3.2 Aim……………………………………………………………………………………50 
3.3 Results ........................................................................................................... 51 
     3.3.1 LEE region sufficiency for Tir functionality ................................................ 51 
vi 
  
     3.3.2 Yersinia enterocolitica-delivered Tir is only partially modified by host 
kinases and does not interact with Intimin ............................................... 52 
     3.3.3 Co-expression of LEE effectors with Tir in Yersinia enterocolitica inhibits 
Tir delivery into HeLa cells ....................................................................... 55 
     3.3.4 Tir does not require Intimin, Map, EspG, EspH, EspF or EspZ activities for 
host kinase modification to T’’ form. ......................................................... 57 
     3.3.5 EspB-Myc fusion protein lacking EspB residues 159-218 doesn’t support 
Tir delivery into Hela cells ........................................................................ 59 
     3.3.6 Probing role for other EspB features by examining functionally 
interchangeability with E. tarda homologue. ............................................ 65 
     3.3.7 Examining functionally interchangeability of E. tarda EspD protein .......... 74 
     3.3.8 Examining if the EspAEt protein can functionally replace EspAEPEC……....78 
     3.3.9 Rescuing the T3SS defect of EPEC ΔespA, ΔespD, ΔespAB and ΔespDB 
mutants by introducing E. tarda region encoding EspA, EspB and EspD 82 
3.4 Discussion ..................................................................................................... 86 
Chapter 4:  Interrogating the functionality of Edwardsiella tarda (E.tarda) type III 
secretion system 
4.1 Introduction ................................................................................................... 92 
    4.1.1 Type III secretion system components ..................................................... 92 
    4.1.2 Edwardsiella tarda (E.tarda) LEE region .................................................. 96 
4.2 Aim. ................................................................................................................ 97 
4.3 Results ........................................................................................................... 98 
     4.3.1 Bioinformatics ........................................................................................... 98 
     4.3.2 E. tarda LEE region has an espZ gene ..................................................... 98 
     4.3.3 Proteins encoded over two adjacent open reading frames ..................... 100 
     4.3.4 The E. tarda escD gene can functionally substitute for EPEC escD ....... 107 
     4.3.5 The E. tarda eae gene encodes for a larger Intimin protein .................... 110 
     4.3.6 E. tarda LEE proteins of highest, medium and lowest homology to EPEC 
counterparts ........................................................................................... 114 
     4.3.7 E. tarda Ler protein replaces EPEC Ler regulatory activity ..................... 115 
vii 
  
     4.3.8 E.tarda Tir protein lacks key EPEC Tir-related subversive features can be 
delivered by EPEC in a CesT/T3SS-dependent manner without evidence 
of modification to T’’ form. ...................................................................... 117 
     4.3.9 The E. tarda cesT gene produced a protein that weakly substitutes for 
CesTEPEC in promoting TirEPEC delivery into HeLa cells .......................... 126 
4.4 Discussion ................................................................................................... 129 
Chapter 5: The enteropathogenic E. coli (EPEC) delivered EspZ effector 
prevents host cells cytotoxicity in response to the Tir-Intimin interaction 
5.1 Introduction .................................................................................................. 136 
5.2 Aim ………………………………………………………………………………….137 
5.3 Results ......................................................................................................... 138 
     5.3.1 mfz(81)go3 mutant phenotypes linked to absence of EspZ delivery ......... 138 
     5.3.2 Critical role for Intimin, Map and EspF proteins in the espZ(81)-associated 
phenotypes ............................................................................................. 141 
     5.3.3 Restoring espZ associated-phenotypes of mfez:km mutant by 
complementing with Map, EspF or Intimin-expressing plasmids ............ 146 
     5.3.4 Critical role for Tir in triggering espZ(81) associated phenotypes ............. 154 
     5.3.5 Supporting roles for Map and EspF in z(81)t  associated phenotypes …..156 
     5.3.6 espZ(81) cytotoxicity-associated phenotypes depend on Tir with critical role 
for kinase modified residues ................................................................... 159 
     5.3.7 Additional complexity in the espZ(81) mutant phenotypes ........................ 161 
     5.3.8 LDH release depends on espZ mutants expressing Tir or Intimin ........... 163 
     5.3.9 Ruling out any possible role for non-LEE effector proteins in espZ(81) 
phenotypes ............................................................................................. 165 
    5.3.10  K12 ‘mini-LEE’ strain behaves like espZ(81) mutant ................................ 171 
    5.3.11 The SIEC-eLEE5 associated phenotypes are CesT dependent ............. 172 
5.4 Discussion ................................................................................................... 177 
Chapter 6:  Final Discussion 
Bibliography ........................................................................................................ 187 
 
viii 
  
List of figures 
Figure 1: EPEC induced attaching and effacing lesions with actin rich pedestals.. ... 2 
Figure 2: Genetic organisation of EPEC LEE Pathogenicity Island. .......................... 4 
Figure 3: Schematic illustration of the EPEC effector delivery system. ...................... 5 
Figure 4: Interactions between the EPEC Intimin and Tir proteins. ............................ 7 
Figure 5: Schematic of EPEC translocated Intimin receptor Tir protein.. ................... 8 
Figure 6: Actin accumulation mechanism in EPEC. ................................................. 10 
Figure 7: The topology of EPEC EspZ.. ................................................................... 12 
Figure 8: Schematic of EPEC translocated effector protein (EspF). ........................ 13 
Figure 9: Schematic of mitochondrial associated protein (Map). ............................. 14 
Figure 10: The model of Intimin topology and binding to Tir.. .................................. 16 
Figure 11: The EPEC non-LEE effectors encoded in the prophages and integrative 
elements. ................................................................................................. 18 
Figure 12: The pore-forming mechanism. ................................................................ 22 
Figure 13: EPEC alters ion transport and induce watery diarrhoea. ........................ 23 
Figure 14: Programmed Cell Death Modes. ............................................................. 25 
Figure 15: EPEC effectors inhibit NF-κB activation in the intestinal epithelial cells. . 28 
Figure 16: The LEE region encodes sufficient information to enable Tir delivery, 
modification and insertion into the host plasma membrane for Intimin 
binding. .................................................................................................. 52 
Figure 17: Tir is only partially modified following delivery into Hela cells by a Yersinia 
enterocolitica (Y/ent) strain that lacks most Yersinia T3SS effectors. .... 54 
Figure 18: Yersinia enterocolitica present Intimin on its surface in a conformation that 
can bind fully modified, membrane-inserted, Tir. ................................... 54 
Figure 19: Co-expressing Tir with other LEE effectors in Yersinia enterocolitica 
interferes with the Tir delivery process................................................... 56 
Figure 20: PCR support of mfz(81)go3eh::km mutant.. .............................................. 58 
Figure 21: Tir delivered by EPEC lacking Map, EspF, EspZ, EspG, EspG2, EspH 
effectors and Intimin proteins is modified to T’’ form.. ............................ 59 
Figure 22: The EspB-mid variant does not support Tir delivery into HeLa cells. ...... 61 
Figure 23: Construction of pACYC-espB-mid.. ........................................................ 63 
Figure 24: EspB-mid supports Tir delivery and modification to T” form.................... 64 
Figure 25: Comparison of E. tarda and EPEC EspB proteins.. ................................ 66 
Figure 26: Interrogating the presence of transmembrane domain in E. tarda and EPEC 
EspB proteins.   ..................................................................................... 68 
ix 
  
Figure 27: Construction of pACYC-espBEt. ............................................................... 70 
Figure 28: The E. tarda EspB protein functionally replaces EPEC EspB to deliver Tir 
into cells where modified to the T” form and interacts with Intimin. ........ 71 
Figure 29: The E. tarda EspB protein functionally replaces EPEC EspB to enable 
Tir/Intimin-dependent pedestal formation. .............................................. 73 
Figure 30: Comparison of E. tarda and EPEC-encoded EspD proteins. .................. 75 
Figure 31: Construction of pACYC-espDEt.  . ........................................................... 75 
Figure 32: E. tarda EspD rescues the EPEC espD mutant defect in delivering Tir linked 
to a defect in Tir modification and Intimin interaction with Tir. ................ 77 
Figure 33: Comparison of E. tarda and EPEC EspA proteins. .................................. 78 
Figure 34: Construction of pACYC-espAEt.. .............................................................. 79 
Figure 35: E.tarda EspA rescues the EPEC ΔespA mutant defect in delivering Tir 
linked to a defect in Tir modification and Intimin interaction with Tir. ...... 80 
Figure 36: ∆espA/pACYC-espAEt strain has Intimin on its surface which can stably 
interact with the Tir T’’ modified form. ..................................................... 81 
Figure 37: Construction of pACYC-espADBEt. .......................................................... 83 
Figure 38: Rescuing the T3SS defect of EPEC ΔespA and ΔespD mutants by plasmid 
introducing pACYC-espADBEt. ............................................................... 84 
Figure 39: Rescuing the T3SS defect of EPEC ΔespAespB and ΔespDespB double 
mutants by plasmid introducing pACYC-espADBEt................................. 85 
Figure 40: Schematic of EPEC injectisome. ............................................................. 93 
Figure 41: Pathogenicity islands of E. tarda genes were compared with the 
corresponding genes in Escherichia coli O127. ...................................... 96 
Figure 42: Alignment of E. tarda and EPEC EspZ proteins.. .................................... 98 
Figure 43: Alignment of E. tarda and EPEC EscD proteins. ................................... 101 
Figure 44: The E. tarda and EPEC EscD proteins are predicted to possess one, 
similarly-located, transmembrane domain.. .......................................... 103 
Figure 45: The E. tarda EscD protein is encoded on two adjacent open reading frames.
 ................................................................................................................................ 104 
Figure 46: The E. tarda SepL protein is interrupted by a stop codon. .................... 105 
Figure 47: The E. tarda EscL protein is interrupted by a stop codon. ..................... 106 
Figure 48: Cloning E. tarda escD region into pACYC184 and generating EPEC escD 
mutant. ................................................................................................. 108 
Figure 49: Rescuing the EPEC escD mutant T3SS defect by introducing pACYC-
escDEt. .................................................................................................. 109 
x 
  
Figure 50: Sequence error in E. tarda LEE eae gene. ........................................... 110 
Figure 51: E. tarda Intimin shares residues critical for EPEC/EHEC Intimin binding to 
Tir......................................................................................................... 111 
Figure 52: Cloning E. tarda eae gene into pACYC184 and introduction into EPEC eae 
mutant. ................................................................................................. 112 
Figure 53: Rescuing the EPEC eae mutant defect in binding membrane-inserted Tir 
by introducing E. tarda eae gene.  . ..................................................... 113 
Figure 54: Cloning E. tarda ler gene into pACYC184 and introduction into EPEC ler 
mutant. ................................................................................................. 115 
Figure 55: The E. tarda ler genes restores the ability of the EPEC ler mutant to express 
and deliver LEE effector proteins. ........................................................ 116 
Figure 56: Comparison of E. tarda and EPEC Tir proteins. ................................... 118 
Figure 57: The E. tarda and EPEC Tir proteins have two putative transmembrane 
domains.  . ........................................................................................... 120 
Figure 58: Construction of pSK-tirHAEt cesTEPEC.   ................................................ 122 
Figure 59: Schematic of pACYC-tirHAET and PCR support for introduction into EPEC 
strains.. ................................................................................................ 124 
Figure 60: EPEC T3SS-dependent delivery of E. tarda Tir into HeLa cells promoted 
by EPEC CesT.. ................................................................................... 125 
Figure 61: Construction of pACYC-cesTEt.. ........................................................... 126 
Figure 62: The E. tarda CesT protein is less effective than EPEC CesT in promoting 
EPEC Tir stability and delivery into host cells. ..................................... 128 
Figure 63: Comparison of E. tarda and EPEC CesT proteins. ............................... 128 
Figure 64: T3SS-independent and -dependent loss of Tir T’’, phosphotyrosine proteins 
and tubulin/actin signals in espZ(81)-infected cells. ............................... 139 
Figure 65: Assessment of espZ multi-mutants. ...................................................... 145 
Figure 66: Absence of eae, espF and map genes from the mfez:km mutant and 
plasmid reintroduction of individual genes. .......................................... 146 
Figure 67: Critical role for Intimin to trigger Tir T” to T’ shift and Tir tyrosine 
dephosphorylation by EspZ-deficient strains. ...................................... 147 
Figure 68: Minor role for EspF in the dephosphorylation of host and Tir tyrosine 
phosphorylated proteins following infection by EspZ-deficient strains. 150 
Figure 69: Prominent role for Map in triggering tyrosine dephosphorylation of host 
proteins of EspZ/Intimin-deficient strains. ............................................ 151 
xi 
  
Figure 70: Map triggered espZ associated Tir/host protein tyrosine dephosphorylation 
phenotypes is N-terminal dependent.. .................................................. 152 
Figure 71: Expression and delivery of MapHA & Tir-∆MTS-Map fusion proteins. ... 153 
Figure 72: Tir is critical for espZ(81) associated phenotypes.. ................................. 155 
Figure 73: Assessment of Tir/EspZ-deficient mutant strains.. ................................ 158 
Figure 74: Intimin induced espZ(81) phenotypes is Tir dependent with critical role for 
serine and/or tyrosine residues............................................................... 160 
Figure 75: Multiple mutant strain mfz(81)go3eh:km, unlike mfz(81)go3e,  triggers espZ(81) 
phenotypes.. ........................................................................................... 162 
Figure 76: LDH release depends on espZ expressing Tir or Intimin proteins.. ....... 164 
Figure 77: Assessment of EspZ deficient TOE-A7 multi-mutants. .......................... 169 
Figure 78: LDH release depends on EspZ deficient TOE-A7 mutants expressing Tir 
but not Intimin.. ..................................................................................... 170 
Figure 79: SIEC-eLEE5 delivers Tir where modified to T”-like form and interacts with 
Intimin. .................................................................................................. 171 
Figure 80: Cell cytotoxic responses following infection with SIEC-eLEE5.  . .......... 173 
Figure 81: The SIEC-eLEE5∆cesT strain does not deliver EspB. .......................... 174 
Figure 82: EspB delivery defect of the CesT-deficient SIEC-eLEE5 strain is rescued 
by plasmid expressing an afimbrial adhesin. ........................................ 175 
Figure 83: CesT activity is critical for SIEC-eLEE5 to induce espZ mutant-associated 
phenotypes.. ......................................................................................... 176 
 
 
 
 
 
 
 
 
 
 
 
 
xii 
  
List of tables 
Table 1A-D: Bacterial strains used in these studies ................................................. 33 
Table 2: List of primers used in this study. ............................................................... 35 
Table 3: Standard PCR reaction mixture using  . ..................................................... 36 
Table 4: Standard PCR reaction condition. .............................................................. 36 
Table 5: plasmids used in this study......................................................................... 39 
Table 6: Suicide vectors used in studies with a brief description, antibiotic resistance 
profile and source reference. ..................................................................... 40 
Table 7: Primary and secondary antibodies with DAPI/TRITIC- Phalloidin stains used 
in this study.. .............................................................................................. 45 
Table 8: Comparison of reported virulence proteins encoded among E. tarda and 
EPEC LEE region.. .................................................................................... 99 
Table 9: Summary of differences between cells infected with EspZ-deficient and EPEC 
strains. ..................................................................................................... 141 
Table 10: Summary of differences between cells infected with EspZ-deficient and 
Tir/EspZ negative mutants strains. ........................................................... 156 
Table 11: Summary of differences between cells infected with EspZ-deficient and 
EPEC strains.. .......................................................................................... 164 
Table 12: Summary of differences between cells infected with EspZ-deficient TOE-A7 
strains. ..................................................................................................... 166 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiii 
  
List of Abbreviations  
A/E lesion: Attaching and effacing lesion  
Ab: Antibody  
ARP2/3: Actin related protein 2/3  
BFP: Bundle forming pilus  
BSA: Bovine serum albumin  
Carb: Carbenicillin  
Cdc42: Cell division cycle 42 
Cmp: Chloramphenicol  
CR: Citobacter rodentium  
C-terminal: Carboxyl-terminal 
DAPI: 4’,6-diamidino-2-phenylindole  
DMEM: Dulbecco’s minimal Eagle’s medium  
E2348/69: EPEC strain E2348/69  
EAF: EPEC adherence factor  
E. coli: Escherichia coli  
EDTA: Ethylenediaminetetraacetic acid  
EHEC: Enterohemorrhagic Escherichia coli  
EIEC: Enteroinvasive Escherichia coli  
EPEC: Enteropathogenic Escherichia coli  
Erk: Extracellular signal-regulated kinase 
Esc: EPEC secretion  
Esp: EPEC secreted/signalling protein  
FL: Full-length 
FCS: Foetal calf serum  
GEF: Guanine exchange factor 
IE: Integrative element  
IKK: IkB kinase kinase  
ITIM: Immune receptor tyrosine based inhibition motifs  
JAM: Junction adhesion molecule  
Km: Kanamycin  
xiv 
  
LB: Luria broth  
LDH: Lactate dehydrogenase  
LEE: Locus of enterocyte effacement  
Ler: LEE encoded regulator  
LPS: Lipopolysaccharide  
Map: Mitochondrial associated protein  
MOI: Multiplicity of infection  
Nal: Nalidixic acid  
NF-κB: Nuclear factor-kappa B  
NHE: Sodium hydrogen (Na+/H+) exchanger  
Nle: Non-LEE encoded  
N-WASP: Neural Wiskott-Aldrich syndrome protein  
OD600: Optical density 600 nm  
PBS: Phosphate buffered saline  
PCR: Polymerase chain reaction   
Per: Plasmid encoded regulator  
PFA: Paraformaldehyde 
PI3K: Phosphoinositide 3-kinase 
PKA: Protein kinase A 
PMSF: Phenylmethane sulfonyl fluoride 
PPR: Polyproline region  
RT: Room temperature  
RTK: Receptor tyrosine kinase  
SDS-PAGE: Sodium dodecyl sulphate polyacrylamide gel electrophoresis  
Ser: Serine  
SGLT1: Sodium glucose transporter 1  
SHIP2: SH2 domain containing inositol 5-phosphatase  
SH2: Src homology 2 
SNX9: Sorting nexin 9  
Src tyrosine kinase: Sarcoma tyrosine kinase 
SOC: Super optimal broth with catabolite repression 
xv 
  
T2SS: Type II secretion system 
T3SS: Type III secretion system 
TVSS: Type V secretion system 
Tet: Tetracycline  
Tir: Translocated intimin receptor  
Thr: Threonine  
TLR: Toll-like receptor  
TNFα: Tumour necrosis factor alpha  
TNFR: TNF receptor  
TRADD: Tumour necrosis factor receptor type1-associated Death domain protein  
TRAF: TNF receptor associated factor  
Tyr: Tyrosine  
UPEC: Uropathogenic Escherichia coli  
WT: Wild type  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xvi 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 Introduction 
1 
  
 
1.1 Pathogenic Bacteria 
1.1.1 Escherichia coli and enteropathogenic E. coli (EPEC) 
Escherichia coli (E. coli) is an aerobic gram-negative bacterium within the family of 
enterobacteriaceae and the genus Escherichia (Kaper et al., 2004). It is a commensal 
organism of the small intestine of humans and animals (Nicolas-Chanoine et al., 2014) 
with some strains causing diarrhoea in humans, whereas others can spread throughout 
the body where they cause urinary tract infection or meningitis (Weintraub, 2007). 
Diarrhoeagenic E. coli are divided into six main pathotypes: enterotoxigenic E. coli 
(ETEC), enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), diffuse 
adherent E. coli (DAEC), enterohaemorrhagic E. coli (EHEC) and enteropathogenic E. 
coli (EPEC). During infection all pathogenic E. coli strains remain extracellular except 
EIEC, which is an intracellular pathogen that can invade and replicate within epithelial 
cells and macrophages, while other E. coli strains, which might be internalized at low 
levels, cannot replicate intracellularly (Gruenheid & Finlay, 2003). 
EPEC is one of the first E. coli pathotypes recognised to be responsible for millions of 
paediatric diarrhoeal cases each year (Clements et al., 2012, Levine et al., 1978). It 
targets the absorptive epithelia (enterocytes) of the human small intestine where 
alteration leads to severe watery diarrhoea. Although EPEC outbreaks of neonatal 
diarrhoea in developed countries are now rare, it is one of the most important 
pathogens infecting infants and causing nonspecific gastroenteritis in the developing 
world (Dutta et al., 2013, Levine & Edelman, 1984). EPEC with other pathogenic strains 
including enterohaemorrhagic E. coli (EHEC), rabbit specific enteropathogenic E. coli 
(REPEC-1) and the mouse specific Citrobacter rodentium are members of the 
attaching and effacing (A/E) family of pathogens. These members share the ability to 
induce pathophenotypic attaching and effacing (A/E) lesions following adherence to 
the apical surface of the intestinal epithelial layer (Wong et al., 2011). The 
distinguishing features of these lesions are i) localised loss of brush border microvilli, 
ii) intimate bacterial adherence to the enterocyte apical plasma membrane, and iii) 
production of actin-rich pedestal-like structures beneath the adherent bacteria (Figure 
1) (Mundy et al., 2005, Robins-Browne et al., 1994, Nataro & Kaper, 1998). 
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Figure 1: EPEC induced attaching and effacing lesions with actin rich pedestals. A) 
The extensive effacement of microvilli on the apical surface of epithelial cells (Caco-2 cell model) 
infected with wild type EPEC. Taken from (Dean et al., 2006). B) EPEC induces pedestal-like 
structures in HeLa cell model. These pedestal structures protrude from the apical surface, cupping 
individual bacteria. The image was artificially coloured to distinguish bacteria (purple) from HeLa cell 
(brown). Taken from (Rosenshine et al., 1996).  
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1.1.2 Interactions of EPEC with epithelial cells 
Infection with EPEC occurs through ingestion or drinking of contaminated food or 
water. Upon entering the gut, EPEC adhere to epithelial cells via bundle-forming pili 
(BFP) (Giron et al., 1991). The bundle-forming pili (BFP) is encoded by the EPEC 
adherence factor (EAF) plasmid (Jarvis et al., 1995). EPEC BFP is a member of the 
type IV pilus and promotes EPEC aggregation to form microcolonies and bind 
enterocytes in a manner named localised adherence (LA) (Giron et al., 1991). The 
disease process depends on the ability of the EPEC to penetrate the intestinal mucus 
layer, attach to enterocytes and transduce signal cascades that control important 
cellular functions, including actin and cytoskeletal dynamics (Donnenberg & Kaper, 
1992). The gastrointestinal epithelial cells are also covered by a glycocalyx 
(glycoprotein-polysaccharide) layer, which covers the apical surface of mucosal 
epithelial cells (McGuckin et al., 2011).  
 
EPEC subverts different mechanisms to colonise intestinal epithelium and penetrate 
the mucus barrier to access the epithelial surface (Clements et al., 2012). EPEC 
possesses a type II secretion system (T2SS) that secretes a surface-
associated lipoprotein, SslE (Baldi et al., 2012, Valeri et al., 2015). SslE is a mucin-
binding protein involved in the degradation of mucin substrates and facilitates EPEC 
penetration of the mucus layer to access the host cells (Valeri et al., 2015). EPEC also 
secretes a serine protease auto-transporter, EspC, which is secreted by type V 
secretion system (TVSS) to the extracellular milieu, causing epithelial damage (Stein 
et al., 1996, Navarro-Garcia et al., 2004). EPEC then utilizes a type III secretion system 
(T3SS) to translocate proteins into the host cell’s cytoplasm. The T3SS with its 
substrates are encoded on the Locus of Enterocyte Effacement (LEE) pathogenicity 
island, which encodes over 40 gene products (Elliott et al., 1998). 
 
 
1.2  Locus of Enterocyte Effacement (LEE) 
The locus of enterocyte effacement (LEE) is a 35 kb pathogenicity island present in all 
attaching and effacing pathogenic strains (Mundy et al., 2005, Robins-Browne et al., 
1994, Nataro & Kaper, 1998). In EPEC (E2348/69), the LEE region consists of 41 
ORFs organized in seven operons from LEE1 to LEE7 (Figure 2) (Gaytán et al., 2016). 
EPEC LEE expression is regulated by a non-LEE transcriptional regulator (PerC) 
encoded by the perABC operon on the EAF plasmid (Gomez-Duarte & Kaper, 1995). 
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The LEE genes, based on their functionality, are classified into a number of groups, 
including the components of a T3SS apparatus (Sep, for Secretion EPEC protein and 
Esc, for EPEC secretion components), secreted translocators and effector proteins 
(Esp, for EPEC secretion protein), chaperones (Ces), regulatory factors (Ler, GrlA, 
GrlR, and CesL), an adhesin (Eae), Intimin (Lin et al., 2014). The LEE operons (LEE2 
to LEE7) are activated by gene located on the LEE1 operon. This gene encodes the 
master regulator Ler (LEE encoded regulator) (Mellies et al., 1999). In addition to Ler, 
LEE also has genes that encode a negative (GrlR) and a positive (GrlA) regulator of 
the Ler expression (Iyoda et al., 2006). CesL can also modulate LEE expression by 
interacting with Ler (Younis et al., 2010). Once EPEC LEE is activated and proteins 
are expressed, this leads to the production of an effector-delivery apparatus composed 
of a T3SS and translocators.  
 
 
 
1.3 The EPEC type III secretion system (T3SS) 
The T3SS apparatus is a macromolecular complex that spans both bacterial 
membranes with a short needle-like projection to enable direct delivery of ‘effector’ 
proteins across the plasma membrane of host cells (Hueck, 1998, Burkinshaw & 
Strynadka, 2014). The T3SS is composed of ~20 proteins that form a basal body, 
Figure 2: Genetic organisation of EPEC LEE Pathogenicity Island. EPEC LEE 41 genes are 
organised into seven polycistronic operons (LEE1 to LEE7). Taken from  (Gaytán et al., 2016). 
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extracellular appendages (needle, filament and the translocation pore), and 
cytoplasmic components (Figure 3). The basal body of the T3SS system, which spans 
both the inner and outer bacterial membrane, consists of ring structures associated 
with the inner (EscJ, EscD), outer (EscC) bacterial membranes and a periplasmic inner 
rod (EscI) (Figure 3) (Romo-Castillo et al., 2014). EscJ, EscD and EscC proteins are 
critical for T3SS assembly and are required for the secretion of the Esp proteins (Ogino 
et al., 2006). EscI, a rod/needle protein, interacts with the outer membrane secretin 
EscC and it is essential for type III secretion (Sal-Man et al., 2012b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Schematic illustration of the EPEC effector delivery system. The effector delivery 
system is composed of a T3SS and the translocators. T3SS is encoded by genes located on the 
locus for enterocyte effacement (LEE), and composed of ~20 proteins that form the basal body, 
extracellular appendages, and cytoplasmic components. T3SS spans the inner and outer bacterial 
membranes to deliver EPEC effector proteins into the host cells.  The basal body of the TTSS (EscC 
and EscV, and the EscJ) spans the periplasm forming a cylindrical structure. EscF constitutes a 
short needle structure that is extended by a long filament formed by EspA subunits. EspA filament 
to form a hollow tube and at the end of EspA the translocator proteins EspB and EspD are placed 
to form the pore in the host cell plasma membrane. T3SS is energized by the cytoplasmic ATPase 
EscN that provide the energy to the system by hydrolysing ATP into ADP. SepD and SepL regulate 
the secreting of the effector proteins. Adapted from (Soto et al., 2017). 
Chapter 1 Introduction 
6 
  
The basal structure of the T3SS export apparatus consists of five essential 
transmembrane proteins (EscR, EscS, EscT, EscU, and EscV) (Figure 3). These 
proteins form the integral inner membrane proteins (Gauthier et al., 2003). EscF is a 
needle protein that is required for T3SS secretion and EspA filament assembly (Wilson 
et al., 2001). EspA (Kenny et al., 1996), EspB and EspD (Donnenberg et al., 1993) 
function to form the translocon portions of the T3SS (Figure 3). EspA is a filamentous 
protein that forms a translocation tube linking the EscF needle to the host cell’s 
membrane (Knutton et al., 1998). These structures act as a channel to translocate 
proteins from the bacteria into the host cells. EspB and EspD are located at the end of 
the EspA filament (Figure 3) where they insert and form a pore into the host cell 
membrane (Frankel et al., 1998). In EPEC, EscN is T3SS ATPase, which is essential 
for the functioning of the T3SS translocator and a potential source of energy for T3SS 
proteins secretion (Zarivach et al., 2007). EscN forms a complex with two other 
essential T3SS proteins EscL/Orf5 (putative ATPase-negative regulator) and 
EscQ/SepQ (a predicted component of cytoplasmic C ring) (Biemans-Oldehinkel et al., 
2011). Orf16/EscP, a T3SS-secreted substrate, acts as a molecular measuring device 
that regulates the needle length and the secretion of the inner rod component EscI 
(Monjarás Feria et al., 2012). In addition, the secretion of both translocators and 
effectors are controlled by SepL (gatekeeper). SepL functions, together with SepD, to 
regulate the secretion hierarchy between translocators and effectors (Deng et al., 
2015). The stability and secretion of some LEE encoded T3SS proteins are mediated 
by LEE encoded chaperones. The LEE have genes encoding the translocator 
chaperones CesA, CesD and CesD2 (Creasey et al., 2003b) and the needle protein 
EscF chaperone EscE and EscG (Sal-Man et al., 2013). The T3SS must traverse both 
bacterial membranes and the peptidoglycan layer. This requires a dedicated 
peptidoglycan lytic enzyme, EtgA, to locally degrade peptidoglycan. EtgA also interacts 
with the T3SS inner rod component, EscI, and this interaction enhances PG-lytic 
activity of EtgA (Burkinshaw et al., 2015). 
 
1.4  EPEC LEE and non-LEE effector proteins  
Enteropathogenic Escherichia coli (EPEC) prototypic strain E2348/69 encodes at least 
21 putative effector proteins (Dean & Kenny, 2009, Iguchi et al., 2009). Seven effector 
proteins are LEE encoded (Tir, EspZ, EspF, Map, EspH, EspG, and the EspB 
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translocator protein), with other effector proteins encoded outside the LEE region, in 
prophages located elsewhere on the chromosome, and termed non-LEE encoded 
(Nle) effector proteins (Iguchi et al., 2009). 
1.5 EPEC LEE effector proteins 
1.5.1 Translocated intimin receptor (Tir) 
Tir is the first effector protein translocated into host cells via the T3SS where act as a 
receptor for outer bacterial membrane protein, Intimin (Kenny et al., 1997b, Mills et al., 
2008). Tir, a 550-amino-acid-protein, has a predicted molecular mass of 56.8kD but 
has an SDS/PAGE gel mobility of 78kD (Kenny et al., 1997b). Upon translocation to 
the host cells, Tir adopts a hairpin-loop conformation with two transmembrane domains 
(residues 234–259 and 353–382) (TMDs), resulting in a central extracellular domain 
(residues 260–352) containing the Intimin-binding domain (IBD) that serves as a 
binding site for Intimin with both N- (residues 1–233) and C-terminal (residues 383–
550) domains exposed to the cytoplasm (Figure 4) (Kenny et al., 1997b, de Grado et 
al., 1999, Kenny, 1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Interactions between the EPEC Intimin and Tir proteins. Intimin is localised in the 
bacterial outer membrane where the C-terminal fragment can bind Tir. Tir is inserted in the host 
plasma membrane with an extracellular intimin binding domain (IBD), that mediate intimin-Tir 
interaction, and the two N- and C-terminal regions are localised in the host cytoplasm. Adapted 
from (Luo et al., 2000). 
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1.5.1.1 Tir features and domains 
Tir facilitates different functions according to its domains. The N-terminal 233 amino 
acid of Tir interacts with numerous host proteins such as α-actinin, talin, and vinculin 
(Freeman et al., 2000). Recruitment of these proteins to the N-terminal of Tir might 
stabilise pedestal formation, influences pedestal length and thus binding of A/E 
pathogens to the host cytoskeleton (Campellone et al., 2006). The N-terminal region 
is also required for efficient delivery, with 26 amino acids containing a T3SS signal 
sequence and the first 100 amino-terminal residues of Tir function as a CesT-binding 
sequence that aids sufficient Tir delivery into the host cells (Crawford & Kaper, 2002). 
In addition, the N-terminal also possesses a polyproline region (PPR) that is essential 
for Tir’s subversive activities - recruits host tyrosine kinases to modify Tir residues and 
pedestal formation (Bommarius et al., 2007). By contrast, the carboxy terminus of Tir 
is targeted by host kinase-mediated phosphorylation events at defined serine and 
tyrosine residues including S434, S463, Y474, Y454, Y511 and Y483 (Figure 5) 
(Phillips et al., 2004); while the extracellular domain interacts with Intimin, which 
mediates intimate bacterial attachment, via binding Tir, to the host cells and production 
of actin-rich pedestals (Kenny, 1999). 
 
 
 
 
 
 
Figure 5: Schematic of EPEC translocated Intimin receptor Tir protein. Tir is 550aa protein with 
three domains. The N-terminal domain (1-233aa) by which Tir bind to the host proteins such as α-
actinin, talin, vinculin and cortactin. The N-terminal also possess a CesT binding sequence and 
Polyproline motif. The C-terminal domains (385-550aa) compromises residues linked to EPEC Tir’s 
subversive activities (S434, S463, Y454, Y474, arginine finger motif (518-521aa) and ITIM like motifs 
(Y483 and Y511), while the area between them (254-363aa) is critical for Tir interaction with intimin. 
Adapted from (Dean & Kenny, 2009).  
 
 
Chapter 1 Introduction 
9 
  
1.5.1.2 Tir phosphorylation and pedestal formation 
Following its delivery into the host cells, Tir acts as a substrate for host kinases, 
including protein kinase A (PKA), which phosphorylate Tir on two serine residues S434 
and S463 (Warawa & Kenny, 2001). This phosphorylation is linked to a conformational 
change in the Tir structure, which may promote insertion of Tir into the host plasma 
membrane, consequently causing an increase in Tir molecular mass by 5kD to the 
partially modified form (T’), which can be detected in the cytoplasm, followed by the 
second modification of a 2kD increase to the fully modified form (T”), which can be 
detected in the membrane on SDS-PA gels (Kenny & Warawa, 2001). Once Tir-serine 
residues (S434 and S463) are phosphorylated, Tir undergoes a tyrosine 
phosphorylation event on tyrosine residues Y474, which, while not correlating with any 
apparent increase in molecular mass, is critical for pedestal formation (Kenny, 1999). 
This phosphorylation is mediated by host tyrosine kinases (Fyn of the Src family 
member and Tec/Abl-family kinases) with sufficient role for Abl-family tyrosine kinases 
Abl1 and Abl2 (Figure 6) (Phillips et al., 2004, Swimm et al., 2004). Tyrosine 
phosphorylation of Tir on Y474 residue is essential for generating a binding site for the 
SH2 domain of the adapter protein Nck and other adapter proteins such as Grb2 and 
CrkII (Lai et al., 2013). This interaction is sufficient to trigger localised actin assembly 
by binding to the proline motifs of N-WASP (Wiskott Aldrich syndrome protein family 
members) and stimulating N-WASP to interact with actin-related protein (Arp2/3) and 
stimulate actin nucleation beneath attached bacteria (Figure 6) (Lai et al., 2013, 
Campellone et al., 2002, Rohatgi et al., 2001, Gruenheid et al., 2001). 
 
However,  in addition to Y474 (Kenny, 1999), Tir is also phosphorylated on residue 
Y454, although at lower efficiency, and induces pedestal formation in a Nck-
independent manner (Frankel & Phillips, 2008). Phosphorylation of Tir on 454 residue 
recruits phosphatidylinositol 3-kinase (PI3K) and prompts the transient accumulation 
of PI(3,4,5)P(3) below adherent EPEC (Sason et al., 2009). Phosphoinositides (PIs) 
are present in the the plasma membrane to modulate the activity of proteins involved 
in EPEC infection. They are required for EPEC adherence to the host cell surface and 
for the construction of the actin pedestal, and may influence host cell death during 
EPEC infection (Sason et al., 2009). Interestingly, during in vitro organ cultures (IVOC) 
EPEC infection, neither EPEC Tir tyrosine phosphorylation nor Tir:Nck signalling 
complexes are necessary for A/E lesion formation and N-WASP recruitment (Schuller 
et al., 2007). 
Chapter 1 Introduction 
10 
  
Tir also, within its C-terminal, encompasses two other tyrosine residues Y483 and 
Y511, which share sequence similarity with cellular immune-receptor tyrosine-based 
inhibition motifs (ITIM). Tir is phosphorylated within the ITIM motif, and recruits protein 
tyrosine phosphatases (SHPs) and subsequently regulates pedestal formation and 
inhibits immune responses (Yan et al., 2013, Smith et al., 2010). In addition, Tir also 
possesses a polyproline region (PPR) in its N-terminal that interact with SH3 domains 
of the kinases. This interaction is essential for pedestal formation. Phosphorylation of 
Tir on Y474 residue by tyrosine kinases leads to the additional recruitment of kinases 
by both PPR–SH3 and Y474–SH2 interactions; consequently, other Tir will be 
phosphorylated, as well as formation of actin pedestals (Bommarius et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Actin accumulation mechanism in EPEC. In EPEC, actin accumulation and pedestal 
formation can be either Nck dependent (tyrosine phosphorylation of Tir-Y474) or independent 
(tyrosine phosphorylation of Tir-Y454). Tyrosine phosphorylation of Tir (Y474 or Y454) within its C-
terminal by host kinases lead or not to recruit the adaptor protein Nck that activates N-WASP, which 
initiates actin polymerisation mediated by the Arp2/3 complex. Taken from (Campellone et al., 2006). 
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1.5.1.3 Tir–Intimin dependent and independent function  
Initially, Tir was believed to function only in an intimin-dependent manner, acting as a 
receptor for Intimin. Following its delivery into the host plasma membrane (Tir–intimin 
interaction), Tir triggers downstream signalling events leading to the formation of actin-
rich pedestals beneath the adherent bacteria in a Tir tyrosine phosphorylation 
dependent manner (Kenny et al., 1997b). Tir–Intimin interaction also aids bacterial 
sinking into the brush border, causing microvilli effacement and inactivation of sodium 
glucose co-transporter SGLT-1, which leads to the severe watery diarrhoea during 
EPEC infection (Kenny et al., 1997b, Dean et al., 2006). 
 
However, recent studies have illustrated the Tir independent functions of Intimin. Tir 
inhibits nuclear factor kappa B (NF-kB) activation, leading to a decreased expression 
of antimicrobial and inflammatory molecules (Ruchaud-Sparagano et al., 2011). 
Moreover, during EPEC infection, EspG/EspG2 promotes calpain activity whose 
function is to induce host cell detachment and cleavage of the host proteins. This 
function is regulated by Tir (Dean et al., 2010a). While Tir downregulates filopodia 
formation triggered by Mitochondrial associated protein (Map), both effector proteins 
stimulate invasion by synergistic mechanisms (Lai et al., 2013, Jepson et al., 2003). 
Down-regulating filopodia formation requires phosphorylation of a Tir tyrosine (Y474) 
residue and sequestering N-WASP from the Cdc42-GTP pathway by Nck (Tomasevic 
et al., 2007). Simultaneously, Tir also possesses a putative arginine finger motif, found 
in GTPase-activating proteins (GAPs), in its C-terminal domain; disrupting this motif 
impairs the ability of Tir to downregulate filopodia (Kenny et al., 2002b). 
 
 
1.5.2 EspZ  
EPEC secreted/signalling protein Z (EspZ) is a small (9kDa) protein consisting of 98 
amino acids and detected at high levels at an early post-infection time point 
comparable to the transmembrane intimin receptor (Tir) (Mills et al., 2008). EspZ is 
translocated by T3SS and predicted to be integrated in a hairpin-loop topology into the 
host cell plasma membrane (Figure 7) with two transmembrane domains and an 
extracellular loop responsible for EspZ activities (Kanack et al., 2005). EspZ localises 
to the pedestal-like structures induced by EPEC and to the mitochondria (Smith et al., 
2010, Kanack et al., 2005) and functions as a pro-survival effector to prevent rapid 
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death of cells during EPEC infection. The N-terminal consists of a translocation signal 
(20 amino acids) (Kanack et al., 2005), while an extracellular loop 10-amino-acid (from 
65 to 74) is critical for EspZ specific activities (Berger et al., 2012). Comparison of EspZ 
sequences from 12 different A/E pathogen strains revealed that EspZ is a 
hypervariable protein, particularly among the extracellular loop 10-amino-acid (Kanack 
et al., 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.5.3 EspF  
EPEC secreted/signalling protein F (EspF) is a 206-amino-acid-protein with several 
distinct functional domains (Figure 8) (Zhao et al., 2013). The N-terminal region 
(residues 1 to 20) is sufficient for EspF secretion and translocation into host cells. EspF 
N-terminal also possess a mitochondria targeting sequence (MTS; residues 13 to 17) 
by which EspF targets mitochondria, causing mitochondrial dysfunction and cell death 
(Nagai et al., 2005). In addition, EspF also targets the nucleolus by the nucleolar 
targeting sequence (residues 21 to 74), leading to the disruption of nucleolar factors 
(Dean et al., 2010b). By contrast, the C-terminal region of EspF (residue 74 to 206) 
(Figure 8) comprises the 3 proline-rich repeat (PRR) domains of 47 amino acids (Alto 
et al., 2007) by which EspF interacts with several host proteins including N-WASP and 
Figure 7: The topology of EPEC EspZ. EspZ integrates into the host cells membrane in the hairpin 
like structure with two transmembrane domains. The N and C termini of EspZ face the cytosolic leaflet 
of the plasma membrane and an extracellular domain plays an important role in the EspZ activity. 
Adapted from (Berger et al., 2012). 
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sorting nexin 9 (SNX9) to induce actin polymerization and membrane remodelling in 
the host cells (Alto et al., 2007). EspF plays an important role during EPEC infection, 
with several cellular processes linked to diarrhoea-related symptoms ascribed to the 
EspF. EspF downregulates sodium hydrogen exchanger 3 (NHE) activity, by which it 
contributes to diarrhoea (Hodges et al., 2008). Other cellular processes are also 
attributed to EspF, including prevention of bacterial uptake into macrophages by 
inhibiting PI-3 kinase, disruption of tight junctions (TJ), disruption of water reabsorption, 
microvilli effacement and elongation around the bacteria (Quitard et al., 2006, Elliott et 
al., 2002, Dean et al., 2006). 
 
 
 
1.5.4 Map 
Mitochondrial associated protein (Map) is a 203 amino acid protein with an N-terminal 
(44 residues) that encodes a mitochondrial-targeting sequence (Figure 9) by which 
Map targets a host mitochondria, leading to mitochondrial dysfunction (Kenny & 
Jepson, 2000, Papatheodorou et al., 2006). Map is a guanine nucleotide exchange 
factor (GEF) that possess WxxxE motif (74-78) at its N-terminal. This motif activates 
host Rho GTPase Cdc42 (cell division cycle 42) at the cell membrane, leading to the 
localised formation of filopodia during the early stages of EPEC infection (Wong et al., 
2012a). Filopodia structures are short-lived (retraction is Tir dependent) and have only 
Figure 8: Schematic of EPEC translocated effector protein (EspF). EspF is 206 amino acid 
protein with an N-terminal encodes a mitochondrial-targeting sequence and possess three proline-
rich repeat (PRR) domains of 47 amino acids within its C-terminal, that facilitate EspF interaction 
with several host proteins including N-WASP and sorting nexin 9 (SNX9). Taken from (Dean & 
Kenny, 2009). 
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been identified on cultured human cell lines, thus, the requirement of filopodia 
formation during infection is unknown (Kenny et al., 2002, Berger et al., 2009). In 
contrast, Map, at the carboxy-terminal, has a classical PDZ1-binding motif (TRL) 
(Figure 9) that interacts with ezrin/radixin/moesin (ERM)-binding phosphoprotein 50 
(EBP50), also known as scaffold protein sodium/hydrogen exchanger regulatory 
factor-1 (NHERF1), and this leads to stabilisation of filopodia. Moreover, Map also 
possesses a mitochondrial toxicity region at its C-terminal (residues 101–152) 
(Papatheodorou et al., 2006). Map also contributes to the maintenance of EPEC 
colonisation (Nguyen et al., 2015) and disrupts intestinal tight junctions, leading to the 
onset of diarrhoea (Singh & Aijaz, 2015). 
 
  
1.5.5 EspH 
EPEC secreted/signalling protein H (EspH) is a small protein of 20kDa that is delivered 
by the T3SS to localise at the host cell membrane (Tu et al., 2003). EspH functions as 
a RhoGEF inhibitor by binding to the DH-PH domain in RhoGEFs, leading to 
inactivation of mammalian RhoGEFs, and subsequently inducing changes in cell 
morphology, triggering cell detachment and inducing cytotoxicity (Wong et al., 2012a, 
Dong et al., 2010). However, bacteria replaced a mammalian RhoGEFs with a bacterial 
mimic mammalian RhoGEFs (Map), and translocating bacterial RhoGEFs (Map) to the 
host cells leads to neutralisation of EspH associated phenotypes, which induces cell 
adhesion and survival (Wong et al., 2012a). EspH also plays a critical role in EPEC 
Figure 9: Schematic of mitochondrial associated protein (Map). Map is 203 amino acid protein 
with an N-terminal encodes a mitochondrial-targeting sequence and possess WxxxE motif (74-78) 
that activate host The Rho GTPase Cdc42. While its C-terminal possess has a classical PDZ1-
binding motif to facilitate its interaction with ezrin and a regulatory factor-1 (NHERF1). Taken from 
(Dean & Kenny, 2009). 
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resisting macrophage phagocytosis by its ability to bind and inhibit DH-PH domain-
containing Rho GEFs (Dong et al., 2010). EspH plays a critical role for efficient 
pedestal formation and pedestal elongation. It promotes N-WASP recruitment and 
Arp2/3 to the bacterial attachment site in Tir tyrosine residues Y474 and Y454 
independent manner (Wong et al., 2012a). Whereas deletion of EspH leads to a short 
pedestal and improved filopodia formation, over-expression of EspH leads to pedestal 
elongation (Tu et al., 2003). 
 
1.5.6 EspG 
EPEC secreted/signalling protein G (EspG), previously named rorf2, is a 398-amino-
acid protein that is secreted and translocated via T3SS into the host cells (Elliott et al., 
2001). It is encoded in the LEE region while its homologous Orf3 (EspG2) is encoded 
on the EspC pathogenicity islet. EspG shows 21% identity of amino acids with the 
Shigella flexneri effector VirA, which has been shown to trigger the destabilization of 
host microtubule (Elliott et al., 2001). EspG interacts with tubulins and stimulates 
microtubule destabilization, consequently leading to activation of microtubule-bound 
GEF-H1 (RhoA-specific guanine nucleotide exchange factor), resulting in the formation 
of actin stress fibres (Matsuzawa et al., 2004). Recently, it was reported to act as a 
scaffolding protein and a regulator of GTPase signalling (Selyunin et al., 2011). EspG 
interacts with master regulators of membrane trafficking (ARF and RAB1), leading to 
inactivation of ARF GTPase and disruption of endoplasmic reticulum to Golgi trafficking 
(Selyunin et al., 2014). 
 
 
1.6 Intimin 
An outer bacterial membrane protein, Intimin is expressed on the EPEC cell surface, 
but not delivered by bacterial T3SS, to form a major adhesin of enteropathogenic 
Escherichia coli (EPEC). It is a 94kDa protein (939 amino acids) encoded by the eae 
gene located in the LEE pathogenicity island (Frankel et al., 1998b). Intimin possesses 
two functional regions, with the N-terminal region (residues 1–550) containing a signal 
peptide region that is responsible for its secretion to the bacterial surface and 
mediating its binding to the peptidoglycan (Leo et al., 2015, McWilliams & Torres, 
2014). In contrast, Intimin uses the 280 amino acids of the C-terminal domain (Int280α) 
to mediate an intimate interaction with translocated intimin receptor (Tir) (Figure 10) 
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(Fairman et al., 2012). Int280α comprises four globular domains (D1, D2, D3 and D4) 
extending from the bacterium with two immunoglobulin-like domains and a C-type 
lectin-like domain responsible for cell-surface carbohydrate recognition and Tir-
independent cell binding (Kelly et al., 1999, Hartland et al., 1999). Additionally, Intimin–
Tir interaction is required for intimate interaction to the infected host cells and pedestal 
formation in a Tir tyrosine phosphorylation dependent manner, as well as for triggering 
tyrosine phosphorylation of phospholipase C-gamma1 (PLC-gamma1) (Kenny & 
Finlay, 1997). Moreover, Intimin also has additional host cell receptors, including β1 
integrin and nucleolin (Frankel et al., 1996, Sinclair et al., 2006). Interaction of Intimin 
with these receptors (β1 integrin and nucleolin) may help Intimin to control the barrier-
disrupting activities of Map and EspF independently of Tir (Dean & Kenny, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: The model of Intimin topology and binding to Tir. The Intimin extracellular carboxy-
terminal domain (Int280α) comprises three immunoglobulin domains (D1, D2 and D3) with a terminal 
C-type lectin cell-binding domain (D4). Intimin binds the extracellular Intimin binding domain of Tir 
(IBA). Taken from (Frankel et al., 2001). 
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1.7 Non-LEE encoded effectors 
Non-LEE effector proteins (NLe) are encoded by genes located outside the LEE 
region, in prophages and integrative elements, and clustered in six pathogenicity 
islands (PP2, PP4, PP6, IE2, IE5 and IE6) (Figure 11) (Creuzburg & Schmidt, 2007). 
In EPEC (strain E2348/69) around 24 non-LEE putative effectors were identified and 
translocated by the LEE encoded T3SS (Dean & Kenny, 2009, Iguchi et al., 2009, 
Deng et al., 2004b). The non-LEE effector proteins function to inhibit phagocytosis and 
activate the innate immune response, and some effectors play a role in colonisation 
and virulence (Wong et al., 2011). During infection, EPEC translocates the non-LEE 
protein, NleB, into the host cells to activate the transcriptional regulator NF-kappaB 
(NF-κB). In contrast, NleC, NleH1/NleH2, NleE and NleA inhibit the activation of NF-
κB (Kim et al., 2007, Yen et al., 2015). While EspJ is reported to inhibit phagocytosis, 
NleB and LifA promote bacterial colonisation of the host cells and NleD promotes 
barrier disruption and loss of barrier function (Pearson et al., 2013, Marches et al., 
2008, Long et al., 2014). Recently, EspL has been proven to inhibit cell death and 
inflammation (Pearson et al., 2017). 
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1.8  EPEC chaperones 
Most T3SS substrates rely on chaperones to aid their stability and/or efficient secretion 
and translocation (Thomas et al., 2005). The type III chaperones are usually small (15-
20kDa), acidic and remain within the bacterial cytoplasm even after trafficking a paired 
protein into an infected host cell (Ramu, 2013). They are grouped into class I (bind 
effectors), class II (bind translocators) or class III (bind needle-forming) proteins. Class 
I is subdivided, on the basis of the number of effectors that the chaperone binds, into 
Figure 11: The EPEC non-LEE effectors encoded in the prophages and integrative elements. 24 
non-LEE predicted effector genes were identified and clustered in six pathogenicity islands (PP2, PP4, 
PP6, IE2, IE5 and IE6). Arrows refer to the genes and strand direction, while different colours refer to  
housekeeping genes (purple), effector genes (blue), virulence genes (green), hypothetical genes 
(orang), prophage-like transposase genes (red) and pseudogenes (gray). Taken from (Dean & Kenny, 
2009) 
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class IA (binds one effector) and class IB (binds multiple effectors). EPEC LEE 
encodes eight different chaperones, CesF, CesL, CesT, CesAB, CesD, CesD2, EscE, 
and EscG/CesA2. EPEC has a class IA (CesF for EspF) and class IB (CesT for >10 
effector proteins) with several class II chaperones (CesB/D and CesAB that both aid 
EspB secretion) and class III chaperones (EscE, and EscG) (Ramu et al., 2013, 
Wainwright & Kaper, 1998, Creasey et al., 2003b, Sal-Man et al., 2013). 
 
CesT, with 156 amino acids, is a multi-cargo class IB chaperone that interacts with 
more than 10 LEE and non-LEE effectors including Tir, Map, EspH, and EspZ (Thomas 
et al., 2005). The N-terminal of CesT is implicated in chaperone dimerization, whereas 
the C-terminal region of CesT is important for CesT dependent effector translocation 
into host cells (Ramu et al., 2013). CesF is a class IA chaperone that interacts with 
EspF to aid EspF stability and translocation into the host cells (Elliott et al., 2002). 
Crucially, CeL, (previously named Orf12/ multiple point controller “Mpc”) a 117-amino-
acid EPEC LEE encoded protein, is classified as a class IA chaperone for an aberrant 
effector SepL (Younis et al., 2010). CesL also interacts with Ler (regulator of LEE gene 
expression), with over-expression of CesL leads to modulation of Ler activation activity 
(Tsai et al., 2006). 
 
EPEC class II chaperones are composed of three chaperones, CesD, CesD2 and 
CesAB. CesD, a 17.5-kDa protein, functions as a chaperone for the EPEC 
translocators, EspD and EspB. CesD interacts with EspD, but not with EspB, and is 
required for sufficient EspD secretion (Wainwright & Kaper, 1998). CesD2 is another 
EspD chaperone that also interacts with EspD and aids its stability and secretion 
(Neves et al., 2003). By contrast, EspA has two chaperones CesAB and CesA2 
(formerly Orf29, renamed EscG in EPEC) that prevent premature oligomerization of 
EspA and assist in its stabilisation in the cytoplasm (Creasey et al., 2003b, Su et al., 
2008). Finally, EscE and EscG/CesA2, an EPEC class III chaperone, function as 
chaperones for the needle protein, EscF. EscE and EscG chaperones interact with 
EscF and prevent premature polymerization of the needle (Sal-Man et al., 2013). 
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1.9  EPEC proteins secretion and regulation 
The EPEC LEE and non-LEE encoded proteins are secreted and translocated into host 
cells, with Tir being the first effector to be translocated, followed by EspZ, NleA, NleH1, 
EspF, EspH, NleH2, EspJ, Map, EspG, NleD, NleF, NleB1, NleE1, NleB2, NleC, NleG, 
NleE2, EspG2, and EspL2 (Mills et al., 2013). The EPEC proteins secretion is induced 
in response to many environmental conditions, with 37 °C an optimal temperature, and 
other factors such as pH, osmolarity, calcium, iron and salt concentrations also critical 
(Kenny et al., 1997a). The EPEC proteins are also hierarchically secreted via different 
mechanisms, which is important for effectors’ function stages (Mills et al., 2013, Deng 
et al., 2017). 
 
1.9.1 Hierarchical control of EPEC proteins secretion 
The hierarchical secretion of EPEC proteins is regulated by two T3SS specificity-
switching mechanisms that are known as molecular switches (Deane et al., 2010). 
Molecular switch one, from the needle to the translocators, starts when the needle 
reaches its proper length, which is regulated by EscP and EscU (Monjaras Feria et al., 
2012). Once the needle has reached the final length, EscP interacts with the C-terminal 
domain of EscU, leading to a conformational change that regulates the switching event 
from needle to the translocators (Monjaras Feria et al., 2012). Recently, EscP has been 
shown to interact with the gatekeeper protein SepL to generate EscP-SepL complex 
(Shaulov et al., 2017). Once bacterial contact with the host cells is made and calcium 
concentration was dropped, EscP-SepL complex is dissociated, triggering the 
secretion of effector proteins (Shaulov et al., 2017). 
 
The second molecular switch from the translocators to the effectors is regulated by a 
family of proteins known as gatekeepers (SepL and SepD), which prevent effector 
secretion before host cell contact. SepL interacts with SepD, and deletion of either 
SepL or SepD results in decreased secretion of the translocators and enhanced 
secretion of effectors (Deng et al., 2015). SepL is thought to interact with EscV, 
resulting in blocking of the access of effectors to the secretion apparatus (Lee et al., 
2014). However, this interaction might be disrupted by low calcium concentration, 
leading to an increase in translocators’ secretion (Lee et al., 2014). In addition, the 
SepL-SepD complex also interacts with a SepL chaperone (CesL) and regulates the 
secretion hierarchy in response to pH changes (Yu et al., 2010). Once pores are 
formed in the host cell membrane, pH is increased and transmitted to the T3SS base, 
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resulting in disrupted SepL/SepD/CesL interaction and consequently allowing 
secretion of effectors (Yu et al., 2010). Furthermore, SepL binds to the effector protein 
Tir and delays its secretion while the translocators are secreted (Wang et al., 2008). 
Recently, SepD and SepL have been shown to regulate secretion hierarchy between 
translocators and effectors by recognising EspB (translocator) export signals (Deng et 
al., 2015). 
 
1.9.2 Substrate–chaperone binding regulates T3SS secretion 
Each effector protein has a chaperone recognition site (50–100 amino acids) and a 
secretion signal sequence located in the N-terminal (first 20 amino acids), and together 
these are necessary and sufficient for targeting effector proteins to the T3SS sorting 
platform and may also contribute to secretion hierarchy (Deng et al., 2015). CesT 
targets effectors to the T3SS by interacting with a component of the T3SS sorting 
platform, ATPase EscN, and is implicated in coordinating hierarchical effector 
secretion (Thomas et al., 2007, Gauthier & Finlay, 2003). CesAB, the EPEC EspA 
chaperone, interacts with the EscN ATPase following CesAB-EspA binding. 
Interestingly, prevention of the interaction between EscN and the CesAB-EspA 
complex resulted in severe secretion (Chen et al., 2013). 
 
  
1.10 Bacterial protein pore-forming and insertion 
Pathogenic bacteria have evolved proteins that can undergo transitions from soluble 
to membrane-inserted forms (Pedelacq et al., 1999). Pore-forming proteins (PFPs) are 
produced in a soluble monomeric form that can assemble into oligomeric complexes 
with the capacity to insert into membranes (Iacovache et al., 2010). The PFT families 
are either multi domain or multi subunit proteins and called AB toxins, where the B 
subunit is responsible for binding to the host cells and forming transmembrane pores 
to translocate the A subunit into the cytoplasm to the target organelle (Reig & van der 
Goot, 2006). PFTs form transmembrane pores via insertion of a generated 
transmembrane β-barrel (β-PFTs) or by inserting a bundle of hydrophobic or 
amphipathic α-helices of PFTs into the membrane (Peraro & van der Goot, 2016, 
Parker & Feil, 2005). PFTs bind to specific receptors (sugars, lipids or proteins) on the 
target cell, leading to an increase in the local concentration and oligomerization of 
PFTs. Thus, exposure of hydrophobic surfaces leads to membrane insertion. In 
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addition, charged bacterial membranes and acidic residues with low pH promote the 
membrane insertion by making some PFTs more hydrophobic, unfolding or inducing a 
conformational change (Peraro & van der Goot, 2016, Parker & Feil, 2005). 
The pore-forming colicins, a class of antibiotics produced by various strains of E. coli 
(Lakey & Slatin, 2001),  consist of a hydrophobic helical hairpin that initiates insertion 
into the lipid bilayer in the colicin umbrella-like model (Figure 12), in which this helical 
hairpin pair leads insertion of the toxin into target membranes followed by spontaneous 
insertion of the entire hairpin (Parker et al.). In contrast, the diphtheria pore-forming 
protein insertion mechanism is dependent on a conformational change triggered by a 
low pH and accompanied by increasing hydrophobicity of the toxin and the ability to 
form ion channels, reviewed in (Peraro & van der Goot, 2016) 
In addition, EPEC translocator protein EspD, Salmonella SipB and IpaB from Shigella 
(Hume et al., 2003, Dasanayake et al., 2011) share approximately the same features 
and insertion mechanism. These proteins contain the amphipathic domains spanning 
residues that are critical for binding to membrane lipid bilayers in pH dependet manner. 
Low pH leads to a conformational change correlated with increasing the α-helix content 
of this protein and promoting insertion into the hydrophobic core of the lipid bilayer. In 
addition, phosphatidylserine is also critical for the incorporation of the E. coli bacterial 
receptor protein Tir (Race et al., 2006) and a Pseudomonas aruginosa, PopD (Faudry 
et al., 2006) into the host cell membrane. However, while SipB, a virulence factor from 
Salmonella, inserts into the membrane and penetrates through the outer leaflet of 
membranes to translocate a 50-residue hydrophilic domain across the bilayer, Tir 
interacts and penetrates through the inner leaflet of the plasma membrane (Race et 
al., 2006). 
 
 
 
 
 
Figure 12: The pore-forming mechanism. (a) The protein form a helical hairpin pair. (b) Followed 
by umbrella conformation with spontaneous insertion. (c) Formation of the channel. Taken from 
(Parker & Feil, 2005). 
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1.11 Manipulation of host cell functions by EPEC effector proteins 
1.11.1 EPEC effector proteins induce watery diarrhoea 
EPEC infection is correlated with severe watery diarrhoea, particularly in under-
developed countries (Dutta et al., 2013, Levine & Edelman, 1984). Although the 
mechanism by which EPEC causes watery diarrhoea is unclear, EPEC disrupts 
enterocyte cellular and barrier functions with alteration in ion transport (Figure 13). 
 
 
 
 
 
 
 
 
 
EPEC induced diarrhoea is dependent on the effacement of absorptive microvilli and 
reduction in the absorptive capacity of enterocytes (Hodges & Gill, 2010). This requires 
bacterial adherence to the brush border membrane with cooperative actions of three 
LEE encoded effectors (Map, EspF & Tir) and the outer membrane protein Intimin 
(Dean et al., 2006). EPEC has been shown to rapidly inactivate sodium-D-glucose 
transporter (SGLT-1), which is responsible for fluid uptake from the normal small 
intestine, in a T3SS dependent manner with a critical role for Map, EspF, Tir effectors, 
and Intimin (Figure 13) (Dean et al., 2006, Meinild et al., 1998). Since water moves to 
high salt concentration areas, changes in ion absorption or secretion leads to diarrhoea 
(Hodges & Gill, 2010). EPEC infection alters the activity of intestinal absorption via Na 
Figure 13: EPEC alters ion transport and induce watery diarrhoea. EPEC infection induced 
diarrhoea via different mechanisms and all depend on T3SS effectors. EPEC induce rapid 
Na+/glucose (SGLT1) inactivation in pathway dependent on a loss of microvilli, a process that is 
dependent on Map, EspF, Tir effector proteins and Intimin. EPEC infection also inhibits Na+/H+ 
exchangers (NHEs), a process dependent on EspF effector protein. In addition, EPEC altars the Na+ 
uptake and Cl− secretion by injecting effector proteins EspG and EspG2. These effectors disrupt 
microtubules, preventing protein trafficking, thus reducing DRA expression at the membrane. Taken 
from (Viswanathan et al., 2009). 
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(+)/H (+) exchanger (NHE), resulting in the inhibition of the uptake of sodium ions (Na+) 
from the gut lumen with an alteration in the Cl− secretion (Hodges et al., 2008). 
Crucially, EPEC EspF effector protein is shown to be responsible for induced inhibition 
of NHE activity (Figure 13) (Hodges et al., 2008). Parallel to EPEC mediated inhibition 
of NHE3, EPEC also mediates a decrease in the expression of major apical anion 
exchanger DRA (SLC26A3), resulting in inhibition of the Cl(-)/OH(-) exchange activity 
(Gill et al., 2007). This EPEC effect is attributed to the T3SS dependent effector 
proteins EspG and EspG2 (Figure 13) (Gill et al., 2007). 
Tight junctions are formed between adjacent enterocytes to hinder the movement of 
membrane components (Hartsock & Nelson, 2008). However, disruption of the tight 
junction influences diarrhoea through unregulated movement of ions, fluids and 
antigens between cells (Abreu, 2010). The ability of EPEC to disrupt the tight junction 
barrier is dependent on the T3SS and the translocated effector proteins EspF, Map 
and NleA (Thanabalasuriar et al., 2010, Shifflett et al., 2005). While EspF is responsible 
for redistributing the transmembrane protein, occludin, NleA inhibits the host cell 
protein trafficking (Thanabalasuriar et al., 2010, Shifflett et al., 2005).  
 
1.11.2  EPEC effectors regulate host cell survival 
Programmed cell death occurs either as a normal mechanism to maintain cell 
populations in tissues or as a defence mechanism during infection (Fink & Cookson, 
2005). The programed cell death results from stimulation of specific signalling 
pathways, and can be divided into lytic (necrosis and pyroptosis) and non-
lytic (Apoptosis) cell death (Jorgensen et al., 2017).  
 
The apoptotic, non-lytic cell death, is induced via extrinsic or intrinsic pathways (Rudel 
et al., 2010), and characterised by cell shrinkage, membrane blebbing or nuclear 
condensation (Figure 14) (Lamkanfi & Dixit, 2010). Apoptosis can be balanced by 
effector(s) with anti-apoptotic activity that neutralise the effects of other, pro-apoptotic 
effectors, and promote cell survival, as reviewed in (Santos & Finlay, 2015). Indeed, 
EPEC infection is not correlated with a late apoptotic phenotype, suggesting it has the 
ability to antagonize host apoptosis during infection (Crane et al., 2001). The ability of 
EPEC to interfere with host apoptotic pathways depends on the T3SS apparatus to 
deliver effector proteins into host cells. Some of these effector proteins promote cell 
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death, while others inhibit cell death by suppressing either an extrinsic or an intrinsic 
apoptotic pathway (Rudel et al., 2010). EPEC, within its surface structure’s “bundle-
forming pili”, induces the extrinsic pathway of apoptosis by stimulating the 
transmembrane death receptors such as tumor necrosis factor (TNF), Fas ligand and 
TNF-related apoptosis-inducing ligand (TRAIL) (Abul-Milh et al., 2001, Peter & 
Krammer, 2003, Strasser et al., 2000). However, the non-LEE effector proteins NleD, 
NleB1 and NleB2 suppress extrinsic apoptosis (Baruch et al., 2011, Pearson et al., 
2013).  
 
 
 
 
In contrast, the intrinsic apoptotic pathway is triggered by intracellular stresses, leading 
to the permeabilization of the outer mitochondrial membrane (MOMP). The MOMP, 
which is formed by Bcl-2 family members Bak or Bax, leads to the release  of 
cytochrome c, activation of caspase-9, caspase-3 and subsequently cell death (Rudel 
et al., 2010). EPEC also trigger intrinsic apoptotic pathways via the EspF, Map and Cif 
effector proteins. EspF and Map effector proteins have a mitochondrial-targeting 
sequence through which both target a host mitochondrion and induce mitochondrial 
lysis, leading to cytochrome c release, caspase activation and intrinsic apoptosis 
(Nagai et al., 2005, Kenny & Jepson, 2000). While the cycle inhibitory factor (Cif) does 
not target the mitochondria, it induces cell cycle arrest and subsequently a delayed 
form of apoptosis in infected cells (Samba-Louaka et al., 2009). In addition, intrinsic 
Figure 14: Programmed Cell Death Modes. Programmed cell death can be either apoptosis, 
necrosis or pyroptosis. While apoptosis is characterised by the retention of plasma membrane 
integrity. In contrast, both necrosis and pyroptosis are characterised by the release of cytoplasmic 
content into the extracellular space. Apoptosis and pyroptosis are characteristic by nuclear 
condensation and DNA fragmentation, whereas the nuclei of necrotic cells swell along with other 
organelles. Taken from (Lamkanfi & Dixit, 2010). 
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apoptosis is also induced via a RhoGEF inhibitor, EspH (Wong et al., 2012b). Over-
expression of EspH activates the caspase-3 in the infected epithelial cells, which can 
be inhibited by bacterial RhoGEF mimics EspT and EspM2 (Wong et al., 2012b). 
 
The intrinsic pathway can be prevented via the anti-apoptotic activity of non-LEE 
effector proteins NleH1 and NleH2, which inhibit pro-caspase-3 cleavage at the 
bacterial attachment site (Hemrajani et al., 2010). Comparably, while the non-LEE 
effector protein, NleF, prevents both intrinsic and extrinsic apoptotic pathways by 
inhibiting caspases-4, -8 and -9  (Blasche et al., 2013), EspZ, an EPEC LEE effector 
protein, inhibits intrinsic apoptosis, promotes host survival and prevents rapid death of 
cells during EPEC infection (Shames et al., 2010). 
 
Pyroptosis is a lytic cell death mode that is characterized by cytoplasmic swelling, 
plasma membrane permeabilization and release of the intracellular components into 
the extracellular space (Figure 14) (Fink & Cookson, 2005).  Pyroptosis is initiated by 
caspase 1 or caspase 11, which are activated by inflammasomes (Lamkanfi & Dixit, 
2009, Martinon et al., 2002). The inflammasome consists of cytosolic sensors such as 
the nucleotide-binding oligomerization domain-like receptors, known as NOD-like 
receptors (NLRs), which detect cytosolic contamination by the T3SS needle, bacterial 
flagellin or toxin (Lamkanfi & Dixit, 2009). Once caspase 1 is activated, it cleaves pro-
interleuken-1β and IL-18 into their mature forms (Lamkanfi & Dixit, 2009) and also 
cleaves gasdermin D (Shi et al., 2015), a member of the enigmatic gasdermin protein 
family. The cleavage of gasdermin D releases the N-terminal domain which moves to 
plasma membrane and induces the formation of a membrane pore and pyroptosis (Qiu 
et al., 2017).  
 
Necrosis is another mode of cell death that results in a similar cellular morphology to 
pyropsis (Figure 14), including cell lysis which leads to the loss of intracellular contents 
into the extracellular space (Vanden Berghe et al., 2010). Bacterial infection leads to 
the stimulation of the serine/threonine kinase receptor interacting protein (RIP1 & 
RIP3) activities, which are required for tumor necrosis factor (TNF)-induced 
necroptosis. RIP1 kinase binds to death receptors such as TNF receptor 1 (TNFR1), 
Fas, and tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAILR1) 
(Schutze et al., 2008). It is also recruited to the Fas-associated death domain protein 
(FADD), resulting in the activation of calpain, an increase in reactive oxygen species 
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(ROS) production and lysosomal membrane permeabilization that thus induces 
necrosis(Hitomi et al., 2008, Declercq et al., 2009). 
 
1.11.3  EPEC effectors manipulate inflammatory signalling pathways 
Intestinal epithelial cells possess pattern recognition receptors (PRRs), including  toll-
like receptors (TLRs), that detect of bacterial stimuli on apical and basolateral surfaces 
of epithelial cells (Girardin et al., 2002, Peterson & Artis, 2014). This lead to activate 
inflammatory signalling pathways such as nuclear factor-κB (NF-κB) and mitogen-
activated protein kinase (MAPK) pathways, leading to regulation of the production of 
cytokines such as IL8, tumour necrosis factor-α (TNF-α) and mediation of host defence 
(Figure 15) (Peterson & Artis, 2014, Neurath et al., 1998).  
 
EPEC is able to manipulate host innate immune defences, prior to the disruption of 
barrier function, by the action of several T3SS-dependent secreted effector proteins. 
Tir is the first T3SS dependent effector translocated into host cells during EPEC 
infection and is implicated in the suppression of NF-κB activation (Ruchaud-Sparagano 
et al., 2011, Mills et al., 2008). Tir interacts with TNF receptor-associated factor (TRAF) 
and inhibits NF-κB activation (Ruchaud-Sparagano et al., 2011). Tir possesses ITIMs 
like motifs (Y483 and Y511) at its C-terminal region by which Tir recruits the regulatory 
protein tyrosine phosphatase SHP-2, enhancing their inhibitory associations with 
TRAF6, resulting in suppression of host cytokine production and prevention of 
downstream NF-κB activation (Figure 15) (Yan et al., 2013). In addition, while the non-
LEE effector proteins NleE and NleB prevent activation of IκB  kinase (IKKβ) and 
consequently the degradation of the NF-κB inhibitor, IκB (Nadler et al., 2010), NleH1 
and NleH2 inhibit the nuclear translocation of NF-κB gene transcription via binding to 
ribosomal protein S3 (RPS3) of NF-κB complexes, thus preventing transcription of pro-
inflammatory genes (Figure 15) (Gao et al., 2009). NleC, a zinc metalloprotease, is 
localised to the cytoplasm beneath infecting bacteria and to the nucleus of infected 
cells and possesses zinc metalloprotease activity (Yen et al., 2010). The NleC cleaves 
the p65 subunit (NF-κB heterodimer subunit), resulting in inhibition of translocation of 
NF-κB to the nucleus and disruption to NF-κB signalling (Figure 15) (Yen et al., 
2010). In contrast, NleD, a zinc metalloprotease, cleaves the MAPK signalling pathway 
components, thus preventing activation of the transcriptional activator of pro-
inflammatory cytokine production factor (Baruch et al., 2011). 
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Figure 15: EPEC effectors inhibit NF-κB activation in the intestinal epithelial cells. EPEC 
effector Tir promotes SHP1/2 interaction with TRAF6, resulting in inhibition of NF-κB induced 
inflammation. While NleE methylates TAB2/3, inhibiting TAK1 activation, NleB glycosylates GAPDH, 
preventing its activation of TRAF2. NleH1 binds to ribosomal protein S3 (RPS3), inhibiting the nuclear 
translocation of the NF-κB complex, while NleH2 promotes RPS3 nuclear translocation. NleC inhibits 
the signalling pathways through the cleavage of host proteins p65 subunit of NF-κB. NleC also 
cleaves p300, an acetyltransferase that promotes p65 activity. (EPEC effectors are highlighted in 
red). Taken from (Santos & Finlay, 2015, Cozzone, 2005). 
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1.12 Project aims 
Enteropathogenic E. coli (EPEC) deliver 24 known T3SS dependent effector proteins 
into host cells (Dean & Kenny, 2009, Iguchi et al., 2009, Deng et al., 2004b). Seven of 
them are encoded in the LEE region with one, Tir, acting as a receptor for the 
pathogen, and another, EspZ, functioning as an anti-cytotoxic factor (Kenny et al., 
1997b, Shames et al., 2010). The mechanisms by which Tir is inserted into the host 
cells membrane and EspZ protects against cell death are slowly being unravelled. 
Thus, the project aims are to examine the possible role for LEE encoded factor(s) in 
the modification of Tir to the T” form; its insertion into the membranes of host cells; and 
to investigate the mechanism by which EPEC EspZ protects against EPEC triggered 
cell death. Moreover, this project also will focus on the Edwardsiella tarda (E.tarda) 
type III secretion system as a useful model to investigate the functionality of T3SS 
components. 
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2.1  Cell culture  
2.1.1 Mammalian cell culture  
The human cervical epithelial cancer cell line (HeLa cells; American Type Culture 
Collection ATCC® CCL-2™) was retrieved from liquid nitrogen stocks for growth in 
Dulbecco’s minimal Eagles medium (DMEM, high glucose; Sigma Cat #D5796) 
supplemented with 10% foetal bovine serum (FBS, Lonza Bio Whittaker, Fisher 
Scientific) lacking antimicrobial or antifungal agents. All cell culture processing was 
performed in a Class II laminar flow hood (Bio-Mat 2). Hela cells were routinely 
passaged in 75 cm2 tissue culture flasks (Corning) and incubated (37°C; 5% CO2) to 
~80-90% confluence before passaging (1:6 dilution) into a new flask. Passaging 
involved washing cells twice with sterile phosphate buffered saline (PBS; 137 mM 
sodium chloride [NaCl], 2.7 mM potassium chloride [KCl], 10 mM disodium phosphate 
and 1.8 mM monopotassium phosphate; pH7.4; Sigma Cat #P5368) before adding 
trypsin (1 x Trypsin-EDTA [ethylenediamineacetic acid]; Sigma Cat #T4174) to detach 
cells and resuspending in DMEM/FCS culture media (prewarmed to 370C) and 
transferring a sixth to a fresh flask. Frozen stocks were generated by adding a 
cryoprotectant (DMSO; Sigma Cat #D2650) to a final 10% concentration in a 
DMEM/FCS/cells suspension (~106 cells/ml) with slow freezing in -80°C freezer before 
transferring to liquid nitrogen. A test stock culture was thawed out to confirm viability. 
2.1.2 Bacterial strains and mammalian cells 
Bacterial strains used are listed in the Table1A-D. Bacteria stocks were stored at -80˚C 
(adding 50% glycerol to final 10% to Luria-Bertani (LB) grown cultures) and, when 
appropriate, streaked onto LB agar plates supplemented with appropriate antibiotics. 
Antibiotics used at final concentration of 50, 25, 100, 25, 12 and 25 μg/ml for Nalidixic 
acid (Nal), Kanamycin (Km), Carbenicillin (Cb), Chloramphenicol (Cm), Tetracycline 
(Tet) and Streptomycin (Step) respectively. Single colonies were used to inoculate LB 
broth - supplemented with selective antibiotic(s) when appropriate – for overnight 
incubation (~16h) at 30 or 37°C with (for molecular biology) or without (for infection 
studies) shaking.  
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Table 1A Strains derived from EPEC E2348/69 (Kenny Lab stock)  
 
 Bacterial Strain 
         
                     Description 
 
 
Antibiotic 
 
            Source 
Wild-type (WT) EPEC 
E2348/69 (0127:H6) 
NalR variant of Prototypical EPEC strain E2348/69 NalR  (Levine et al., 1985) 
espZ mutant Lacks the espZ gene. KmR Kenny Lab (S Quitard) 
cfm14    T3SS-deficient; Transposon in escN  KmR (Donnenberg & Kaper, 1991) 
eae Lacks the Intimin gene NalR Kenny Lab (B Kenny) 
espB (UMD864)  Effector-delivery system deficient NalR (Taylor et al., 1998) 
espA (UMD872)  Effector-delivery system deficient NalR/KmR (Kenny et al., 1996b) 
espD (UMD870) Effector-delivery system deficient NalR/KmR  (Lai et al., 1997) 
escD T3SS-deficient NalR This study 
cesTKm  Lacks CesT effector chaperone  Nal
R/KmR Kenny Lab (B Kenny) 
sepL T3SS-deficient StrepR (Monjaras Feria et al., 2012) 
escK T3SS-deficient StrepR (Soto et al., 2017) 
escL T3SS-deficient StrepR (Soto et al., 2017) 
escP T3SS-deficient StrepR (Monjaras Feria et al., 2012) 
espDB 
 
Lacks EspD and EspB; thus non-functional 
effector-delivery system  
NalR/KmR Kenny Lab (B Kenny) 
espAB Lacks EspA and EspB thus non-functional 
effector-delivery system 
NalR/KmR Kenny Lab (B Kenny) 
mzKm Lacks Map & EspZ  Nal
R/KmR Kenny Lab (S Quitard) 
fzKm Lacks EspF & EspZ  Nal
R/KmR Kenny Lab (S Quitard) 
hzKm Lacks EspH & EspZ  Nal
R/KmR Kenny Lab (S Quitard) 
goz  Lacks EspG, Orf3/EspG2 & EspZ  NalR/KmR Kenny Lab (S Quitard) 
zt(full) Lacks EspZ & Tir (missing residues 1-550) Nal
R This study 
tb  Lacks Tir & EspB and thus non-functional T3SS NalR This study 
ezKm  Lacks Intimin & EspZ  Nal
R/KmR Kenny Lab (S Quitard) 
etzKm Lacks Intimin, Tir & EspZ Nal
R/KmR Kenny Lab (S Quitard) 
mezKm Lacks Map, Intimin & EspZ Nal
R/KmR Kenny Lab (S Quitard) 
mtzKm Lacks Map, Tir & EspZ  Nal
R/KmR Kenny Lab (S Quitard) 
mfzKm Lacks Map, EspF & EspZ  Nal
R/KmR Kenny Lab (S Quitard) 
ftzKm Lacks EspF, Tir & EspZ  Nal
R/KmR Kenny Lab (S Quitard) 
mfezKm Lacks Map, EspF, EspZ and Intimin Nal
R/KmR Kenny Lab (S Quitard) 
etmzKm Lacks Intimin, Tir, Map & EspZ  Nal
R/KmR Kenny Lab (S Quitard) 
etfzKm Lacks Intimin, Tir, EspF & EspZ  Nal
R/KmR Kenny Lab (S Quitard) 
fzKme Lacks EspF, EspZ and Intimin  Nal
R/KmR This study 
tmfzKm Lacks Map, EspF, EspZ & Tir  Nal
R/KmR Kenny Lab (S Quitard) 
mfzKmgo3 Lacks Map, EspF, EspZ EspG & Orf3/EspG2  Nal
R/KmR Kenny Lab (S Quitard) 
mfz(81)go3 As mfzKmgo3 but EspZKm is swapped with EspZ(81) 
that is missing 81 of 98 residues 
NalR This study 
mfz(81)go3e As mfz(81)go3 but also lacks Intimin (outer 
membrane protein) 
NalR This study 
mfz(81)go3ehKm As mfz(81)go3e but also lacks EspH (marked by 
Km-encoding gene) 
NalR/KmR This study 
mfz(81)go3hKm As mfz(81)go3 but lacks EspH (marked by Km-
encoding gene) 
NalR/KmR This study 
mfz(81)go3ehKmb As mfz(81)go3ehKm but also lacks EspB and thus 
non-functional T3SS  
NalR/KmR This study 
mfz(Km)go3t(full) Lacks Map, EspF, EspZ, EspG, Orf3/EspG2 & Tir Nal
R This study 
∆go3core Lacks EspG & Orf3/EspG2 & core region NalR Kenny Lab (S Quitard) 
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Table 1B Strains derived from EPEC E2348/69 (Japan & Rosenshine Lab stock) 
 
Bacterial Strain 
 
           
         Description 
 
 
Antibiotic 
 
    Source 
TOEA7 EPEC E2348/69 (NalS) lacks LEE EspG effector &14 Nle   None (Yen et al., 2010) 
TOEA7/pTet As TOEA7 with pTet plasmid TetR This study 
TOEA7-f/pTet As TOEA7/pTet but lacks EspF TetR This study 
TOEA7-fz/pTet As TOEA7/pTet but lacks EspF & EspZ TetR This study 
TOEA7-fzm/pTet As TOEA7/pTet but lacks EspF, EspZ & Map TetR This study 
TOEA7∆fzmhKm/pTet As TOEA7/pTet but lacks EspF, EspZ, Map & EspH TetR/KmR This study 
TOEA7-fzmt(full)/pTet As TOEA7/pTet but lacks EspF, EspZ, Map & Tir Tet
R This study 
TOEA7-fzme/pTet As TOEA7/pTet but lacks EspF, EspZ, Map & Intimin TetR This study 
TOEA7-fzmehKm /pTet As TOEA7/pTet but lacks EspF, EspZ, Map, Intimin & EspH  Tet
R/KmR This study 
TOEA7-fzmthKm /pTet As TOEA7/pTet but lacks EspF, EspZ, Map, Tir & EspH Tet
R/KmR This study 
TOEA7-fzmthKme /pTet As TOEA7/pTet but lacks EspF, EspZ, Map, Tir, EspH & 
Intimin 
TetR/KmR This study 
TOEA7-b/pTet As TOEA7/pTet but lacks EspB, thus non-functional T3SS TetR This study 
TOEA7-fzmehKmb/pTet As TOEA7-fzmehKm/pTet but lacks EspB and thus non-
functional T3SS 
TetR/KmR This study 
TOEA7ΔcoreKm /pTet As TOEA7/pTet but lacks LEE ‘core’ region  TetR/KmR This study 
Ler Lacks EPEC E2348/69 Ler protein (master positive 
regulator of LEE gene expression) 
KmR (Mellies et al., 
2007) 
 
Table 1C: Non-EPEC pathogens  
 
Bacterial Strain 
 
         
                Description 
 
  
Antibiotic 
 
  Source 
Yersinia pseudo-
tuberculosis YIII+ 
Lack genes for most known T3SS Yop effectors  KmR/CmR (Hakansson et al., 1996) 
Yersinia enterocolitica 
MRS40(pIML421) 
Lack genes for most known T3SS Yop effectors  NalR (Cornelis et al., 1986) 
Edwardsiella tarda 
(E.tarda) 
fish pathogen carrying LEE region that is  
homologous to the EPEC LEE region 
None (Nakamura et al., 2013) 
 
Table 1D: Non-pathogenic K12 E.coli with or without EPEC factor 
 
 
Bacterial Strain 
 
         
                            Description 
 
 
Antibiotic 
 
  Source 
DH10B   Non-pathogenic E. coli K12.  None Thermo Fisher 
Scientific 
SM10 λpir  E.coli SM10 (λpir strain) contains the λpir gene allows 
replication of R6K ori-based suicide plasmids. 
KmR (Donnenberg & Kaper, 
1991) 
TOB01  
 
Non-pathogenic E. coli K12 carrying pTOK-01 plasmid 
encoding bfp and perABC operons. Also has pTOK-02 
(no insert).  
KmR/CmR 
 
 (Yen et al., 2010) 
 
TOBO2   
 
As per TOBO1 but LEE (from EPEC B171) region on 
pTOK-02 plasmid.  
KmR/CmR 
 
(Yen et al., 2010) 
SIEC 
 
Pili/Fimbrin adhesin-deficient K12 (non-pathogenic) 
E.coli with EPEC LEE1, LEE2, LEE3 & LEE4 operons 
integrated in chromosome (IPTG inducible)  
None (Ruano-Gallego et al., 
2015) 
SIEC-LEE5 As SIEC but also has LEE5 operon None (Ruano-Gallego et al., 
2015) 
SIEC∆p1-LEE5 As SIEC-LEE5 but  lacks promoter to drive expression of 
T3SS components needed for the effector-delivery 
process 
None (Ruano-Gallego et al., 
2015) 
SIEC-LEE5∆cesTKm As SIEC-LEE5 but lacks a functional CesT gene KmR This study 
 
Table 1A-D: Bacterial strains used in these studies providing a brief description, antibiotic 
selection profile and source. (Km) indicates that associated disrupted gene carries genes 
encoding kanamycin resistance with (full) indicating that the entire gene – ATG to stop codon -has 
been disrupted, while (81) indicates that 81 of 98 EspZ residues are missing. Core refers to that the 
loss of LEE region genes encoding the EspH, CesF, Map, Tir, CesT and Intimin protein. 
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2.2  Molecular biology  
2.2.1 Polymerase chain reaction (PCR) and agarose gel electrophoresis  
Polymerase chain reaction was performed to support strain genotype or amplify genes 
for cloning or DNA sequencing. Oligonucleotide primers (listed in Table 2) were 
designed using Sigma Life Science program (http://www.sigmaaldrich.com/catalog/ 
product/sigma/ oligo?lang=en&region=GB) and obtained from (Sigma-Aldrich-UK). For 
cloning, oligos were designed to amplify genes with extensions to provide restriction 
enzyme site or complemented sequence to the vector region as recommended by 
Gibson assembly protocol (Gibson et al., 2009). Taq DNA polymerase (New England 
Bio-labs: #M0273L) was used for PCR screening programs while Q5 Hot start high-
fidelity DNA polymerase (New England Bio-labs; Cat #M0493S) was used for cloning 
and sequencing. Standard PCR reactions (25 μl) were prepared by mixing the required 
components (New England Bio-labs) listed in Table 3. For DNA amplification a 
Thermo-cycling PCR run under conditions given in Table 4. The PCR products were 
mixed (ratio 1:9) with 10x ficoll gel loading dye (100 mM EDTA, 1.0% SDS, 0.25% 
bromophenol blue, 0.25% xylene cyanol) and analysed, alongside 1 Kb 2 log DNA 
ladder (New England Bio-labs; Cat #N3200S), on 0.7-1% TAE (40 mM Tris-acetate, 1 
mM EDTA) agarose (MELFORD; #MB1200). The fluorescent nucleic acid stain 
GelRedTM (Biotium; used 1:25,000) was added to the agarose with gel electrophoresis 
in TAE buffer at 100 volts with stained DNA visualised via a UV transilluminator (Bio-
Rad).  
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1 EP-espA FP    GATAACGAGCAGAGGAGTAATAC 
2 EP-espA RP   CAGACCTCACAGACTGGATATCG 
3 EP-espZ FP    GCCTATGGGATAATTTGG 
4 EP-espZ RP   GCATCCATTACCTCTC 
5 EP-eae FP CATTCTAACTCATTGTGGTGG 
6 EP-eae RP CTAGCTAGAGACTTGATTACC 
7 EP-map FP GTGCTGGAGGAAAAGTTCTG 
8 EP-map RP CAGCGCAGTAAGTTTCC 
9 EP-espB FP GATGTCTGATTCTGCGCGAG 
10 EP-espB RP CACTGCCACAAAGAAACTC 
11 EP-espH FP CCCTTTGGCAACCGTAAAGC 
12 EP-espH RP AAATATCGTCCCCAGAACAG 
13 EP-espF FP ATGGAATTAGTAACGCTGCTTCTACAC 
14 EP-espF RP TTGGTTACCCTTTCTTCGATTGCTCATAG 
15 EP-espG FP ACAAAAACTATGGCTGACGCATCAC 
16 EP-espG RP TTCAGCGCATGACATCTCATCCCAG 
17 EP-espG2/orf3 FP TAGGTATAACCCTATGCCTGTGTTC 
18 EP-espG2/orf3 RP AACAAATTCAGGCTGACACAGTACC 
19 EP-escD FP CCATTAGCCATTGGAAACTCACG 
20 EP-escD RP    CGTCGCTAGTATCATTACCC 
21 EP-escP FP    CGAACAAAAGAGAATCTGC 
22 EP-escP RP    GGTTCCGATAACTGGCAAC 
23 EP-sepL FP    GGAAGCTGTTGTACAGTAC 
24 EP-sepL RP GGAGATTGCAATAATATCCG 
25 EP-escK FP GCCAATCAACAATGAATCAACG 
26 EP-escK RP CCTCTGGTATGATATCTTC 
27 EP-escL FP CCTTTATGGACCATAGTC 
28 EP-escL RP    GCCAATGGTCATTAATTGAG 
29 EP-cesT FP GCTCTAGACAACGTTGCAGCATGGGTAA 
30 EP-cesT RP    GCGAATTCTCATGTTTGGGCTCCACCAC 
31 ET-tir FP  CGAGATCTGATCGCGAGGATTATG 
32 ET-tir RP GCTCTAGATACTAAGGTGACGTTAC          
33 ET-escD FR CGGGATCCGGCTGCATTGATTATTGC 
34 ET-escD RP GCGTCGACCCGTTGGTTGTGTCAGG 
35 ET-gto FP CGGATATCGATCGCGAGGATTATG 
36 ET-gto RP    AAGTCGACGTTTGCCCAGCATAAG 
37 ET-espB FP    CGGGATCCGGCAATGATCTGGTTCG 
38 ET-espB RP GCGTCGACCTCATCGCCATCAAGTC 
39 ET-espD-G FP CACACCCGTCCTGTGGCAATACCGAACGATTTC 
40 ET-espD-G RP TCTCAAGGGCATCGGGATACCTGACGCGTTATTC 
41 EP-tir-G FP CACACCCGTCCTGTGGGAACGTGTCAAATTTCTAAATAAAAG 
42 EP-tir-G RP TCTCAAGGGCATCGGAGTTACCCATGCTGCAAC 
43 ET-espA-G FP GCGACCACACCCGTCCTGTGCAGATGTTATAGATAGAGACTCG 
43 ET-espA-G RP   AAGGCTCTCAAGGGCATCGGCCAACGGAGGATATAGTTAAATTAG 
44 ET-espADB FP AAGGCTCTCAAGGGCATCGGCCAACGGAGGATATAGTTAAATTAG 
45 ET-espADB RP TCTCAAGGGCATCGGCATGGCGAAGATGATATCC 
46 ET-eae-G FP GCGACCACACCCGTCCTGTGCTGCGCGTTAGCTACGTG 
47 ET-eae-G RP AAGGCTCTCAAGGGCATCGGGTTACTAACACAAGACAGAATGGC 
48 ET-cesT-G FP GACCACACCCGTCCTGTGCGCCAATTAATATCTCGC 
49 ET-cesT-G RP AAGGCTCTCAAGGGCATCGGGGAATCAGCTTACTATCTTGG 
50 ET-tir-G FP GCGACCACACCCGTCCTGTGCATACTGTATGATCATGGTTG 
51 ET-tir-G RP AAGGCTCTCAAGGGCATCGGGCGAGATATTAATTGGCG 
52 ET-ler-G FP GCGACCACACCCGTCCTGTGCGAGAAGTCCATACATTAG 
53 ET-ler-G RP AAGGCTCTCAAGGGCATCGGGTTCAGATGTCGACTGTTC 
54 EP-espBmid-G FP GCCGGGCCTCTTGCGGGATAATCTAGACGCGCTCTATTGGTACAAC 
55 EP-espBmid-G RP ACGATGCGTCCGGCGTAGAGTTGAGCTCCTTAATACCCGAAAAGTG 
56 ET-escP FP   GCGACCACACCCGTCCTGTGTAACTCACTAACGGAAG 
57 ET-escP RP AAGGCTCTCAAGGGCATCGGCAACCAAATCGATTACAACC 
58 ET-escL FP GCGACCACACCCGTCCTGTGCGTTGCCCAGACTATTTG 
59 ET-escL RP   AAGGCTCTCAAGGGCATCGGGGCTGACTTCCTATAGATATAAG 
60 ET-escK FP GCGACCACACCCGTCCTGTGCATGGTTATCAACATGGAGAG 
61 ET-escK RP   AAGGCTCTCAAGGGCATCGGGATCTCACTGGCGCTTAAG 
62 ET-sepL FR GCGACCACACCCGTCCTGTGCTGAGTGCGCTTGTACAG 
63 ET-sepL RP AAGGCTCTCAAGGGCATCGGCTAGGGTACCGTCTACCTG 
64 ET-eae FP CAACGGTAATGCGTGATGG (Used for sequencing eae gene) 
65 ET-eae RP CGTATAAGAGGCCGTTTGTC (Used for sequencing eae gene) 
66 EP-escD FP GATGAAGAATCCGGGGCTAC (Used for sequencing escD gene) 
67 EP-escD RP    CGTCGCTAGTATCATTACCC (Used for sequencing escD gene) 
     
  
Table 2: List of primers that is used in this study. 
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A)     Component     25µl reaction        Final Concentration 
10X  Taq reaction buffer 1 µl         1x Taq reaction buffer 
10 mM  dNTPs 0.5 µl           200 μM dNTPs 
10 µM forward primer 0.5 µl           0.2 μM 
10 µM reverse primer 0.5 µl           0.2 μM 
Template bacterial DNA    1 µl           variable 
Taq DNA polymerase  0.125 µl           0.625 units 
dH2O     Up to 25 µl   
 
 
 
 
 
                  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
B)      Component    25µl reaction         Final Concentration 
  
Q5 reaction buffer 5 µl          1x reaction buffer 
10 mM  dNTPs 0.5 µl           200 μM dNTPs 
10 µM forward primer 0.5 µl           0.2 μM 
10 µM reverse primer 0.5 µl           0.2 μM 
Template bacterial DNA 1 µl           variable 
Q5 Hot start high-fidelity 
DNA polymerase 
0.25 µl           0.02 units/µl 
dH2O Up to 25 µl   
A)    Step      Cycles Temperature and Time 
           Initial denaturation 1 95
o
C for 30 seconds 
           Denaturation 
           Annealing 
           Extension 
  
  
30 
  
95
o
C for 30 seconds 
                          53-63
o
C for 1 min 
                          68
o
C for 1 min/kb 
Final Extension 1                           68
o
C for 2 min 
B)     Step Cycles        Temperature and Time 
  
Initial denaturation 1                98
o
C for 30 seconds 
Denaturation 
Annealing 
Extension 
  
  
30 
  
               98
o
C for 10 seconds 
               53-68
o
C for 30 seconds 
               72
o
C for 30-60 seconds 
Final Extension 1                72
o
C for 2 min 
Table 3: Standard PCR reaction mixture using   A) Taq DNA polymerase or B) Q5 
Hot start high fidelity DNA polymerase. Note, template bacterial DNA was either 
extracted plasmid or obtained from bacteria by resuspending a bacterial colony in 60μL 
sterile water and incubation at 100°C for 5 min, using 1µl was in PCR reactions. 
 
 
Table 4: Standard PCR reaction condition. A) Taq DNA polymerase and B) Q5 
Hot start high-fidelity DNA polymerase. Annealing temp is predicted by sigma 
software 
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2.2.2 Plasmid extraction  
To isolate DNA plasmid, the appropriate strain was inoculated into 5-10 ml LB broth, 
with appropriate antibiotic(s), for overnight growth at 37°C with shaking (~250 rpm). 
Bacteria were harvested by centrifugation (11752 xg; 3 min; room temperature [RT]) 
and supernatant discarded. Plasmids were extracted using the Mini plasmid 
purification kit (Thermo Scientific; Cat # K0503), following the recommended protocol. 
DNA plasmid concentration was determined (A260 reading) using Nano-Drop 1000 
spectrophotometer (Lab-tech) and were typically 0.1-0.2µg/µl.  
 
2.2.3 DNA sequencing  
To determine the DNA sequence, the target gene was PCR amplified using Q5 Hot 
start high-fidelity DNA polymerase (New England Bio-labs; Cat #M0493S) with an 
appropriate primer (Table 2). PCR products were then cleaned-up using GenElute™ 
PCR Clean-Up Kit (Sigma Cat #NA 1020-1KT) following the recommended protocol. 
DNA concentration was determined (A260 reading) using Nano-Drop 100 
spectrophotometer (Lab-tech) prior to sending along with primers for sequencing 
(Source Bioscience, Cambridge, UK). Comparative analysis of resulting sequences 
with native gene sequence was performed by pairwise alignments programme 
(http://www.ebi.ac.uk/Tools/psa/emboss_needle/). 
 
2.2.4 Preparation of electrocompetent cells  
Strains were grown in LB, with appropriate antibiotic(s) at 37oC, unless otherwise 
indicated, at 225-250 rpm overnight (~16-18h). Bacterial cultures were diluted 1:100 
into 100 mL fresh LB broth medium, containing selective antibiotic(s) when 
appropriate, for growth (37oC shaking) until reached optical density (OD600) of 0.6-0.7. 
Bacterial cultures were cooled down on ice (gentle shaking) prior to centrifugation 
(12,000 xg for 15 mins at 4oC). The resulting pellet was washed with ice cold sterile 
water (50 mL) and centrifuged under the same conditions prior to an additional repeat 
wash and centrifuge. The resulting bacterial pellet was resuspended in sterile ice-cold 
15% glycerol (25 mL) and centrifuged using the same conditions. Finally, the pellet 
was resuspended in sterile ice-cold 15% glycerol (0.5 mL) and divided into 40 µL 
aliquots for immediate use or snap frozen (liquid nitrogen) for storage at -800C. 
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2.2.5  Electroporation of bacterial cells 
10-100 ng of DNA solution (isolated plasmid or ligation mix-Table 5) was added to a 
freshly made or thawed (on ice) 40 μl aliquots of  electrocompetent bacterial cells for 
5 min prior to transferring to an ice-cold 2 mm-gap electroporation cuvette (Cell 
projects; Cat #EP-102) and electroporating (2KV, 200Ω, 25mF for  4-5µs) using a 
GenePulser II (BioRad). 1ml of pre-warmed (37°C) SOC media (2% tryptone, 0.5% 
yeast extract, 10mM sodium chloride [NaCl], 2.5 mM potassium chloride [KCl], 10 mM 
magnesium chloride [MgCl2] and 10 mM magnesium sulfate [MgSO4] pH=7) was 
gently added immediately with cells incubated for 1h at the appropriate temperature; 
routinely 37oC. 10, 100 and 890 µL of bacterial cell suspension was routinely plated 
onto LB agar plates containing appropriate antibiotic(s) and incubated overnight (16-
20h) at an appropriate temperature. Single colonies were streaked to single colonies 
on fresh selective agar plates and screened for introduction of required gene by 
colony PCR and the verified correct colony was grown overnight in 3 ml LB broth, 
with selective antibiotic(s), for use to prepare frozen glycerol stocks (see Section 
2.2.4). 
 
2.2.6  Transformation of bacteria using heat-shock procedure 
Frozen chemical competent bacteria K12, NEB® Turbo Competent E. coli (High 
Efficiency; New England Bio-labs; Cat #C2984H), were thawed on ice for 10 min prior 
to adding ~5 to 100 ng (2 -5µ l )  of plasmid DNA (Table  5)  to 25 µL aliquots, mixed 
gently, and kept on ice for 30 min. The bacteria were then heat-shocked at 42°C for 
30 seconds followed by immediate incubation on ice for a further 5 min.  Pre-warmed 
37°C of SOC medium (950 µl) was added to the cells, gently mix, and cells were 
incubated at 37°C with 225-250 rpm shaking for 60 min prior to plating 50 and 450 
µL onto LB agar containing the appropriate selective antibiotic(s). The plates then were 
incubated overnight at 37 ºC with single colonies screened for introducing of plasmids 
by PCR. The verified correct colony was grown overnight in 3 ml LB broth, with 
selective antibiotic(s), for use to prepare frozen glycerol stocks (see Section 2.2.4). 
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       Plasmid 
               
                       Description 
 
Antibiotic 
     
         Reference  
pCR-2.1 Cloning vector CbR Invitrogen 
pACYC184 Cloning vector CmR/TetR (Chang & Cohen, 1978) 
pTet pACYC184 with Cm gene inactivated TetR Kenny Lab (B Kenny) 
pAC-LacZ-3’gtoe pACYC184 expressing Tir, CesT and Intimin  TetR Kenny Lab (B Kenny) 
pSK-espH::HA pACYC184 expressing EspH::HA fusion protein  CmR Kenny Lab (B Kenny) 
pSK-espZ::HA pSK expressing EspZ::HA fusion protein  CbR Kenny Lab (S Quitard) 
pSK-map::HA pSK expressing for Map as a Map::HA fusion 
protein 
CbR (Dean et al., 2013) 
pACYC-espB pACYC184 expressing EspB CmR Kenny Lab (S Quitard) 
pBR-espF pBR expressing EspF  CbR (Nagai et al., 2005) 
pACYC-eae pACYC184 expressing Intimin  CmR Kenny Lab (S Quitard) 
pACYC-cesT pACYC184 expressing CesT chaperone CmR Kenny Lab (S Quitard) 
pTrc-escL pTrc expressing EscL CbR (Soto et al., 2017) 
pTrc-escP pTrc expressing EscP CbR (Monjaras Feria et al., 
2012) 
pTrc-sepL pTrc expressing SepL CbR (Monjaras Feria et al., 
2012) 
pET-escK pET expressing EscK CbR (Soto et al., 2017) 
 
pGEM-espBmid 
pGEM vector expressing EspB lacking myosin 
binding area (AA 159 to 218) 
CmR (Iizumi et al., 2007) 
pACYC-espBmid pACYC184 expressing for EspB lacking myosin 
binding area (AA 159 to 218) 
CmR This study 
pSK-3’gtHAo pSK expressing Tir (as a Tir::HA fusion protein) 
and CesT  
CbR Kenny Lab (S Quitard) 
pACYC- espAEt pACYC184 carrying EspA from E.tarda Cm
R This study 
pACYC- espDEt pACYC184 carrying EspD from E.tarda Cm
R This study 
pACYC-espBEt pACYC184 carrying EspB from E.tarda  Cm
R This study 
pACYC- espADBEt pACYC184 carrying EspA, EspB & EspD from 
E.tarda 
CmR This study 
pACYC-escDEt pACYC184 carrying EscD from E.tarda  Cm
R This study 
pACYC-lerEt pACYC184 carrying Ler from E.tarda  Cm
R This study 
pACYC-eaeEt pACYC184 carrying Intimin from E.tarda  Cm
R This study 
pSK-tirEt::HA pSK expressing Tir from E.tarda as a Tir::HA 
fusion 
CbR This study 
pACYC-tirEt::HA pACYC184 carrying Tir from E.tarda as a Tir::HA 
fusion 
CmR This study 
pACYC-gtoEt pACYC184 carrying Tir from E.tarda and its 
chaperone, CesT 
CmR This study 
pACYC-cesTEt pACYC184 carrying CesT from E.tarda  Cm
R This study 
pACYC-sepLEt pACYC184 carrying SepL from E.tarda  Cm
R This study 
pACYC-escKEt pACYC184 carrying EscK from E.tarda  Cm
R This study 
pACYC-escPEt pACYC184 carrying EscP from E.tarda  Cm
R This study 
pACYC-EscLEt pACYC184 carrying EscL from E.tarda  Cm
R This study 
pSK-map pSK expressing Map  CbR (Kenny & Jepson, 2000) 
pSK-map(ATG-TAG) E78A pSK expressing Map carrying a E78A substitution  Cb
R (Dean et al., 2013)  
pSK-map(TAA-TAG) ∆TRL pSK expressing Map lacking final 3 residues, TRL CbR (Dean et al., 2013) 
 
pSK-3'g5't-∆MTS-map 
pSK expressing a Tir::Map fusion protein (Tir 
residues 1-101; Map residue 41-206) Map 
mitochondria targeting sequence (MTS) swapped 
with the N-terminal of Tir 
CbR (Dean et al., 2013) 
pACYC-3’gtHAo pACYC184 expressing Tir (as Tir::HA fusion) and 
CesT 
CmR Kenny Lab (B Kenny) 
unpublished  
pACYC-3’gtHAinto pACYC184 expressing Tir (with HA tag within 
Intimin binding domain) and CesT 
CmR Kenny Lab (B Kenny) 
Unpublished 
pACYC-tirEPEC pACYC184 carrying Tir Cm
R This study 
 
pACYC-tir-∆SY 
pACYC184 expressing Tir carrying S434A; 
S463A, Y454F; Y474F substitutions  
 
CmR 
  
(Kenny, 1999) 
 
 
Table 5: plasmids used in this study. Given a brief description of the plasmids and/or cloned gene 
product alongside with antibiotic selection and source.  
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2.2.7  Construction of EPEC gene knockout mutants 
Gene knockouts were carried out as previous described (Donnenberg & Kaper, 1991) 
with available suicide vectors (see Table 6). Briefly, provided SM10 λpir (KmR) strains 
carrying the appropriate, usually pCVD422-based (CbR), suicide vector (Table 6) which 
is carrying the disrupted gene, was co-incubated with the recipient EPEC (NalR) strain 
on LB plate overnight at 37oC. This lead to transfer, via conjugation, the suicide vector 
to the recipient EPEC (NalR) strain. Next day, cells within several confluent areas of 
the plate were scrapped off into LB broth contains Nal antibiotic and grown to stationary 
phase before plating onto NalR/CbR plates selected for transconjugants. The specified 
single colony was then inoculate into LB broth with appropriate recipient strain selected 
antibiotic (NalR) and grown to stationary phase before plating on LB containing 5% 
sucrose and Nal antibiotic for 16-20h at 30oC. Growth in the absence of CbR selection 
provided an opportunity for a double cross-over event to remove the gene duplication, 
While plating on Nal plates containing 5% sucrose leads to kill cells carrying the suicide 
vector which carries a sacB gene and select for strains lacking the suicide vector which 
can’t be maintained without λpir functions. Single colonies were picked and screened 
for antibiotic resistance (grow on Nal but not Cb or Km plates). PCR analysis was used 
to determine the presence of intact or disrupted gene.  
 
 
Suicide Plasmid 
                
               Description 
 
Antibiotic  
 
            Source 
 
pCVD442-espZ(81) Carries disrupted espZ gene (lacks 81 of 
98 residues) 
CbR Kenny Lab (S Quitard) 
pCVD442-espHKm Carries disrupted espH gene  Cb
R/KmR Kenny Lab (S Quitard) 
pCVD442-espF Carries disrupted espF gene CbR (Warawa et al., 1999) 
pCVD442-tirfull Carries disrupted tir gene Cb
R (Kenny et al., 1997b) 
pCVD442-cesTKm Carries disrupted cesT gene Cb
R Kenny Lab (S Quitard) 
pCVD442-map Carries disrupted map gene CbR (Kenny & Jepson, 2000) 
pCVD442-espB Carries disrupted espB gene CbR (Foubister et al., 1994) 
pCVD442-eae Carries disrupted eae gene CbR (Donnenberg & Kaper, 1991) 
pCVD442-escD Carries disrupted escD gene CbR (Ogino et al., 2006) 
pKNG101-core For deleting LEE core region   StrepR (Ruchaud-Sparagano et al., 2007) 
pCACTUS-espBmid Delete and swap EspB with EspB-mid Cm
R (Iizumi et al., 2007) 
 
 
Table 6: Suicide vectors used in studies with a brief description, antibiotic resistance profile 
and source reference. (Km) indicated that associated disrupted gene carries genes encoding 
kanamycin resistance with (full) indicating that the entire gene – ATG to stop codon -has been 
disrupted, while (81) indicated that the 81 of 98 EspZ residues is missing. Core refers to that the 
core region that has genes encoding EspH, CesF, Map, Tir, CesT and Intimin, has been deleted. 
Mid refers to that the plasmid expressing for EspB protein that missing the myosin binding area 
(residues from 159aa to 218aa). 
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2.2.8 Plasmid construction  
2.2.8.1 TA cloning  
The TA cloning kit (Invitrogen; Cat #45-0046) was used to insert PCR products directly 
into the kit provided pCR.2.1 plasmid. However, the PCR product can insert in either 
orientation so the gene was amplified with restriction enzyme cleaving sites introduced 
into the oligonucleotides [introduced via PCR amplification] (Table 2). Once cloned to 
the TA vector (pCR-2.1), gene was digested using flanking unique restriction enzyme 
sites for introduction into the destination expression vector that was digested with the 
appropriate restriction enzymes. For example, Edwardsiella tarda (E. tarda) genes 
were amplified with oligonucleotides (carrying BamHI/SalI or EcoRV/SalI restriction 
sites Table 2) using E. tarda genomic DNA, kindly provided by Dr Yoji Nakamura, as a 
template for Q5 Hot start high-fidelity DNA polymerase (New England Bio-labs; Cat 
#M0493S) and described (Section 2.1) PCR conditions. The reaction was then placed 
on ice and 1 unit of Taq polymerase (New England Bio-labs: #M0273L) was added, 
mixed and incubated at 72°C for 10 minutes to add a single deoxyadenosine (A) to the 
3´ ends. PCR reactions were analysed on agarose gels (usually 1% TAE agarose [see 
section 2.1] to confirm success and estimate DNA concentration. Appropriately 2 µl 
(50 ng; 20 fmoles) of pCR-2.1 vector and 1-2 µl (~57 ng; 60 fmoles) of insert were 
added together for ligation (ratio 1:3) in a total volume 10 µl with 1 µl T4 DNA ligase 
(Invitrogen; Cat # 15224-017), as described by provider, and incubated 16-18 hrs at 
14°C prior to transforming 2-3 µl to NEB® Turbo Competent E. coli (High Efficiency) 
competent cells (New England Bio-labs; Cat #C2984H) as described (see Section 
2.2.6). Bacterial suspension were plated on LB plate containing Carbenicillin (Cb) and 
50 µL of 50 mg/mL X-Gal (5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside) 
(Promega; Cat #V3941), and incubated 16-20 h at 37oC. White colonies were PCR 
screened for presence of an appropriated insert.  
 
2.2.8.2 Generation of pACYC-espBET; -escDET and -tir_cesTET vectors 
Cloned inserts were released from the pCR.2.1 recombinant plasmid by digesting with 
appropriate restriction enzymes (see above) for fragment isolation and cloning into 
pACYC184 pre-digested with the same restriction enzymes. Briefly, the plasmids were 
digested with two enzymes (BamHI/SalI or EcoRV/SalI [New England Bio-labs]) and 
vector/insert fragments isolated (gel extraction Kit [Thermo Scientific Cat #K0691]) 
following manufacturer’s instruction for ligation (3:1 insert to vector ratio), following 
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manufacturer’s instruction, in total 20 µl volume adding 0.1unit T4 DNA ligase 
(Invitrogen; Cat # 15224-017) and incubated overnight at room temperature. The 
product then was introduced into Turbo Competent E. coli cells as described above 
(see Section 2.2.6). Bacterial colonies that grew on chloramphenicol agar plates were 
PCR screened to confirm presence of cloned gene.  
 
2.2.8.3 Gibson Assembly Cloning 
Some genes were cloned using the Gibson Assembly Cloning Kit (New England Bio-
labs; Cat #E2621S) which uses recombination to introduce PCR-amplified DNA 
fragments. This process requires the generation of oligos with 20 bp extensions that 
correspond to the vector insertion site (Gibson et al., 2009). Briefly, the recipient vector, 
for example pACYC184, was pre-digested with BamHI and SalI restriction enzymes 
and gel purified (see above) while the insert with PCR amplified (Q5 Hot start high-
fidelity DNA polymerase [New England Bio-labs; Cat #M0493S]), with appropriate 
oligonucleotide primer sets designed using NEBuilder Assembly construction tool 
(http://nebuilder.neb.com/). The concentration of PCR product and isolated vector 
were determined (Nano-Drop 100 spectrophotometer [Lab-tech]), following 
manufacturer’s instruction, for addition to Gibson assembly master mix (New England 
Bio-labs; Cat #E2621S), at a ratio 2:1 [25 ng of vector 2-3 µl + 12 ng of insert 1-2 µl + 
Mix 5 µl and deionized H2O to the 10 µl total volume and incubated 12-16 hr at 50oC]. 
Turbo Competent E. coli cells were transformed with 2-5 µl of the reaction mix and 
processed as described (Section 2.2.6) with PCR screening of colonies for those with 
the cloned insert. 
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2.3  Bacterial infection  
2.3.1  Hela cells infection 
HeLa cells were seeded 48 hours prior to experimentation to obtain 80-90% confluency 
on day of infection. Bacterial cultures (in LB containing, when needed, appropriate 
antibiotics) were grown overnight without shaking at 37ºC or, for Yersinia strains, 28ºC. 
The Optical Density (OD) was measured at 600nm (UV1101- Biotech photometer; a 
value of 1 = 1 x 109 bacteria) with mammalian cells infected at a Multiplicity of Infection 
(MOI) of 40:1 - bacteria to host cells - unless otherwise indicated. Infections usually 
used LB grown bacteria but sometime bacteria were diluted (1/10) into serum free 
DMEM (supplemented, when needed, with antibiotic) for 2-3h, before measuring the 
OD. The infections time is varied (see text and legends), but were undertaken at 37ºC 
in a humidified 5% CO2 atmosphere, unless otherwise indicated. In some experiments, 
infected cells were washed (37ºC PBS) and incubated with DMEM containing 
gentamysin (100μg/ml) for 1h to kill extracellular bacteria prior to PBS washing and 
infecting with a second-wave of bacteria. Following infection cells were placed on ice 
and washed twice with ice cold PBS [0.01M phosphate buffer saline (0.138 M NaCl; 
0.0027 M KCl, pH 7.4 Sigma Cat #P5368)] and processing as given below. 
  
2.3.2 Isolation of cellular protein fractions  
The protocol was similar to that described in previous publications from the Kenny 
laboratory, for example see (Kenny & Warawa, 2001, Kenny & Finlay, 1997). Briefly, 
ice cold Triton lysis buffer (1% v/v Triton X100 in 50mM PBS [pH 7.5] containing 0.4 
mM NaVO4, 1 mM NaF, and 0.1 mM phenylmethylsulfonyl fluoride [PMSF; Sigma 
P7626], and protease cocktail [Sigma Cat #P-8340; 1:100 dilution]) was added prior to 
scraping cells with a rubber policeman (SARSTEDT Cat #83.1830) and transferring to 
1.5 ml tubes for incubation on ice 5min. The samples were then centrifuged (5 min; 
11752×g; 4°C) and the soluble fraction (contains host cytoplasm and membrane 
proteins plus delivered effector proteins) transferred to a fresh ice cold tube prior to 
adding 5X Laemmli sample buffer (60 mM Tris-HCl pH 6.8, 1% w/v SDS, 5% v/v 
glycerol, 5% v/v β-mercaptoethanol & 0.01 % w/v bromophenol blue) to final 1X 
concentration. The remaining insoluble pellet (contains host nuclei and cytoskeleton 
plus adherent bacteria) was washed in ice cold 1x PBS and re-suspending in 1X 
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Laemmli sample buffer (Laemmli, 1970). The soluble and insoluble samples were 
heated (10 min, 100°C), vortexed well and centrifuged (11752×g, 3 min, room 
temperature) prior to use or storage at -20°C.  
 
2.3.3 Western Blot analysis  
Soluble and insoluble fractions derived from ~1x106 infected cells were loaded, 
alongside protein marker (precision plus standards [BIO-RAD Cat #161-0373]) onto 
SDS-PAGE gel (Sodium dodecyl sulfate-polyacrylamide gel electrophoresis) - usually 
10% polyacrylamide resolving gel with 5% stacking gel (Laemmli, 1970). Gels were 
run in SDS-PAGE running buffer (25 mM Tris-HCl, 192 mM glycine and 0.1% w/v 
SDS; pH 8.3) at 200 volts for 1h using a vertical electrophoresis mini-cell system 
(Bio-Rad). The gel was placed onto a polyvinylidene fluoride (PVDF) membrane (GE 
Healthcare Cat #G9949937) for protein transfer using the Mini Trans-Blot cell (Bio-
Rad) at 110 volts for 60min (Kenny & Finlay, 1997). Transfer efficiency/quality was 
evaluated by Ponceau S staining (Sigma Cat #P7170-1L) - reversible by washing with 
1x PBS – and the membrane blocked overnight (4°C) in PBS containing 5% (w/v) 
skimmed milk powder (1% Dried skimmed milk-UK). 
         For detection using alkaline phosphatase-conjugated antibodies. Blocked 
membranes were incubated with appropriate antibodies (Table 7) in PBS for 1h at room 
temperature, washed in PBS (3x 5 min), and then incubated with an appropriate 
secondary antibody (Table 7) in PBS for 1h at room temperature prior to washing twice 
in PBS and then in developing buffer (0.05 M NaCl, 0.001M MgCl2 and 0.02 M Tris 
Base pH 9.5) prior to adding developing agents (NBT [nitro blue tetrazolium; Promega 
Cat #S380S] and BCIP [5-bromo-4-chloro-3-indolyl-phosphate; Promega Cat 
#S381S]) in 10mL alkaline phosphatase buffer according to the manufacturer’s 
instructions.  
        For detection using horseradish peroxidase (HRP)-conjugated antibodies, primary 
antibodies were incubated 1h in Tris Buffer Saline containing Tween (TBST; 150 mM 
NaCl, 10m M Tris-HCl, 0.05% v/v Tween-20 pH 7.5) followed by washing (3x 5 min 
TBST) and incubation with horseradish peroxidase-conjugated HRP secondary 
antibody (anti-Mouse HRP or anti-Rabbit HRP) in TBST for 1h at room temperature. 
The blots were then washed (3x 5 min in TBST) prior to overlaying with luminol reagent 
(1:1 ratio of Luminol Enhancer and Stable peroxide solution; Thermo Scientific, Cat 
Chapter 2 Materials and Methods 
45 
  
#34080) for 5 min with the luminescent signal captured on X-ray film (GE Healthcare 
Cat #HP35102A). HRP-developed blots were often re-blocked (PBS containing 5% w/v 
skimmed milk powder) overnight (4°C) and then probed with antibody for detection 
using alkaline phosphatase-conjugated antibodies as described above. 
 
 
 
 
   Primary antibody  
 
 
    
      Species  
 
Dilution used in 
 
Source 
IF 
 
WB 
Anti-Tir Rabbit poly Ab   1:2000    1: 5000 Kenny Lab 
Anti-EspF  Rabbit poly Ab    NA    1: 2000 Kenny Lab 
Anti-EspB  Rabbit poly Ab    NA    1: 2000 Kenny Lab 
Anti-EspA Rabbit poly Ab    NA    1: 500 Kenny Lab 
Anti-EspD  Rabbit poly Ab    NA    1: 1000 Kenny Lab 
Anti-β-Actin Mouse Mo Ab    NA    1:10000 Sigma #A2066 
Anti-Tubulin Rabbit Mo Ab    NA    1: 40000 Sigma #T3526 
Anti-HA-Taq Mouse Mo Ab   1:50    1:1000 Sigma 
Anti-phospho-tyrosine clone 4G10 Mouse Mo Ab    NA    1:1000 Millipore #05-321 
 
 
Secondary antibody  
 
Species 
 
Dilution used in 
 
 
                       Source 
IF WB 
Anti-Rabbit IgG-HRP  Goat NA 1: 5000 Jackson Immuno Research; #111-053-003 
Anti-Rabbit IgG-AP  Goat NA 1: 5000 Jackson Immuno Research; #111-053-144 
Anti-Mouse IgG-HRP Goat NA 1: 5000 Jackson Immuno Research; #115-035-003 
Anti-Mouse IgG-AP Goat NA 1: 5000 Jackson Immuno Research; #115-056-068 
(TRITC)-phalloidin NA 1:100 NA Sigma; #P1951-.1MG 
DAPI  NA   1:1000 NA Invitrogen; #D1306  
 
 
2.3.4 Immunofluorescence microscopy  
Hela cells (~1x105) were seeded onto 13mm glass coverslips (VWR Cat #631-1578) 
in 24 well plates 48h prior to infection to reach 80-90% confluency by infection day. 
Post-infection, the cells were washed twice with ice cold PBS and fixed with ice cold 
PBS containing 2.5% paraformaldehyde (Chem Cruz; Cat #sc281692) for 20 min at 
room temperature. Following two PBS washes the cells were treated with PBS 
containing 1% (v/v) Triton X-100 - makes the host membrane permeable – containing 
tetramethyl-rhodamine-isothiocyanate (TRITC)-phalloidin (1µg/ml [1:100; final 
concentration 10 ng]; binds polymerised actin) and 4’6-diamidino-2-phenylinodole 
Table 7: Primary and secondary antibodies with DAPI/TRITIC- Phalloidin stains used in 
this study. Antibodies are used to label and/or detect target protein in western blot or 
immunofluorescence. 
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(DAPI; strains DNA) for 1h. When appropriate, primary antibody(ies) were also present 
and then, post washing, labelled with an appropriate fluorescent-conjugated secondary 
antibody (Table 7). PBS washed coverslips were mounted onto 20 µl FluorSave 
reagent (Millipore Cat #345789-20) prior to examining (Zeiss Axioskop epi-fluorescent 
microscope) and, when appropriate, images captured using a Hamamatsu C4742-95 
charge-coupled device camera and Improvision software. 
 
2.3.5 Lactate dehydrogenase (LDH) cytotoxicity assay  
Release of cytoplasmic lactate dehydrogenase (LDH) protein into the cell culture 
media was detected using the Pierce LDH Cytotoxicity Assay Kit (Thermo Fisher 
scientific Cat #88954) following the manufacturer’s instructions. Briefly, at the indicated 
time following infection of Hela cells (~1x105 per wells of 24 well plate) the extracellular 
medium was taken and centrifuged (11752 xg, 3 min) with 50 μl aliquots transferred to 
a flat bottomed 96 well plate (Corning; Cat #3370) adding 50 μl of kit provided reaction 
mixture for 30 min (in dark at room temperature). The reaction was terminated by 
adding 50 μl stop solution and the absorbance of the reaction product formazan 
measured at 490 nm and 680 nm (FLUOstar opitma microplate reader). The 
percentage cytotoxicity was calculated following subtraction of background level 
release from uninfected cells from that released in treated samples, this then divided 
by the value of maximum LDH activity (that released from uninfected cells following 
addition of kit provided 1x lysis buffer) multiplying by 100.
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Chapter 3:  Interrogating roles for EPEC T3SS secretion 
substrates in Tir modification to T” form and 
membrane insertion processes 
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3.1  Introduction  
Translocated intimin receptor (Tir) is the first example of a bacterial protein delivered 
into the host cells to act as a receptor for a pathogen (Kenny et al., 1997b). Tir is 
delivered by the type three secretion system (T3SS) of not only EPEC but also all A/E 
pathogens where it becomes inserted into the host plasma membrane in a hairpin like 
conformation, via two transmembrane domains (TMDs), resulting in the central 
extracellular (Intimin-binding) domain with both terminal domains exposed to the host 
cytoplasm (Kenny, 1999, de Grado et al., 1999). The insertion mechanism is 
controversial with studies from our group supporting insertion from the host cytoplasm. 
Thus, an initial immunoblot-based study linked Tir insertion to a number of kinase-
modified intermediates with the first, T’ (due to phosphorylation on a serine residue 
leading to a 5kDa increase in apparent molecular mass) followed by further 
modification to the T’’ form (due to phosphorylation on another serine increasing an 
apparent molecular mass by another of an 2kDa) linked to insertion and Intimin binding 
(Kenny, 1999, Warawa & Kenny, 2001). Tir also undergoes host kinase modification 
on tyrosine residues (without altering apparent molecular mass) linked to subversive 
activities inducing Intimin-dependent recruitment of the Arp2/3 actin nucleating 
machinery to generate pedestal-like structures beneath the adherent bacteria (Lai et 
al., 2013, Campellone et al., 2002, Rohatgi et al., 2001, Gruenheid et al., 2001). In 
contrast, Gauthier (2000) argues for insertion into the host cell membrane during the 
translocation process, presumably via an EspB/D pore, with detection of Tir in the host 
cytoplasm suggested to be due to overloading of the translocation system (Gauthier et 
al., 2000). However, time course studies revealed the Tir T’ form in the cytoplasm prior 
to T” in the membrane, arguing for a cytoplasmic intermediate (Kenny, 1999). In 
addition, introducing Tir into host cells by three different EPEC-independent 
mechanisms i.e i) transfection, ii) adding purified Tir to detergent permeabilized host 
cells or iii) delivering Tir  by the T3SS of another pathogen (Yersinia 
pseudotuberculosis), led to an only partially modified Tir form (T’) which was unable to 
interact with Intimin (Kenny & Warawa, 2001). This defect in Tir modification could not 
be restored by co-infection with EPEC missing only one effector, Tir, suggesting that 
other factors had to be co-expressed and/or delivered with Tir to aid T’ to T” 
modification and insertion into the host cells membrane in a conformation that could 
be bound by Intimin (Kenny & Warawa, 2001). In contrast, confocal microscopy 
examination of EPEC infected red blood cells (RBCs) was suggested to support direct 
insertion of Tir into the RBC plasma membrane (Shaw et al., 2002). Surprisingly, Tir 
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has also been reported to be integrated into host cells membrane in a T3SS-
independent manner (Michgehl et al., 2006). Interestingly, this form was detected first 
in the host cytoplasm before the host cell membrane, supporting the cytoplasmic 
insertion hypothesis. Crucially, the indirect insertion of Tir into the host cell’s membrane 
is also supported via a transfection study which demonstrated the ability of Tir to insert 
into the host membrane from the host cytoplasm as Intimin was shown to interact with 
Tir and trigger pedestal formation in a small percentage of cells.  Moreover, targeting 
Tir to the membrane by replacing the N- terminal domain with a type II transmembrane 
protein led to increased levels of Intimin-Tir interaction (Campellone et al., 2004a) and 
presumably Tir insertion, suggesting other factors are needed to aid its insertion.    
  Importantly, the cytoplasmic insertion mechanism was also supported by the confocal 
microscopy studies with cultured enterocytes (mimic of EPEC’s in vivo target), which 
detected a transient pool of Tir within the host cytoplasm prior to sequestration to the 
apical membrane (Ruchaud-Sparagano et al., 2011). This pool was evident for a 
longer time with cells infected with an Intimin-deficient strain, suggesting that Intimin 
interaction with non-Tir independent receptors, including β-integrin and nucleolin 
(Frankel et al., 1996, Sinclair et al., 2006) triggers Tir recruitment from the cytoplasm 
to the host membrane.  
  Finally, in vitro biophysical studies, using a mimic of the human erythrocyte inner 
leaflet revealed that Tir can be inserted into the host membrane in hairpin like structure 
following Tir exposure to the erythrocyte inner leaflet (Race et al., 2006), supporting 
the idea that EPEC Tir is inserted into the membrane from the host cytoplasm. Factors 
needed for Tir insertion into the host plasma membrane appear to be LEE encoded as 
introduction of the EPEC E2348/69 LEE region into non-pathogenic E.coli provides the 
capacity to produce actin-rich pedestals (McDaniel & Kaper, 1997), a process 
dependent on membrane insertion linked to modification of Tir on serine and tyrosine 
residues 
  We hypothesise that the LEE region encodes T3SS-dependent factors that 
need to be co-delivered with Tir to enable the T’ to T’’ modification process leading to 
Tir insertion into the host membrane to provide a receptor for Intimin. 
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3.2  Aim 
The aim of experiments described in this chapter was to investigate roles for known 
LEE-encoded T3SS effectors (Map, EspB, EspF, EspH, EspG, EspZ) and/or 
translocator (EspA, EspD, EspB) proteins in the Tir T’ to T’’ modification/plasma 
membrane insertion processes.  
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3.3  Results 
3.3.1 LEE region sufficiency for Tir functionality  
Firstly, we wanted to confirm (McDaniel & Kaper, 1997) that the LEE region encodes 
all the factors needed to deliver a functional Tir molecule into mammalian cells and to 
interrogate the prediction of Tir modification to T’/T’’ forms. Thus, infection studies were 
undertaken with available non-pathogenic E.coli (K12) strains, TOB01 and TOB02  
(Yen et al., 2010). TOB01 carries a plasmid (pBFP_Per) encoding the BFP pilus 
targeting EPEC to enterocytes (Giron et al., 1991) and Per promotes LEE gene 
expression operons from another EPEC strain B171(Mellies et al., 1999, Mellies et al., 
2007). TOB01 also carries an ‘empty’ (no cloned fragment) plasmid with TOB02 
identical to TOB01 except that the EPEC B171 LEE region is cloned into this second 
plasmid (Yen et al., 2010). Infection studies also included EPEC E2348/69 TOE-A7 
mutant strain that lacks genes for 14 non-LEE-encoded effectors (Yen et al., 2010). 
Therefore, Hela cells were left uninfected or infected with the various strains before 
isolating Triton X-100 soluble (contains host cytoplasm and membrane proteins plus 
delivered effectors) and insoluble (contains host nuclei and cytoskeletal proteins plus 
adherent bacterial proteins) fractions for Western blot analysis as previously described 
(Kenny & Warawa, 2001). 
 
As reported (Kenny, 1999), Tir was delivered by EPEC as evidenced by T’/T” forms in 
the soluble fraction and, due to its interaction with Intimin (Kenny, 1999), the T’’ form 
in the insoluble fraction (Figure 16). Similarly, TOE-A7 delivered Tir into the host cells 
which was modified to a T”-like form and detected in both soluble and, again due its 
interaction with Intimin, insoluble fraction. By contrast, Tir was absent from uninfected 
and TOB01 (LEE-negative)-infected cells (Figure 16). However, TOB02 behaved like 
EPEC (Figure 16) thereby confirming (McDaniel & Kaper, 1997) that the LEE region 
encodes all the information needed for Tir delivery, modification to T’/T” forms and 
insertion into the host cell membrane for Intimin binding.  
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3.3.2 Yersinia enterocolitica-delivered Tir is only partially modified by host kinases 
and does not interact with Intimin  
Having demonstrated LEE sufficiency for Tir delivery, Kinase modification to T’/T” 
forms and Intimin binding, we wished to explore whether the known LEE-encoded 
effectors (EspG, Map, EspF, EspH, EspZ, EspB), individually or collectively, aid the Tir 
modification and/or membrane insertion processes. These studies took advantage of 
the fact that another T3SS-expressing pathogen, Yersinia pseudotuberculosis 
(engineered to lack most Yersinia T3SS effectors), can express and deliver Tir into 
host cells in a manner greatly promoted by co-expressing the Tir chaperone, CesT 
(Kenny & Warawa, 2001). Thus, we wished to introduce additional LEE effector-
encoding plasmids, but this strategy was hindered by the engineering-associated 
introduction of antibiotic resistance genes (Hakansson et al., 1996). Therefore, studies 
interrogated if an available Yersinia enterocolitica strain, also engineered to lack most 
Yersinia T3SS effectors but without introducing antibiotic resistance genes (Cornelis 
et al., 1986), hereafter called Y/ent, could also deliver Tir. Thus, a plasmid encoding 
Tir, CesT and Intimin (p-tir-cesT-Int) was introduced into Y/ent for infection of HeLa 
cells alongside EPEC and Y/ent strains. Western blot analysis of isolated Triton X-100 
soluble and insoluble fractions for Tir revealed that, as reported, EPEC delivered Tir 
Figure 16: The LEE region encodes sufficient information to enable Tir delivery, modification 
and insertion into the host plasma membrane for Intimin binding. HeLa cells were left uninfected 
or infected with indicated strains prior to isolating Triton X-100 soluble (contains host cytoplasm and 
membrane plus delivered effector proteins) and insoluble (contains host nuclei and cytoskeletal 
proteins plus adherent bacterial proteins) fractions for western blot analysis to probe for Tir. The 
position of unmodified (T
o
) and host kinase modified (T’/T”) Tir forms are indicated (arrows). Strains 
used were EPEC, TOE-A7 (lacks 14 Nle effectors) mutant and non-pathogenic E.coli K12 strains 
carrying plasmids encoding EPEC BFP/Per operons (TOB01) or BFP/Per/LEE operons (TOB02) from 
the EPEC strain B171. BFP encodes an adhesin (Bundle Forming Pilus; BFP) while Per provides a 
positive regulator of LEE gene expression. 
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as evidence by T’/T” forms in the soluble fraction with T” form in the insoluble fraction 
(Figure 17). As expected, no Tir-related bands are evident in fractions from the Y/ent-
infected cells (Figure 17) whereas only one Tir modified form (T’) was evident in the 
soluble (not insoluble) fractions of cells infected with the plasmid, p-tir-cesT-Int,  
carrying Y/ent strain (Figure 17). This data demonstrates that Yersinia enterocolitica 
can, like Yersinia pseudotuberculosis (Kenny & Warawa, 2001), deliver Tir into Hela 
cells where it only undergoes partial modification (to T’-like form) and, apparently, is 
not able to interact with Intimin in a manner that leads to its migration into the insoluble 
fraction.  
A possible reason for the Yersinia-delivered Tir T’ form not migrating into the insoluble 
fraction could be a defect in Intimin expression or presentation on the Yersinia surface 
in a conformation that can bind Tir. To examine this possibility, a two-wave infection 
protocol was carried out in which cells were initially infected with the Intimin-deficient 
strain (eae) which delivers Tir (Kenny et al., 1997b), followed by a second-wave 
infection with Y/ent or Y/ent carrying the Intimin-encoding plasmid. As expected, both 
EPEC and the eae mutant delivered Tir which was modified to the T’/T” forms (Figure 
18) with the T’’ form only detected in the insoluble fraction of cells pre-infected with 
EPEC, not the eae mutant (doesn’t express Intimin), strains (Figure 18). Importantly, 
subsequent infection of cells pre-infected with the eae mutant was linked to the T” form 
migrating into the insoluble fraction but only when infecting with the Y/ent strain which 
carried the Intimin-expressed plasmid (Figure 18). This result reveals that Y/ent cannot 
only express Intimin but presents it on the Yersinia surface in a conformation that can 
interact with plasma membrane-inserted Tir. Moreover, the work supports the idea 
(Kenny & Warawa, 2001) that the Yersinia-delivered partially modified (T’) Tir form is 
not inserted in the plasma membrane or is not in a conformation that can stably interact 
with Intimin. 
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Figure 17: Tir is only partially modified following delivery into Hela cells by a Yersinia 
enterocolitica (Y/ent) strain that lacks most Yersinia T3SS effectors. HeLa cell were 
infected with indicated strains prior to isolating Triton X-100 soluble (contains host cytoplasm 
and membrane proteins plus delivered effector proteins) and insoluble (contains host nuclei and 
cytoskeletal proteins plus adherent bacterial proteins) fractions for western blot analysis to probe 
for Tir. The positions of unmodified (To) and modified (T’ and T”) Tir forms are indicated (arrows). 
Strains used were EPEC, Yersinia enterocolitica lacking most T3SS effectors (Y/ent) or Y/ent 
carrying a plasmid encodes Tir, the Tir chaperone CesT and Intimin (p-tir-cesT-Int)   
 
 
Figure 18: Yersinia enterocolitica present Intimin on its surface in a conformation that 
can bind fully modified, membrane-inserted, Tir. HeLa cell were infected with EPEC or 
Intimin-deficient (eae) strains for 3hr before gentamycin-killing bacteria and infecting with a 
Yersinia enterocolitica that lacks most Yersinia effectors (Y/ent) or Y/ent carrying the plasmid p-
tir-cesT-Int (encodes Tir, the Tir chaperone CesT and Intimin). Triton X-100 soluble (contains 
host cytoplasm and membrane proteins plus delivered effector proteins) and insoluble (contains 
host nuclei and cytoskeletal proteins plus adherent bacterial proteins) fractions were isolated for 
western blot analysis probing Tir. The positions of unmodified (To) and modified (T’/T”) Tir forms 
are indicated (arrows). 
 
 
Chapter 3 Results I 
55 
  
3.3.3 Co-expression of LEE effectors with Tir in Yersinia enterocolitica inhibits Tir 
delivery into HeLa cells 
Having developed a model in which Yersinia expresses Intimin on its surface and 
delivers Tir into HeLa cells where it only undergoes partial modification, we wanted to 
co-express LEE effectors - initially individually - to determine whether any would 
promote modification to the T’’ (Intimin-interacting) form. To enable detection, these 
studies would use available plasmids (See Chapter 2; Table 5) encoding effectors with 
C-terminal epitope (HA, HSV or Flag) tags. It is important to note that EspF has a 
dedicated chaperone, CesF (Elliott et al., 2002) – required for efficient Yersinia 
mediated delivery into Hela cells (A. Al-Layla, unpublished)  -  EspB has two (CesAB, 
CesD) chaperones (Wainwright & Kaper, 1998) while Map, EspH and EspZ share the 
Tir chaperone, CesT  (Thomas et al., 2005) with EspG having no known chaperone 
(Thomas et al., 2005). Thus, initial studies focused on the Map, EspH and EspZ 
effectors - as they share the Tir chaperone - leading to the introduction of the 
appropriate plasmids into the Y/ent p-tir-cesT-Int (encode Tir, CesT and Intimin) strain. 
Western blot analysis of the insoluble fraction - containing adherent bacteria - from 
infected Hela cells revealed a strong signal for a HA-related protein of the expected 
molecular mass for Map-HA (Figure 19A) with weak signal for EspH-HA (Figure 19A) 
and EspZ-HA (not shown; not captured on shown gel due to small, ~10kDa, molecular 
mass). However, only one protein (Map-HA) was evident, at very low levels, in the 
soluble fraction (Figure 19A). Probing for Tir, in two independent experiments (Figure 
19A and 19B), was suggestive of reduced Tir expression when the strain carried a 
second plasmid (encoding HA-tagged effector) and failure to deliver Tir into cells 
(absence of T’ form). Given this outcome it was decided to cease with this approach.  
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Figure 19: Co-expressing Tir with other LEE effectors in Yersinia enterocolitica interferes 
with the Tir delivery process. HeLa cell were left uninfected or infected (3h) with indicated strains 
before isolating Triton X-100 soluble (contains host cytoplasm and membrane proteins plus 
delivered effector proteins) and insoluble (contains host nuclei and cytoskeletal proteins plus 
adherent bacterial proteins) fractions for western blot analysis probing for A) HA-tagged and Tir or 
B) Tir protein. The position of unmodified (To) and host kinase modified Tir (T’/T”) forms are 
indicated as are HA-tagged proteins (arrows). Strains used were EPEC, Yersinia enterocolitica 
lacking genes encoding most Yersinia effectors (Y/ent) carrying p-tir-cesT-Int  or, in some cases, 
an additional plasmid (encoding LEE Map [pSK-map-HA], EspH [pSK-espH-HA]or EspZ [pSK-
espZ-HA] effectors as HA fusion proteins). Boxes highlight position of weak HA-related bands. 
 
 
A) 
 
 
 
 
 
 
 
 
 
 
 
B) 
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3.3.4  Tir does not require Intimin, Map, EspG, EspH, EspF or EspZ activities for host 
kinase modification to T’’ form. 
As an alternative strategy to interrogate roles for LEE effector activity in the Tir 
modification process, a strain unable to express all known LEE effectors, except EspB 
as it is critical for delivering effector proteins (Kenny et al., 1996, Foubister et al., 1994), 
was generated (See Chapter 2; Table1). The Intimin gene (eae) was also inactivated 
as Intimin can alter cellular processes through binding Tir and host receptors, such as 
nucleolin (Kenny et al., 1997b, Sinclair & O'Brien, 2002). The generation of this multi-
mutant, mfz(81)go3eh::km, was supported by PCR analyses (Figure 20) before using it, 
alongside EPEC, to infect HeLa cells. Western blot analysis of isolated fractions 
revealed both strains capable of Tir delivry as evidenced by T’/T’’ forms in the soluble 
fraction with T” form in the insoluble fraction of cells infected with EPEC but, as 
expected, not the Intimin-deficient mfz(81)go3eh::km strain (Figure 21). Strain genotype 
was further supported by the presence (EPEC) and absence (mfz(81)go3eh::km) of the 
EspF protein (Figure 21). Examining intermediate strains - mfz(km)go3 (generated by 
Sabine Quitard), mfz(81)go3, mfz(81)go3e (See Chapter 2; Table1) - revealed near 
identical results except that the T” form was absent from insoluble fractions of cells 
infected with Intimin-deficient strains and, as before, no strain expressed/delivered 
EspF (data not shown). This work demonstrates that Tir delivery and modification to 
the T’’ form does not require the activity of the Intimin surface protein or five LEE 
effectors (EspG, EspZ, EspH, EspF, Map), implicating a role for i) the remaining known 
effector (EspB), ii) plasma membrane-inserted translocator (EspD , EspB) proteins or 
iii) unknown LEE-encoded effector(s).  
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Figure 20: PCR support of mfz(81)go3eh::km mutant. A) Schematic of EPEC LEE pathogenicity 
islands with inactivated genes circled (red oval). B) PCR reactions were carried out with primers 
sets designed to specifically amplify the tir, map, espF, espZ, espG, eae or espH genes to determine 
presence or absence from strains. PCR reactions included a positive (EPEC) and negative (strain 
known to lack the probed for gene) controls. Mutant strain name written in order genes disrupted 
i.e. m (map), f (espF), z(81) (espZ),  g (espG), o3 (orf3/espG2), e (eae [encodes Intimin]), h::km 
(espH).  ‘z(81)‘ and ‘h::km’ indicate that 81 of 98 EspZ residues are missing with espH gene replaced 
by a kanamycin-encoding gene respectively.  PCR products were run, alongside 2 Log DNA ladder 
marker, on 1% agarose gel containing Gel Red nucleic acid stain. 
 
A) 
B) 
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3.3.5 EspB-Myc fusion protein lacking EspB residues 159-218 doesn’t support Tir 
delivery into Hela cells  
The mfz(81)go3eh::km mutant retains one effector, EspB – as it is essential for 
delivering effector proteins (Kenny et al., 1996, Foubister et al., 1994) - but a variant, 
EspB-mid (lacks 60 residues; 159-218), reportedly deliver effectors but can no longer 
efface absorptive microvilli or inhibit phagocytosis (Iizumi et al., 2007). Therefore, we 
decided to interrogate whether replacing EspB with EspB-mid would impact on the Tir 
modification to T’’ process. To exclude possible redundancy with other LEE effectors 
and Intimin activities the espB gene was inactivated - using an available suicide vector 
(Donnenberg & Kaper, 1991) - from mfz(81)go3eh::km generating mfz(81)go3eh::km_b. 
Figure 21: Tir delivered by EPEC lacking Map, EspF, EspZ, EspG, EspG2, EspH effectors 
and Intimin proteins is modified to T’’ form. Hela cells were left uninfected or infected with 
indicated strains (3hr) before isolating Triton X-100 soluble (contains host cytoplasm and 
membrane proteins plus delivered effectors) and insoluble (contains host nuclei and cytoskeletal 
proteins plus adherent bacterial proteins) fractions for western blot analysis probing for Tir, EspB 
or EspF proteins. Strains used were EPEC or the mfz(81)go3eh::km mutant; latter lacks functional 
map (m), espF (f), espZ (z(81)), espG (g), orf3/espG2 (o3), Intimin (e) and espH (h::km) genes. 
Where appropriate, immunoblots were cropped and moved for presentation purposes. The position 
of Tir unmodified (T
o
) and host kinase modified (T’/T”) forms are indicated as well as the positions 
of EspB and EspF proteins. As indicate is the position of molecular weight protein markers. 
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Plasmids encoding EspB or the kindly provided EspB-mid variant (Iizumi et al., 2007) 
were introduced into the mfz(81)go3eh:km_b mutant strain and used to infect HeLa cells 
as before.  
Western blot analysis of samples following a standard 3h infection failed to detect Tir 
in cells infected with the EspB-mid complemented strain - linked to a binding defect - 
leading to extended infection times where a 9h infection was needed to detect Tir 
delivery (not shown). However, 9hr infections resulted in cell detachment/death but 
these phenotypes could be, largely, prevented by replacing the media every 3hr. Thus, 
Hela cells were re-infected with EPEC, cfm or mfz(81)go3eh:km for 6h or with 
mfz(81)go3eh:km_b mutant complemented with EspB (pACYC-espB) or EspB-mid 
(pGEM-espB-mid) for 9h - with 3 hourly media changes -prior to isolating Triton X-100 
soluble and insoluble fractions for Western blot analysis.  
As expected, the T3SS mutant strain expressed Tir with no T’/T’’ kinase-modified forms 
detected in the Triton X-100 soluble or insoluble fractions (Figure 22B). By contrast, 
EPEC infection led to T’/T” forms in the soluble fraction and, due to its interaction with 
Intimin, the T’’ form in the insoluble fraction (Figure 22B). Not surprisingly, a T3SS 
mutant Tir profile was obtained with the espB mutant while introducing a plasmid 
carrying the native espB gene led to an EPEC-like Tir T’/T’’ profile (Figure 22B). 
However, introducing the EspB-mid encoding plasmid resulted in a T3SS mutant like 
Tir profile (Figure 22B). Probing for EspB confirmed its expression by EPEC, but not 
espB mutant, as well as EspB complemented espB mutant strains but, as expected, 
the molecular mass was reduced for EspB-mid variant (Figure 22B). However, the 
reduction in apparent molecular mass was less than expected, as lacks 60 residues 
(~20% of EspB) a protein band with a predicted migration of ~30kDa (versus 37kDa 
for EspB) protein. This difference led to the encoding plasmid being isolated for espB 
gene sequencing which revealed the unexpected presence of a C-terminal myc 
epitope tag revealing that the variant used in co-immunoprecipitation studies (Iizumi et 
al., 2007) was erroneously provided. As it was possible that this epitope tag 
compromises EspB’s translocator functionality, an alternative strategy was undertaken 
to examine the impact of replacing EspB with the EspB-mid variant. Thus, the provided 
suicide vector pCACTUS-∆espB-mid (Iizumi et al., 2007) was used to replace the LEE 
espB gene from EPEC and mfz(81)go3eh::km_b strains. While PCR analysis confirmed 
the presence of espB-mid on the provided vector several attempts to generate the 
required mutant strains were unsuccessful. Thus, we decided to subclone the espB-
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mid gene into a bacterial expression vector for complementation studies with EspB-
deficient strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: The EspB-mid variant does not support Tir delivery into HeLa cells. A) Schematic 
of LEE pathogenicity islands with effector genes, other than tir, and Intimin gene highlighted (red 
ovals). B) Hela cells were infected with indicated strains for 9hr (replacing media every 3 hours 
for EPEC and cfm infected cells) prior to isolating Triton X-100 soluble (contains host cytoplasm 
and membrane proteins plus delivered effectors) and insoluble (contains host nuclei and 
cytoskeletal proteins plus adherent bacterial proteins) samples for western blot analysis (10% 
SDS-PA gel) probing for Tir, EspB and EspF. The position of unmodified (T
o
) and host kinase 
modified (T’/T”) forms are indicated as are EspB, EspB-mid, EspF and protein marker bands with 
arrows. Strains used were EPEC, T3SS mutant (cfm), mfz(81)go3eh::km - lacks functional map 
(m), espF (f), espZ (z(81)), espG (g), orf3/espG2 (o3), Intimin (e) and espH (h::km) gene - 
mfz(81)go3eh::km_b as per mfz(81)go3eh::km but also lacks espB gene. Plasmids encoding EspB 
(pACYC-espB) or EspB-mid (pGEM-espB-mid) were introduced into mfz(81)go3eh::km_b mutant. 
 
 
A) 
B) 
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3.3.5.1 Cloning and characterization of the espB-mid gene  
Briefly, the espB-mid gene was amplified from pCACTUS-∆espB-mid for introduction 
into pACYC-184 (pre-digested with restriction enzymes BamHI and SalI) using the 
Gibson Assembly Kit (Figure 23). The resulting recombinant plasmid, pACYC-espB-
mid, was shown to have the correct insert by sequencing which revealed the absence 
of a C-terminal extension and 120bp encoding residues 159 to 218. This plasmid was 
introduced into the mfz(81)go3eh::km_b mutant and used to infect Hela cells.  
As initial investigations failed to identify a binding defect, infections were carried out for 
4h before isolating soluble and insoluble fractions for western blot analysis. Probing for 
EspB supported the expression and delivery of EspB-related proteins by all but not the 
negative control (mfz(81)go3eh::km_b) strain. As expected, the EspB protein in cells 
infected with the EspB-mid complemented strain had a smaller apparent molecular 
mass, consistent with the absence of 60 residues (Figure 24). Crucially, Tir was evident 
in its kinase modified T’ and T’’ forms in the soluble fraction from cells infected with all 
strains except the EspB-negative control (mfz(81)go3eh::km_b) strain (Figure 24). The 
EspB-mid variant may have a reduced capacity to deliver Tir as possibility less T’/T’’ 
forms detected (Figure 24). As expected, the T’’ form was only evident in the insoluble 
fraction of EPEC infected cells (Figure 24) as the EspB-complemented strains do not 
express Intimin. These findings confirm that EspB-mid protein retains its translocation 
activity  with residues 159 to 218 not required for Tir modification to T’’ form. However, 
it remains possible that other EspB regions/motifs are needed for the Tir T’ to T’’ 
modification process. 
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Figure 23: Construction of pACYC-espB-mid. A) The ability of designed oligonucleotides to PCR 
amplify espB (from EPEC as template) and espB-mid gene (from pCACTUS-∆espB-mid) was 
assessed at different annealing temperatures (60, 63, 67Co). B) The expression vector pACYC184 
digested with BamHI and SalI restriction enzymes and run, next to uncut pACYC184, on an agarose 
gel prior to isolating the digested fragment for use with the PCR-generated insert fragment in the 
Gibson Assembly protocol. C) Insertion of PCR fragment into pACYC184 was supported by 
additional bands. D) The ligation product was introduced into NEB chemical competent E.coli and 
colonies PCR-screened, alongside positive (EPEC) and negative (pCACTUS-∆espB-mid) controls, 
for those carrying the insert. E) PCR support for introduction of pACYC-∆espB-mid into 
mfz(81)go3eh::km_b. 
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Figure 24: EspB-mid supports Tir delivery and modification to T” form. HeLa cells were 
infected with indicated strains for 4h before isolating Triton X-100 soluble (contains host cytoplasm 
and membrane proteins plus delivered effectors) and insoluble (contains host nuclei and 
cytoskeletal proteins plus adherent bacterial proteins) fractions for western blot analysis probing 
for Tir or EspB proteins. Strains used were EPEC, mfz(81)go3eh:km (doesn’t express 
Map/EspF/EspZ/EspG/EspG2/Intimin/EspH proteins) or mfz(81)go3eh:km_b (as mfz(81)go3eh::km 
but also lacks functional EspB protein) mutants. The latter strain either had no plasmid or carried 
a plasmid encoding EspB (pACYC184-espB) or EspB-mid (pACYC184-espB-mid) proteins. 
Indicated by arrows are the positions of EspB, EspB-mid and Tir (unmodified, T
o
 and host kinase 
modified T’/T” forms) as well as the molecular weight marker proteins.  
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3.3.6 Probing role for other EspB features by examining functionally 
interchangeability with E. tarda homologue. 
Recently a fish pathogen, Edwardsiella tarda (E. tarda), was reported to carry a LEE 
region that, theoretically, encodes a T3SS/Esp effector delivery system but lacks 
genes for all EPEC LEE effectors genes except tir (Nakamura et al., 2013).  However, 
this LEE region also encodes the Tir chaperone, CesT, and Intimin protein suggesting 
that Tir is delivered into the plasma membrane of targeted fish cells to act as a receptor 
for Intimin to promote pathogen-host cell interactions. Tir delivery into the host 
cytoplasm by EPEC is proposed to have (Intimin-independent) functions such as 
interacting with host proteins and/or regulate the activity of co-delivered LEE effectors 
(Dean et al., 2010a, Jepson et al., 2003, Patel et al., 2006, Goosney et al., 2001). Thus, 
the absence of Map, EspF-G and EspZ effector-encoding genes on the E. tarda LEE 
region raised the possibility that E. tarda Tir may be directly inserted into the plasma 
membrane and thus lacks a LEE-encoded Tir ‘cytoplasm to membrane’ insertion 
mechanism. To interrogate this possibility, we requested the E. tarda LEE sequence 
to examine whether the EspB-encoding gene was intact and, if so, the level of 
homology with EPEC EspB.  
3.3.6.1 Divergence of EPEC and E. tarda EspB proteins  
Bioinformatics interrogation of the E. tarda LEE region sequence revealed a 340aa 
EspB-like protein which was, thus, slightly larger than EPEC EspB (321AA). Crucially, 
comparison of the protein homologues revealed low levels of identity/similarity (37.8% 
& 55.7% respectively) with regions of the E. tarda EspB protein containing small in-
frame insertion and deletions (Figure 25). Perhaps not surprisingly there was good 
homology (Figure 25) between i) the N-terminal ~38 residue that provide a T3SS signal 
sequence, ii) N-terminal region linked to providing a regulated (SepL/SepD) 
translocation signal iii) the single transmembrane domain and iv) residues implicated 
in EspB-EspD interaction (Luo & Donnenberg, 2011, Deng et al., 2015). However, it 
should be noted that features i-iii) were linked to insertions or deletions which may 
impact/alter their functionality. Interestingly, the coiled-coil feature linked to protein- 
protein interaction and implicated in EspB’s ability to bind myosin protein to inhibit  
phagocytosis and promote microvilli effacement (Iizumi et al., 2007) is associated to 
insertions (within or flanking) questioning whether these subversive activities are 
preserved in the E. tarda homologue. 
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Examining the EspB proteins (TMpred program) supported the predicted presence of 
a single transmembrane region (residues 97 to 120) with differences in the myosin 
binding region (Figure 26). Given these differences studies investigated whether the 
espBEt gene could functionally replace EPEC espB version and, if so, the impact on 
the tir T’ to T” modification process.   
 
 
 
 
 
 
EPEC-EspB         1 -MNTIDNN-NAAIAVNSVLSSTTDSTSSTTTSTSSISSSLLTDGRVDISK     48 
                      :||:|.: |.|..:|||        :|....|...|..|..|.:|::: 
E.tarda-EspB      1 MINTVDGSANNASGINSV---------NTALGVSPTPSETLPAGALDLNE     41 
 
EPEC             49 LLLEVQKLLREMVTTLQDYLQKQLAQSYDIQKAVFESQNKAIDEKKAGAT     98 
                    |||::|.|||:.:..||:|.|:|:.||:.||:|.|.||:|||:|::.||| 
E.tarda          42 LLLQIQVLLRKALRVLQEYQQQQVGQSFKIQEAAFASQDKAIEERRKGAT     91 
 
EPEC             99 AALIGGAISSVLGILGSFAAINSATKGASDVAQQAASTSAKSIGTVSEAS    148 
                     .|||||.|.|.||:|||||.|..|.:... |..||:..|.|.|.|:... 
E.tarda          92 TALIGGIIGSTLGVLGSFAGITQAREAVK--AGSAAAKIADSTGDVTSEL    139 
 
EPEC            149 TKALAKASEGIADAADDAAGAMQQTIATAAKAASRTSGITDDVATSAQ--    196 
                     .|:.|:.|: :||||.|.|.:.||.::..|...||.|.|.||:|.:.|   
E.tarda         140 AKSTAQLSK-VADAAADTAQSTQQALSRTASITSRASDIADDMAQNTQQA    188 
 
EPEC            197 ---------KASQVAEEAADAAQELAQKAG-----------LLSRFTAAA    226 
                             :|:.|||:|..:...:|..|.           |.||....| 
E.tarda         189 VSRAASLTRRAADVAEDAVTSTAPMAAVANDVASATDDVVELSSRLKCMA    238 
 
EPEC            227 -------GRISGSTPFIVVTSLAEGTKTLPTTISESVKSNHDINEQRAKS    269 
                           ..||.:..||....||:|.|.||.|||..:|.::|:...|||: 
E.tarda         239 ESVTNKFDSISQNGAFIAGVHLAQGVKELPGTISAGLKVSNDLAADRAKN    288 
 
EPEC            270 VENLQASNLDTYKQDVRRAQDDISSRLRDMTTTARDLTDLINRMGQAARL    319 
                    :|:.|..:.:.|:|||:.::|::..||.|:|...|::.|::.|.|||.|: 
E.tarda         289 LEDYQQQSRNIYQQDVQGSKDEVRQRLNDITEVTRNINDILTRQGQAVRI    338 
 
EPEC             320 AG    321 
                     || 
E.tarda          339 AG    340 
Figure 25: Comparison of E. tarda and EPEC EspB proteins.The E. tarda and EPEC EspB 
protein sequences were aligned (http://www.ebi.ac.uk/Tools/psa/emboss_needle/). Highlighted 
are the predicted: (in blue) region encoding the T3SS secretion signal, (in yellow) the SepD/Sep-
dependent translocation signal region, (in grey) residues linked EspB-EspD interaction, (in black) 
the transmembrane domain and (in red) the coiled coil region linked to protein-protein interaction 
with bold underlined residues highlighting the myosin binding region. 
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Output from TMpred 
 
2 possible models considered, only significant 
TM-segments used 
-----> Slightly prefered model: N-terminus outside 
 1- Strong transmembrane helices, total score: 
2069 
   # from   to      length    score           orientation  
       99    117     (19)       2069                o-i 
------> Alternative model  
1- Strong transmembrane helices, total score: 
2021 
 # from    to       length    score          orientation  
       99    119       (21)      2021                i-o 
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Output from Tmpred 
 
2 possible models considered, only significant 
TM-segments used 
-----> STRONGLY prefered model: N-terminus 
outside 
 1 strong transmembrane helices, total score: 
1864 
# from   to    length   score     orientation  
    93    110   (18)      1864          o-i  
------> Alternative model 
 1 strong transmembrane helices, total score: 
1760 
# from   to     length   score    orientation  
    89    110    (22)      1760          i-o  
Figure 26: Interrogating the presence of transmembrane domain in E. tarda and EPEC EspB proteins.  The EPEC and E. tarda EspB proteins 
sequences were interrogated (http://www.ch.embnet.org/software /TMPRED_form.html) leading to the predicted of one transmembrane domain (residues 
97 to 120). The program requires setting of minimal and maximal hydrophobic helix length, in this case it was 17 and 33 respectively. Solid line is the 
prediction for inside to outside TM helix and interrupted line is the prediction for outside to inside TM helix.  
 Also shown are the positions of the predicted myosin binding region (MBR) and EspB-EspD interaction sites (B/D).  
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3.3.6.2 Cloning E. tarda espB into pACYC-184 
The E. tarda espB gene (espBEt) was PCR amplified (Figure 27A) using, kindly 
provided, E. tarda genomic DNA, and oligonucleotides (See Chapter 2; Table 2) 
designed to introduce flanking restriction enzyme (BamHI/SalI) sites. The PCR product 
produced a single band of expected size (~1kb) which was ligated into the TOPO TA 
cloning vector (pCR2.1) before introducing into K12 E.coli (Figure 27B and 27C). 
BamHI/SalI restriction enzyme digestion of pCR2.1-espBEt and pACYC184 provided 
the insert (espBEt ~1kB) and pACYC184 (~4kB) vector bands that were ligated together 
prior to introducing into K12 E. coli (Figure 27D-E). The plasmid was isolated with 
generation of pACYC-espBEt supported by restriction digestion and PCR analysis 
(Figure 27F-G). 
3.3.6.3 Functional interchangeability of E.tarda EspB  
To assess the translocator activity of the E. tarda EspB protein, HeLa cells were 
infected with EPEC or espB mutant carrying no plasmid or plasmids encoding EPEC 
or E. tarda EspB proteins prior to isolating Triton X-100 soluble and insoluble fractions 
for Western blot analysis. As expected, EPEC, unlike the espB mutant, delivered Tir 
as evidenced by detection of modified T’/T” forms in the soluble and T” form in the   
insoluble fractions (Figure 28). Crucially, the espB mutant defect was rescued by 
introducing plasmids encoding the EPEC or E. tarda EspB proteins; latter supported 
by antibodies raised against EPEC EspB failing to detect the E. tarda variant (Figure 
28). The delayed and reduced level of Tir (unmodified or modified forms) in fractions 
from cells infected with the E. tarda EspB-expressing strain is suggestive of issues in 
E. tarda EspB protein expression, stability or translocator activity. Nevertheless, this 
work reveals the E. tarda espB gene encodes a protein that can functionally replace 
the translocator activity of the EPEC EspB protein to deliver Tir which then undergoes 
host kinase mediated modification to theT” form that can interact with Intimin.   
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Figure 27: Construction of pACYC-espBEt. A) The E. tarda espB (espBEt) gene was PCR 
amplified providing a single band of expected molecular mass (~1kb). B) The PCR product was 
ligated into TOBO TA cloning vector (pCR-2.1) before introducing into K12 E.coli with (C) pCR-
2.1-espBEt plasmid generation supported by restriction digestion analysis, D & E) The pCR2.1-
espBEt and pACYC184 plasmids were digested with BamHI and SalI restriction enzymes prior to 
isolating the espBEt (~1Kb) and pACYC184 (~4kb) vectors bands for ligation, with success indicate 
by additional bands. F) Generation of pACYC-espBEt was supported by restriction digest analysis 
with G) PCR support for the generation of pACYC-espBEt.  
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Figure 28: The E. tarda EspB protein functionally replaces EPEC EspB to deliver Tir into cells 
where modified to the T” form and interacts with Intimin. Hela cells were infected with indicated 
strains for 3 and/or 6h before isolating Triton X-100 soluble (contains host cytoplasm and membrane 
proteins plus delivered effectors) and insoluble (contains host nuclei and cytoskeletal proteins plus 
adherent bacterial proteins) fractions for western blot analysis probing for Tir and EspB. Strain used 
were EPEC, the ΔespB mutant or ΔespB carrying pACYC184-based plasmids encoding the EPEC 
(pACYC-espB) or E. tarda (pACYC-espBEt) EspB proteins. The position of unmodified (T
o
) and host 
kinase modified (T’/T”) forms are indicated alongside the EspB and protein marker proteins.  
. 
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3.3.6.4 Actin nucleating functionality of Tir delivered via the EspBEt protein  
To interrogate if Tir delivered via the E. tarda EspB protein was functional, studies 
examined for Tir-directed actin nucleation as this event depends on Tir being 
phosphorylated on tyrosine residues and binding Intimin (Kenny, 1999, Rosenshine et 
al., 1996). Thus, HeLa cells were seeded on glass coverslips and infected (4h) prior to 
fixing cells and staining for polymerised actin (Phalloidin-TRITC [Red]) and DNA (host 
and bacterial; DAPI [blue]) as described (Dean & Kenny, 2004). 
 Immunofluorescence microscopy evaluation of fluorescent signals revealed 
that, as reported (Rosenshine et al., 1996, Kenny & Finlay, 1997), EPEC but not the 
espB mutant triggered actin polymerization - i.e. pedestal formation - beneath adherent 
bacteria (Figure 29). Crucially, pedestal formation was also detected for cells infected 
with the espB mutant carrying the EspBEt encoding plasmid. However, the number of 
pedestals was significantly lower in cells infected with espB mutant carrying the 
plasmid encoding EspBEt, in contrast to cells infected with EPEC (Figure 29). This data 
provides further support that the EspBEt protein can functionally replace its EPEC 
homologue to not only deliver Tir into host cells for kinase mediated modification and 
insertion into the plasma membrane but places it in a conformation that can be bound 
by Intimin to trigger subversive signalling activites. Thus, the LEE factor implicated in 
the Tir T’ to T” modification process either depends on i) features conserved in the 
EPEC and E. tarda EspB proteins, ii) other translocator (EspD; EspA) proteins or iii) 
other, unknown, LEE encoded effectors.  
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Figure 29: The E. tarda EspB protein functionally replaces EPEC EspB to enable Tir/Intimin-
dependent pedestal formation. Hela cells (on glass coverslips) were infected with indicated strains 
for 4h before fixing cells and staining for polymerized actin (Phallodin-TRITC [Red]) or DNA (bacterial 
and host [DAPI; Blue]) that was visualized by fluorescence microscopy. Strain used were EPEC, the 
espB mutant or espB carrying pACYC184-espBEt (EspBEt). The scale bar represents 10 μm. 
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3.3.7 Examining functionally interchangeability of E. tarda EspD protein 
Studies were also undertaken to examined the possibility that the host membrane-
inserted EspD translocator could aid Tir T’ to T” modification and/or membrane 
insertion processes. To inform of this process, the E. tarda LEE region was examined 
for an espD gene to determine if predicted to produce a full length protein and its 
homology to EPEC EspD. 
3.3.7.1 Comparison of E. tarda and EPEC EspD proteins 
Alignment of the EspD sequences (Figure 30) revealed a slightly larger E. tarda protein 
(385 versus 380 residues) with 50.9% identity (66.9% similarity) to the EPEC 
homologue. Of note was the presence of in-frame insertions and deletions within the 
N-terminal region. EspD is reportedly the major component of a 6-7 subunit 
EspD/EspB complex in the host membrane which provides a pore (2.5-5nm) – linked 
to EspA via EspD (Ide et al., 2001) - through which effectors are delivered into cells. 
The key features linked to EspD functionality are highlighted in Figure 30 and include 
two predicted transmembrane domains – unlike one for EspB – with N-terminal and C-
terminal coil-coiled, as well as amphipathic regions linked with EspD-EspD interactions 
(Dasanayake et al., 2011, Daniell et al., 2001). The final 12 C-terminal amino acid 
residues of EPEC EspD are essential for its secretion (Deng et al., 2015).  
3.3.7.2 Cloning E. tarda espD into pACYC-184 
To interrogate the functional interchangeability of E. tarda EspD and possible role in 
Tir modification and insertion mechanism, espDEt was cloned and used to complement 
the EspD deficient EPEC strain. Briefly, the espDEt gene (~1.3kB) was amplified from 
kindly provided E. tarda genomic DNA and added to isolated pACYC-184 (~4kB) vector 
band, following digestion with BamHI/SalI restriction enzymes, to generate pACYC-
espDEt using the Gibson Assembly kit (see Chapter 2; Section 2.2.8). The presence of 
pACYC-espDEt in EPEC EspD deficient (∆espD) mutant strain was supported by PCR 
analyses (Figure 31D). 
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EPEC-EspD          1 MLNVNNDIQSV-RSGASAATATSGINQSEVTSALDLQLVKSTAP------     43 
                     |::.|..|.|| .|.|..|.|..|       ::|...::..|.|       
E.tarda-EspD       1 MMDTNLTISSVGPSMALDAVAPGG-------NSLKSSVIPLTQPILQPRA     43 
 
EPEC              44 ----SASWTESTALPTPP--AGHSLVTPSAAEDVLSKLFGGISGEVTSRT     87 
                         .:|...|:.||.||  ..|.:||||||||||.||||||||| .|.: 
E.tarda           44 QVDEGSSSFNSSPLPLPPGSVAHRMVTPSAAEDVLDKLFGGISGE-RSGS     92 
 
EPEC              88 EGTEPQRSTQNASSGYPYLSQVNNVDPQAMMMMATLLSLDASAQRVASMK    137 
                     :.|..........:..|.|::::.|||.|||:|.|.||::.|.|::.|:| 
E.tarda           93 DSTGLFADKGEDKTALPILARLSQVDPIAMMLMVTSLSMETSTQKIGSLK    142 
 
EPEC             138 NSNEIYADGQNKALDNKTLEFKKQLEEQQKAEEKAQKSKIVGQVFGWLGV    187 
                     :||.||||||:|||.:|..||||||||||||||||||||::||||||||| 
E.tarda          143 DSNRIYADGQDKALASKLEEFKKQLEEQQKAEEKAQKSKVLGQVFGWLGV    192 
 
EPEC             188 AATAIAAIFNPALWAVVAISATAMALQTAVDVMGDDAPQALKTAAQAFGG    237 
                     .||||||:||||||.|||||||:||||||||||||.||||||:|||.||| 
E.tarda          193 LATAIAALFNPALWVVVAISATSMALQTAVDVMGDKAPQALKSAAQVFGG    242 
 
EPEC             238 LSLAAGILTAGIGGVSSLISKVGDVANKVGSNIVKVVTTLADTFVDNVAS    287 
                     :|:|||:.|||:|.:||::.....||.|:|..:.|||..:.:.||:|.|: 
E.tarda          243 ISMAAGLATAGVGALSSILKSASSVAQKLGETVTKVVAKVTEKFVENTAA    292 
 
EPEC             288 KISAVANGLTTSSRSIGTTVLNNDAAYYNVLSQVSAFAVENLTRQSEYLS    337 
                     |:.|:|.|||.||:||||||||.:::...:.|..:||:|:||......:. 
E.tarda          293 KVGAIATGLTESSKSIGTTVLNKESSDALIDSLAAAFSVKNLDMNYRLMG    342 
 
EPEC             338 QSAKAELEKATLELQNQANYIQSASQLMSDSARVNIRIVSGRV    380 
                     :|..:.|.:|..|..:...::|..|.:|||:||||.||:.|.. 
E.tarda          343 ESTGSMLRRAADEGNDLVRFLQGTSNVMSDTARVNSRIIRGLA    385 
 
Figure 30: Comparison of E. tarda and EPEC-encoded EspD proteins. E. tarda and EPEC EspD 
protein sequences were aligned (http://www.ebi.ac.uk/Tools/psa/emboss_needle/).  Highlighted (in 
blue) is the T3SS secretion signal region, (in black) two predicted transmembrane domain, (in red) N 
and C-terminal coiled coil regions (associated with protein-protein interactions) and (in green) an 
amphipathic regions. 
Figure 31: Construction of pACYC-espDEt.  A) The E. tarda espD (espDEt) gene was PCR 
amplified, providing a single band of expected molecular mass (~1.3kb). B) pACYC-184 was digested 
with BamHI and SalI restriction enzymes prior to isolating ~4kb vector bands for C) use with espDEt 
(~1.3Kb) fragment in Gibson Assembly protocol to generate pACYC-espDEt with D) introduction of 
pACYC-espDEt into the EPEC ΔespD mutant supported by PCR.  
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3.3.7.3 E. tarda EspD weakly rescues the EPEC ΔespD mutant defect leading to low 
level of Tir modification to T’/T’’ form 
To determine whether EspDEt can functinally replace EPEC EspD’s translocator  
functions, studies examined its ability to rescue the Tir delivery defect of the EPEC 
∆espD mutant strain (Lai et al., 1997). As initial studies revealed a binding defect for 
the ∆espD mutant when carrying the EspDEt encoding plasmid, cells were infected for 
up to 9 hr – replacing the media every 3 hrs, as before – prior to isolating Triton X-100 
soluble and insoluble fractions.  
 
Western blot analysis of the samples confirmed (Kresse et al., 1999, Lai et al., 1997) 
that the ∆espD mutant expresses Tir but can not deliver it into host cells. However, 
unexpectedly, a single band linked to T0 was detected in the soluble fraction of cells 
infected with ∆espD mutant (Figure 32). The detection of this band may be related to 
a cross contamination from bacterial lysis or endocytosis of Tir into such membranous 
compartments. Importantly, this band (T0) was not modified to the T’-like form. In 
contrast, introduction of the EPEC EspD encoding plasmid restores Tir deliver 
(evidenced by detecting the T’/T” forms in the soluble fraction and, due to interaction 
with Intimin, the T” form in the insoluble fraction; Figure 32). Interestingly, introducing 
the EspDEt encoding plasmid restored Tir delivery with only very low levels of modified 
Tir (T’’ form) detected in the soluble (none in insoluble) fraction (Figure 32). Probing 
for EspB revealed similar signals in the soluble and insoluble fractions of cells infected 
with the ∆espD mutant (whether carrying EspD-encoding plasmids or not; Figure 32). 
This work suggests that the E. tarda espD gene encodes a protein that can functional 
replace the translocator activity of EPEC EspD but negative impacts on the process 
that modifies Tir to T’/T” forms and Intimin’s ability to stably interact with modified Tir.   
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Figure 32: E. tarda EspD rescues the EPEC espD mutant defect in delivering Tir linked to a 
defect in Tir modification and Intimin interaction with Tir. HeLa cells were infected for 6 or 9hr 
with indicated strains before isolating Triton X-100 soluble (containing host cytoplasm and 
membrane proteins plus delivered effectors) and insoluble (containing host nuclei and cytoskeletal 
proteins plus adherent bacterial proteins) fractions for western blot analysis probing for Tir and 
EspB. The position of unmodified (T
o
) and host kinase modified (T’/T”) forms are indicated (by 
arrows) as are EspB and protein markers. Strains used were the ∆espD mutant that carried no 
plasmid (-) or plasmids carrying the EPEC (espDEPEC) or E. tarda (espDEt) espD genes. 
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3.3.8 Examining if the E. tarda EspA protein can functionally replace EPEC EspA 
As EspD, unlike EspB, interacts with EspA, studies also examined if the E. tarda EspA 
protein would functionally replace the translocon activity of EPEC EspA. Examining the 
E. tarda LEE sequence identified an espA gene encoding a slightly larger (199 versus 
192 residue) protein with 62% identity (74.5% similarity; Figure 33). Key features linked 
to T3SS secretion and protein functionality are highlighted with, of note, most of 
additional residues reflecting an N-terminal extension (Figure 33).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EPEC-EspA          1 -------MDTSTTASVASANASTSTSMAYDLGSMSKDDVIDLFNKLGVFQ     43 
                            :|..:..||........| :.|||.||||.||..||.|:|.|| 
E.tarda-EspA       1 MFLIYRRIDDMSDISVGGGFQVDGT-LGYDLSSMSKADVQALFEKVGAFQ     49 
 
EPEC              44 AAILMFAYMYQAQSDLSIAKFADMNEASKESTTAQKMANLVDAKIADVQS     93 
                     |||::|:.||.|||.::...||:||||||.||.||||.|||||||||||| 
E.tarda           50 AAIMLFSSMYSAQSKMTTKVFAEMNEASKASTEAQKMENLVDAKIADVQS     99 
 
EPEC              94 SSDKNAKAQLPDEVISYINDPRNDITISGID-NINAQLGAGDLQTVKAAI    142 
                     |||||.|.:||.|||.|||||.|:|.|||:. .:...:|||||||||||: 
E.tarda          100 SSDKNTKVKLPQEVIDYINDPSNEIKISGLSVGLTEAMGAGDLQTVKAAL    149 
 
EPEC             143 SAKANNLTTTVNNSQLEIQQMSNTLNLLTSARSDMQSLQYRTISGISLGK    192 
                     .|||||||:.||::||:|||:||||||:||.|||:|||||||||||::|| 
E.tarda          150 GAKANNLTSVVNSNQLQIQQLSNTLNLMTSTRSDLQSLQYRTISGITIGK    199 
Figure 33: Comparison of E. tarda and EPEC EspA proteins.The E. tarda and EPEC EspA protein 
sequences were aligned (http://www.ebi.ac.uk/Tools/psa/emboss_needle/) with key features 
highlight (in blue) the region linked to the T3SS secretion signal, (in black) transmembrane domain, 
(in red) coiled coil region - critical for EspA filament assembly but not effector translocation (Delahay 
et al., 1999) - and (underlined) alpha-helical regions (I and II) linked to CesA chaperone binding (Yip 
et al., 2005). 
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3.3.8.1 Cloning E.tarda espA into pACYC184 
The same strategy, as described for espDEt, was used to clone espAEt into pACYC-
184 (Figure 34), with introduction of pACYC-espAEt into the EPEC ΔespA mutant 
supported by PCR analysis (Figure 34E). 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.8.2 Similar phenotyope for ΔespA/pACYC-espAEt and ΔespD/pACYC-espDEt 
strains 
Preliminary studies also revealed a binding defect for the ∆espA mutant when carrying 
the EspAEt encoding plasmid, so infections were carried out for up to 9 hr – replacing 
the media every 3 hrs for control strains – prior to isolating Triton X-100 soluble and 
insoluble fractions.  
 
Western blot analysis confirmed (Kenny et al., 1996) Tir expression but not delivery by 
the ∆espA mutant with plasmid re-introducing the EPEC espA gene resulting in an 
EPEC-like phenotype i.e. similar levels of T’/T” forms in the soluble fraction and, due 
to interaction with Intimin, T’’ form in the insoluble fraction (Figure 35). Interestingly, 
while introducing the espAEt gene carrying plasmid also restored Tir delivery – 
Figure 34: Construction of pACYC-espAEt. A) The E.tarda espA gene was PCR amplified 
as a single band of expected molecular size (~0.8kb) over a range of annealing temperatures. 
B) pACYC-184 was digested with BamHI and SalI restriction enzymes prior to isolating ~4kb 
vector bands for C) use with espAEt (~0.8Kb) PCR fragment in Gibson Assembly protocol to 
generate pACYC-espAEt. PCR analysis supports introduction of espAEt carrying plasmid into 
D) non-pathogenic E.coli and E) EPEC ΔespA mutant.  
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evidenced by only low level of T’’-like form was evident in the soluble fraction (Figure 
35), no T’’ form was evident in the insoluble fraction (Figure 35). However, 
unexpectedly, bands linked to T0 and EspB were detected in the soluble fraction of 
cells infected with ∆espA mutant. The detection of these bands may be related to a 
cross contamination from bacterial lysis or endocytosis of Tir and EspB into such 
membranous compartments. Importantly, this band (T0) was not modified to the T’-like 
form. Probing for EspB in both soluble and insoluble fractions failed to define 
differences to explain the different Tir profiles (Figure 35). This work suggests that the 
E. tarda espA gene encodes a protein that can only weakly functional replace the 
translocator activity of the EPEC EspA protein but, like E tarda EspD, negative impacts 
on the Tir To to T’/T’’ modification process and/or Intimin’s ability to stably interact with 
the Tir T’’ form.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35: E.tarda EspA rescues the EPEC ΔespA mutant defect in delivering Tir linked to a 
defect in Tir modification and Intimin interaction with Tir. HeLa cells were infected for 6 and/or 
9hr with indicated strains before isolating Triton X-100 soluble (containing host cytoplasm and 
membrane proteins plus delivered effectors) and insoluble (containing host nuclei and cytoskeletal 
proteins plus adherent bacterial proteins) fractions for western blot analysis probing for Tir and EspB. 
The position of unmodified (T
o
) and host kinase modified (T’/T”) forms are indicated (by arrows) as 
are EspB and protein markers. Strains used were EPEC and ∆espA mutant carrying no plasmid (-) 
or a plasmid carrying the EPEC (espAEPEC) or E. tarda (espAEt) espA genes. This study included two 
∆espA/pACYC-espAEt clones. 
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3.3.8.3 The ΔespA/pACYC-espAEt mutant has a functional Intimin surface protein  
The surprising detection of the Tir T” modified form in the soluble but not insoluble 
fraction of cells infected with the ΔespA mutant carrying pACYC-espAEt questioned 
whether the strain had a functional Intimin protein. To address this possibility, the two-
wave infection protocol was undertaken to determining, as before (Chapter 3; Section 
3.3.2), whether Tir T’’ in cells pre-infected with the Intimin (eae) mutant would migrate 
into the insoluble following a second wave infection with the ΔespA complemented 
strains.  
 
 Western blot analysis of isolated soluble fractions revealed Tir T’’ in the soluble, 
with a little in the insoluble, fraction of cells pre-infected with the eae mutant, with 
subsequent infection by the ΔespA complemented (plasmid carrying espAEt or 
espAEPEC genes) strains clearly increasing the level of Tir T’’ in the insoluble fraction 
(Figure 36). This finding illustrates that the ΔespA mutant has a surface Intimin protein 
which can stably interact with the Tir T’’ form. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36: ∆espA/pACYC-espAEt strain has Intimin on its surface which can stably interact 
with the Tir T’’ modified form. HeLa cells were infected with the Intimin-deficient (eae) mutant for 
3hr before gentamycin-killing extracellular bacteria and leaving one well uninfected or re-infecting 
with the ∆espA mutant carrying either the pACYC-espAEt or pACYC-espAEPEC plasmids. Post-
infection cells were washed before isolating Triton X-100 soluble (contains host cytoplasm and 
membrane proteins plus delivered effector proteins) and insoluble (contains host nuclei and 
cytoskeletal proteins plus adherent bacterial proteins) fractions for western blot analysis (10% SDS-
PA gel), probing for Tir or EspB. The positions of unmodified (To) and modified (T”) forms are indicated 
(by arrows) as are EspB and protein markers. 
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3.3.9 Rescuing the T3SS defect of EPEC ΔespA, ΔespD, ΔespAB and ΔespDB 
mutants by introducing E. tarda region encoding EspA, EspB and EspD 
Given that EspA interacts with EspD, but not EspB, while EspD also interacts with 
EspB (Luo & Donnenberg, 2011) studies investigated the possibility that there are 
species specific interactions between E. tarda and EPEC EspA/EspD proteins for 
maximal T3SS functionality. To test this hypothesis the E. tarda translocator gene 
region  (espADBEt) was PCR amplified and cloned into pACYC184 (Figure 37).  
 
 The resulting plasmid was initially introduced into the EPEC ∆espA and ∆espD 
mutants for infection studies prior to isolating Triton X-100 soluble and insoluble 
fractions. Western blot analysis revealed an EPEC like profile for the plasmid 
complemented strains while the single mutants, as expected, failed to deliver Tir 
(Figure 38). It should be noted that there was not only greater levels of the Tir T” form 
in the soluble fraction but also in the insouble fraction indicative of stable Tir-Intimin 
interaction (Figure 38). Indeed, similar results were obtained when the pACYC-
espADBEt plasmid was introduced into the ∆espAespB and ∆espDespB double 
mutants (Figure 39). An ∆espAespD double and ∆espAespDespB triple mutant was 
not available. Introduction of pACYC-espADBEt was further supported by probing for 
EspB as the antibodies (generated to EPEC EspB) don’t recognise the E. tarda variant 
and thus failed to detect an EspB protein despite plasmid introduction rescuing the 
mutant defect. 
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Figure 37: Construction of pACYC-espADBEt. Schematic of pACYC184 plasmid carrying E. tarda 
espADB gene region with (A-D) agarose gel data illustrating steps in generating and confirming 
plasmid construction/introduction into bacteria. A) PCR amplification, over a range of annealing 
temperatures, of single band with expected size for the espADBEt gene region, B) pACYC184 digestion 
with BamHI and SalI restriction enzymes to isolate ~4Kb vector fragment for C) use with PCR fragment 
in the Gibson Assembly protocol to produce pACYC-espADBEt with D) introduction of pACYC-
espADBEt into E.coli supported by PCR analyses using primers specific to espAEt (lanes labeled A), 
espDEt (lanes labeled D), espBEt (lanes labeled B) and the espADBEt region (lanes labeled F). The 
positive (+ve) and negative (-ve) controls were E. tarda genomic DNA and colony that grew in Cm and 
Tet plates (this indictor for Tet gene was not interrupted by inserted gene) respectively. 
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A) 
 
 
 
 
 
 
 
 
 
 
 
B) 
Figure 38: Rescuing the T3SS defect of EPEC ΔespA and ΔespD mutants by plasmid 
introducing pACYC-espADBEt. HeLa cells were infected 6 or/and 9h with indicated strains prior to 
isolating Triton X-100 soluble (containing host cytoplasm and membrane proteins plus delivered 
effector proteins) and insoluble (containing host nuclei and cytoskeletal proteins plus adherent 
bacterial proteins) fractions for western blot analysis (10% SDS-PA gel) probing for Tir or EspB. The 
position of Tir unmodified (T
o
) and host kinase modified (T’/T”) forms, EspB and protein markers are 
indicated. Strains used were EPEC, ∆espA or ∆espD mutant with mutant strain carrying no plasmid 
(-) or plasmid with espAEPEC, espDEPEC or espADBEt genes  
 
Chapter 3 Results I 
85 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39: Rescuing the T3SS defect of EPEC ΔespAespB and ΔespDespB double mutants 
by plasmid introducing pACYC-espADBEt. HeLa cells were infected 6 or/and 9h with indicated 
strains prior to isolating Triton X-100 soluble (containing host cytoplasm and membrane proteins 
plus delivered effector proteins) and insoluble (containing host nuclei and cytoskeletal proteins plus 
adherent bacterial proteins) fractions for western blot analysis (10% SDS-PA gel) probing for Tir or 
EspB. The position of unmodified (T
o
) and host kinase modified Tir (T’/T”) forms are indicated 
alongside the EspB and protein markers bands. Strains used were EPEC, ∆espAespB (∆espAB) 
or ∆espDespB (∆espDB) double mutants, with double mutants carrying no plasmid (-) or a plasmid 
carrying the espADBEt genes.  
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3.4  Discussion  
In this study, we investigated the hypothesis that Tir modification to the T”-like form 
requires the activity of LEE-encoded effector and/or translocator proteins. Firstly, we 
demonstrated that the LEE region encodes sufficient information for Tir T’ to T’’ 
modification and ruled out critical roles for all classical LEE effectors (Map, EspF, 
EspG, EspH, EspZ) and the Intimin protein. However, the work is suggestive of roles 
for several translocator proteins - EspA and EspD (not EspB which has known effector 
activities) - to enable Intimin interaction with Tir (T’’ form). Furthermore, we illustrated 
that Yersinia enterocolitica, like Yersinia pseudotuberculosis, can deliver Tir into host 
cells where it only undergoes partial modification (to T’-like form) but cannot interact 
with Intimin. Finally, we show (for the first time) that Yersinia can present EPEC Intimin 
on its surface in a conformation that allows it to stably bind plasma membrane-inserted 
Tir, but not the Yersinia delivered Tir T’ form. 
Previous studies with non-pathogenic E. coli carrying the LEE region from either EPEC 
E2348/69 or B171 strains (Yen et al., 2010, McDaniel & Kaper, 1997) reported LEE 
sufficiency to trigger actin nucleation beneath the adherent bacteria; a phenotype 
linked to Intimin interaction with Tir (Kenny & Finlay, 1997).  Thus, this finding implies 
that Tir was delivered, modified, phosphorylated on tyrosine 474 and interacts with 
Intimin (Warawa & Kenny, 2001, Kenny, 1999). However, the Tir modification profile 
was not examined in these previous studies (Yen et al., 2010, McDaniel & Kaper, 
1997). Here we show, for the first time, that the LEE region from EPEC B171 is 
sufficient for Tir delivery and host modification to the T” form. It should be noted that 
these strains carried plasmids encoding an adhesin, BFP, (Giron et al., 1991) and a 
positive regulator of LEE gene expression, Per (Mellies et al., 1999, Mellies et al., 
2007) from the corresponding EPEC LEE-providing strains. While it is possible that 
these factors may promote the Tir modification process, a recent study with non-
pathogenic E. coli  carrying a mini-LEE region - but lacking BFP and Per (Ruano-
Gallego et al., 2015) - triggered Tir/Intimin-mediated actin nucleation beneath the 
adherent bacteria. Our studies with this strain confirmed its actin nucleation capacity 
and demonstrated modification of delivered Tir to the T” form (see Chapter 5; Section 
5.3.10). It is likely that LEE from EPEC E2348/69 (0127:H6) also contains all the factors 
required for Tir modification to T” form. The latter is supported by finding that a strain 
(TOE-A7) lacking most proven (14 of 17) non-LEE effectors delivered Tir which was 
modified to the T’’ form and interacted with Intimin.   
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Furthermore, we not only confirmed that Yersinia (which encodes a T3SS) can deliver 
Tir into the host cells - where it is only partially modified and cannot interact with Intimin 
(Kenny & Finlay, 1997, Warawa & Kenny, 2001) - but also show that a Yersinia 
enterocolitica strain can be used instead of Yersinia pseudotuberculosis. It should be 
noted that these strains lack genes encoding the main Yersinia encoded (Yop) 
effectors. We adapted the Yersinia Tir-delivery model by introducing a plasmid that not 
only encodes for Tir and its chaperone CesT but also Intimin in the hope that Intimin 
would be presented on the Yersinia surface in a manner that can bind to membrane-
inserted Tir T’’ form to aid the screening program. As far as we are aware, we have 
shown for the first time that Yersinia can express and transport Intimin to its surface 
where it can interact with the plasma membrane-inserted Tir T’’ protein.  This finding, 
together with the LEE sufficiency data supports the hypothesis that LEE encoded 
factors are required to be expressed and/or delivered with Tir to enable modification 
from T’ to T” form and insertion into the plasma membrane in a conformation that can 
be stably bound by Intimin. 
The initial strategy to screen for LEE effectors aiding Tir modification by introducing 
plasmids encoding single or multiple LEE effectors into the Tir/CesT/Intimin-expressing 
Yersinia was abandoned as the resulting strains expressed, but no longer delivered 
Tir.  These results are consistent with those of another PhD student (A. Al-Layla; 
unpublished) where introducing two different plasmids into Yersinia sometimes 
negated delivery of the EspF effector. We suggest that introduction of different 
combinations of plasmids and/or expressed cloned gene products stress Yersinia 
leading to activation of regulatory circuits that switch-off its T3SS. Further studies are 
needed to examine this possibility. Nevertheless, the work showed that Yersinia 
enterocolitica can, like Yersinia pseudotuberculosis, express Tir and Intimin with the 
former protein delivered into HeLa cells where modified to the T’-like form while Intimin 
is correctly presented on the Yersinia surface where can stably bind the Tir T” form, 
but not the, Yersinia delivered, T’ form. 
An alternative strategy to define LEE factors aiding Tir modification involved using 
strains lacking multiple LEE genes. This illustrated that the bacterial outer membrane, 
Intimin and the LEE encoded classical effector proteins (EspG, Map, EspF, EspH and 
EspZ) play no obvious roles in the Tir expression, delivery, modification to the T” form 
or insertion into the host cells membrane processes. Moreover, this strategy showed 
that the resulting T” form can interact with the Intimin suggesting that Tir is completely 
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functional in the absence of the other, classical, LEE effectors. These results are 
consistent with a recent study with non-pathogenic E. coli carrying a mini-LEE region, 
from EPEC E2348/69 (Ruano-Gallego et al., 2015) that encodes a functional effector-
delivery system plus Tir, CesT and Intimin proteins but lacks genes for the other 
classical effector proteins (EspG, Map, EspF, EspH and EspZ). Our work has 
confirmed that this Mini-LEE strain delivers Tir into HeLa cells and illustrates, for the 
first time, modification to the T” form (see Chapter 5; Section 5.3.10), supporting non-
essential contributions for Intimin and all classical LEE effectors in the Tir T’ to T” 
modification process. Collectively, this finding argues for a possible role for the non-
classical effector protein, EspB (a translocator), other translocators (EspA; EspD) or 
other T3SS substrates encoded on the mini-LEE region. 
Comparison of attaching and effacing pathogen LEE regions has revealed high 
homology between most T3SS components with more variation among proteins that 
interact with host cells i.e. effectors and translocators (Perna et al., 1998). The mini-
LEE region encodes 26 proteins  (Ruano-Gallego et al., 2015) of which all, but not the 
translocators and Tir, are in the highly homologous family of proteins. This suggests 
that the translocators may aid the T’ to T” Tir modification and/or membrane insertion 
processes. However, it is also possible that there are unrecognised Orf (less than 
scanned for 50AA minimum size) encoding T3SS substrates that mediate and/or 
contribute to the Tir modification processes. The later idea is not implausible as the 
LEE encodes small proteins such as EspZ (98AA), the EscF needle protein (73AA) 
and the EscF chaperone, EscE (72 AA). If such a protein exists, it would be predicted 
to be shared with a low percentage of homology by all A/E pathogens. 
The three translocator proteins (EspB, EspD, EspA) are critical for T3SS functionality 
(Taylor et al., 1998, Kenny et al., 1996, O'Connell et al., 2004) with only one, EspB, 
known to possess effector functions (Taylor et al., 1998, Kodama et al., 2002, Iizumi 
et al., 2007). Crucially, evaluation of these proteins for effector functionality is not 
possible using a gene deletion strategy. However, an EspB (EspB-mid) variant lacking 
60 amino acids was examined as it maintains its T3SS functions but no longer binds 
host myosin proteins to inhibit phagocytosis (Iizumi et al., 2007). Initial studies with the 
provided EspB-mid expressing plasmid failed to rescue the espB mutant defect linked 
to the presence of C-terminal myc taq. This myc-tagged EspB variant was used for co-
immunoprecipitation studies (Iizumi et al., 2007) and presumably blocks the EspB 
translocator activity. A key role for the C-terminal domain in the translocation process 
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is consistent with the non-functionality of EspB following introduction of a GSK tag (13-
amino-acid) after residue 186 or 305 of the 320 residues of EspB protein (Luo & 
Donnenberg, 2011). However, once we made an untagged EspB-mid variant, our 
studies confirmed its ability to restored T3SS functionality to an espB mutant, leading 
to Tir delivery and modification to T” form. However, there was a noticeable reduction 
in the level of Tir T’/T” forms suggesting that EspB-mid may be less capable for 
delivering effectors. The latter has implications on the conclusion that EspB plays an 
important, direct, role in anti-phagocytosis and effacement processes (Iizumi et al., 
2007) as perhaps the observed defect relate to delayed or reduced delivery of 
effectors. 
The possible role for EspB in the Tir modification process was further investigated by 
examining the functional interchangeability with a divergent homologue (37.8% 
identity/55.7% similarity) from a fish pathogen, E tarda FCP503. Crucially, this strain 
carries a LEE region encoding transcriptional regulators, Intimin, T3SS proteins, 
chaperones, translocators and Tir, but not other classical LEE effectors (Nakamura et 
al., 2013). It was postulated that this strain, that lacks other LEE effectors, may insert 
Tir directly into the membrane of fish cells and thus does not to need bestow 
translocators or other proteins with functions to aid Tir membrane insertion from the 
host cytoplasm. However, despite the low level of identity, the E. tarda variant (EspBEt) 
completely restored the capacity of the EPEC EspB deficient mutant to translocate Tir 
into HeLa cells where modified to T” form and stably binds Intimin; latter illustrated by 
detecting pedestal formation (Rosenshine et al., 1996, Kenny, 1999). However, the 
complemented strain appeared to be less capable of delivering Tir and/or promoting 
its modification to the T’/T” forms but whether this reflects issues with EspBEt 
expression, translocation - latter perhaps due to different codon usage, instability 
and/or reduced recognition by EPEC T3SS - or effector functionality differences 
remains to be determined. Interestingly, the EspBEt chaperone, CesAB, is only 35% 
identical to its EPEC homologue (see Chapter 4; Table 8). Interestingly, EspBEt shares 
limited sequence similarity between residues found to be critical to EspB-EspD binding 
(Luo & Donnenberg, 2011) raising the possibility of reduced EspBEt-EPEC EspD 
interactions with an impact on effector (Tir and presumably others) translocation levels. 
Collectively, the work ruled out a key role for the myosin binding region (60 residues) 
and features not conserved with EspBEt in aiding Tir modification to the T’’ form. 
However, it remains possible that EPEC and E tarda EspB proteins share features that 
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aid the Tir modification process but further studies are needed to investigate this. 
Alternatively, perhaps the Tir modification process is aided by the activity of other 
translocators or undefined T3SS substrates. 
The possible contribution of other translocators (EspD and EspA) in the Tir modification 
process was investigated by examining the functional interchangeability with the E. 
tarda homologues - EspDEt (50.9% identity) and EspAEt (62.0% identity). Interestingly, 
complementing the appropriate EPEC single mutant resulted in very small amount of 
a modified (T”-like) form. However, this Tir species did not appear to interact with 
Intimin questioned whether it is indeed the T” form. While this defect might be due to 
poor expression or stability of EspDEt and/or EspAEt, which does not appear to be the 
case as introducing the EspADBEt operon into the single (or available double; noting 
triple espABD mutant not available) mutants restored Tir delivery with greater level of 
the T” form. This work demonstrated that the EspAEt/EspDEt homologues can 
functionally substitute for their homologues but only when co-expressed. The latter 
finding probably reflects co-divergence of E. tarda EspD and EspA proteins, which are 
known to interact (Luo & Donnenberg, 2011), reducing their ability to work with the 
EPEC homologues. Strain specific differences are supported by the finding that the 
PopB/PopD translocators of P. aeruginosa are inefficient substitutes for Yersinia 
YopB/YopD translocators unless co-expressed with the hydrophilic translocator PcrV 
protein (Frithz-Lindsten et al., 1998). While our data has not found a critical role for 
EspA or EspD proteins in the process that modifies Tir to the T” form, it is suggestive 
of an unexpected role in the Tir-Intimin interaction. Further studies are needed to 
confirm this hypothesis and, if appropriate, shed insight on the mechanism. 
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4.1  Introduction 
The prototypic EPEC strain E2348/69 modulates cell traits through a syringe-like 
apparatus composed of a type III secretion system (T3SS; Esc and Sep proteins) that 
spans the bacterial envelope with an extension (needle and translocator proteins). The 
Esc/Sep/translocator proteins are encoded on a 35 Kb-pathogenicity island called the 
Locus of Enterocyte Effacement (LEE) alongside genes for transcriptional regulators, 
T3SS substrates (translocator and effector proteins), chaperones (aid T3S substrate 
secretion) and the virulence-critical Intimin outer membrane protein (McDaniel et al., 
1995, Gaytan et al., 2016). LEE encoded regulators include Ler which functions as a 
master positive regulator while, GrlR acts as a negative regulator of LEE gene 
expression and GrlA as a positive regulator (Iyoda et al., 2006). The syringe-like 
apparatus is used to translocate ‘effector’ proteins into mammalian cells of which the 
LEE encodes seven:  EPEC secreted/signalling protein F (EspF), EspG, EspH, EspZ, 
EspB, Translocated intimin receptor (Tir) and Mitochondrial-associated protein (Map) 
(Hueck, 1998, Burkinshaw & Strynadka, 2014). The T3SS/translocator system is 
composed of ~20 proteins that form a basal body, export apparatus (needle, filament 
and translocator pore) with roles for cytoplasm-located components (See Figure 40).  
4.1.1 Type III secretion system components 
4.1.1.1 Export Apparatus   
The export apparatus consists of EscR, EscS, EscT, EscU, and EscV proteins (Figure 
40) predicted to be expressed immediately after T3SS induction with each being 
essential for T3SS functionality (Yerushalmi et al., 2014). EscU has two major domains 
with the N-terminal domain containing four predicted transmembrane regions while the 
cytoplasmic C-terminal domain undergoes auto-cleavage at a conserved amino acid 
sequence (Thomassin et al., 2011). This self-cleavage event is required for efficient 
effector delivery into infected cells (Thomassin et al., 2011). EscU also interacts with 
two components of the basal body (see below) -  EscP ‘ruler’ protein that measures 
the length of the EscF needle and EscI which link inner membrane and outer 
membrane complexes –  with this interaction involved in the switching event from early 
needle (EscI/EscF) to the intermediate translocators (Monjaras Feria et al., 2012). 
EscV, like EscU, has two distinct domains with the N-terminal region possessing eight 
transmembrane helices and a C-terminal cytoplasmic domain that is much larger than 
EscU’s (Gaytan et al., 2016).  
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4.1.1.2 Basal Body 
The basal body is comprised of four main proteins - EscD and EscJ form the inner 
membrane ring (IM) with EscC protein the outer membrane ring (OM) while EscI 
provides a periplasmic inner rod that connects the rings (Figure 40). EscD has a 
putative transmembrane domain at its N terminus (residues 120 to 141) that may 
associate with the inner membrane, while a segment of EscD is located in the 
periplasm interacts with EscC (Ogino et al., 2006). By contrast, EscJ has a sec-
dependent signal sequence and interacts with the needle protein, EscF (Crepin et al., 
2005, Ogino et al., 2006). EscC has two distinct domains with the N-terminal and C-
terminal regions in the periplasm and outer membrane respectively (Figure 40) 
(Gauthier et al., 2003). In addition, EscC has been shown to interact with both the EscF 
Figure 40: Schematic of EPEC injectisome. The basal body of the T3SS is composed of the inner 
(EscD and EscJ) and outer (EscC) ring proteins, the export apparatus (EscRSTUV) which connects 
the inner and outer membrane ring structures, the cytoplasmic components (EscN, EscL & EscO) and 
C-ring plate sorting platform (EscQ, EscK & EscL). EscF forms the needle which is extended by 
polymerisation of the EspA translocation protein and tipped by two other translocator (EspB and EspD) 
protein that can insert in the host cell plasma membrane to form a pore and complete the effector-
delivery conduit. ATPase EscN provides the energy to the system, while SepD and SepL act as a 
molecular switch. Adapted from (Romo-Castillo et al., 2014) 
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needle protein and EscD and with one of the ATPase complex components, EscO 
(Creasey et al., 2003a, Ogino et al., 2006, Sal-Man et al., 2012a). EscC, EscD, and 
EscJ are required for the secretion of effector proteins (Ogino et al., 2006). 
 
4.1.1.3 Cytoplasmic Components 
There are five essential cytosolic proteins of which three (EscN, EscL, EscO) form an 
ATPase complex (Figure 40) critical for T3SS functionality (Romo-Castillo et al., 2014). 
EscN is an ATPase, and potential source of energy, localized to the inner leaflet of the 
bacterial cytoplasmic membrane where it energizes the release of chaperones from 
effectors for subsequent secretion (Gauthier & Finlay, 2003). EscN interacts with a 
negative regulator, EscL (previously Orf5) (Figure 40), which can inhibit ATPase 
activity. The formation of an EscN/EscL/EscO complex promotes a conformational 
change that allows EscO to promote EscN oligomerization and stimulates EscN 
ATPase activity (Romo-Castillo et al., 2014). EscO (previously Orf15 or EscA) is 
localized in the periplasm and associated with the inner membrane to interact with the 
outer membrane OM ring membrane protein EscC (Sal-Man et al., 2012a) and also 
interacts with the chaperones CesA2 (EscG) and CesL (Mpc) (Lin et al., 2014). The 
ATPase complex components EscN, EscL and EscO interact with EscQ (previously 
SepQ) – a cytoplasmic protein that interacts with EscL and EscK (formerly Orf4) to 
form a sorting platform. The latter platform acts with chaperones and molecular switch 
(SepL and SepD) proteins to control the correct hierarchy of substrate (early 
[EscI/EscF], intermediate [translocators] and late [effectors]) secretion (Lara-Tejero et 
al., 2011, Soto et al., 2017). 
 
4.1.1.4 Extracellular Appendage 
The extracellular appendage structure is comprised of the needle protein (EscF), an 
extension filament (EspA) and pore-forming proteins (EspD and EspB) that connects 
the bacterial cytoplasm to host cytoplasm (Figure 40) to enable the direct delivery of 
effector. In EPEC, the EscF needle length is regulated by the EscP ‘ruler’ protein which 
interacts directly with EscF and measures needle length during the assembly process 
(Journet et al., 2003). The needle extension is an unusual feature of EPEC, and related 
pathogens, through the polymerization of EspA subunits with EspB/EspD proteins at 
the end for insertion to the host plasma membrane to complete the conduit from 
bacterial to host cytoplasm (Figure 40) (Knutton et al., 1998). Each translocator protein 
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is critical for delivery, not extracellular secretion, of effector proteins (Lai et al., 1997, 
Foubister et al., 1994, Kenny et al., 1996).  
 
The hydrophobic translocators, EspB and EspD, interact with both each other and with 
hydrophilic EspA (Luo & Donnenberg, 2011). Upon contact with the epithelial cell, 
EspD is inserted into the plasma membrane of the target cell to form a pore with two 
predicted transmembrane domains (Wachter et al., 1999). EspD has two coiled coil 
motifs in its N-terminal to mediate EspD oligomerization, and can interact with itself 
through a C-terminal coiled- coil domain which is necessary to form a pore (Daniell et 
al., 2001, Wachter et al., 1999). By contrast EspB is predicted to have one 
transmembrane domain with an extracellular location of the EspB N-terminal domain 
and the C-terminal domain exposed to the host cytoplasm to interact with cellular 
signaling pathways that are important in EPEC-induced cytoskeletal reorganization 
(Luo & Donnenberg, 2011, Taylor et al., 1998, Kenny & Finlay, 1995). Indeed, while 
the N-terminal of EspB interacts with the actin-binding protein α-catenin (Kodama et 
al., 2002), the C-terminal has been found to bind host myosin proteins linked to 
subverting host cellular processes, leading to microvilli effacement and EPEC 
phagocytosis inhibition (Iizumi et al., 2007). The pores formed by EspB and EspD are 
composed of six to eight subunits with a minimal pore size of 3–5 nm (Ide et al., 2001). 
However, EspD-EspD interaction forming a pore with an inner diameter of 2.5 nm 
which consist of six to seven subunits (Chatterjee et al., 2015). By contrast, EspB 
seems to play a secondary role in pore formation since espB mutant caused only a 
slight reduction in haemolysis (Shaw et al., 2001) suggesting a critical role for EspD in 
pore formation. The T3SS must traverse both bacterial membranes and the 
peptidoglycan layer. This requires a dedicated peptidoglycan lytic enzyme, EtgA, to 
locally degrade peptidoglycan (Koraimann, 2003). However, the EtgA PG-lytic activity 
is enhanced by interacting with the T3SS inner rod component, EscI, (Burkinshaw et 
al., 2015). 
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4.1.2 Edwardsiella tarda (E.tarda) LEE region 
Recently, a fish pathogen Edwardsiella tarda (E. tarda) was reported to possess a 
LEE-like region (Nakamura et al., 2013). E. tarda, an  enterobacteriaceae family 
member, is a Gram-negative intracellular pathogen of fish and mammals (Mohanty & 
Sahoo, 2007) which can also causes haemorrhagic septicaemia and gastro-intestinal 
infections in humans (John et al., 2012). The ~30kDa LEE pathogenicity island 
apparently encodes 29 proteins (of greater than 50AA) and has homologues in the 
EPEC region (which encodes 41 proteins). The E. tarda genes also fall into five 
operons but the order is different (Figure 41). Interestingly, the ‘missing’ genes encode 
all the EPEC effectors, except Tir and EspB, two chaperones (CesF [substrate EspF] 
and one of two EscF chaperones; EscE]), 2 transcriptional regulators (GrlA; GrlR) and 
a protein of unknown function (rORf1). Thus, the region has genes for Intimin, CesT 
(Tir chaperone), type three secretion system (T3SS), translocators (EspA, EspB and 
EspD), other chaperones (CesA, CesD, and CesD2), master transcriptional regulator 
(Ler) and transglycosylase (EtgA). Indeed, adjacent to the LEE region is a sequence 
encoding another effector and chaperone similar to those encoded by other enteric 
pathogens (Nakamura et al., 2013). Thus, the E. tarda LEE region may encode an 
injectisome that delivers Tir, and other effectors, into host cells with Tir serving as a 
receptor for the Intimin surface protein to promote pathogen-host cell interaction.   
 
 
 
Figure 41: Pathogenicity islands of E. tarda genes were compared with the corresponding 
genes in Escherichia coli O127. Taken from (Nakamura et al., 2013). 
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4.2  Aim 
The aim of work presented in this chapter was to use bioinformatics approaches to 
interrogate the degree of homology and likely functionality of E. tarda LEE genes as a 
possible model for understanding T3SS/translocator functionality in transferring 
effectors into target cells and mechanism of Tir insertion into the plasma membrane. 
Chapter 4 Results II 
98 
  
4.3  Results  
4.3.1 Bioinformatics  
4.3.2 E. tarda LEE region has an espZ gene  
The E. tarda LEE DNA sequence was kindly provided by Dr Yoji Nakamura enabling 
bioinformatics to define open reading frames of >50 AA 
(http://nc2.neb.com/NEBcutter2/index.php) for translation to protein sequences and 
comparison to database proteins (https://blast.ncbi.nlm.nih.gov/Blast.cgi). These 
analyses confirmed the absence of genes for homologues of the EPEC LEE EspG, 
EspH, EspF, Map, CesF, GrlA, GrlR and rOrf1 proteins (Table 8) but, surprisingly, 
revealed an EspZ-encoding gene. Interestingly the predicted E. tarda EspZ protein was 
larger (129 versus 98 residues) due, mainly, to N and C-terminal extensions. 
Interestingly, the greatest degree of homology was between the predicted 
transmembrane domains with least homology in the extracellular domain (Figure 42).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42: Alignment of E. tarda and EPEC EspZ proteins. The E. tarda and EPEC EspZ proteins 
sequences were aligned (http://www.ebi.ac.uk/Tools/psa/emboss_needle/). Highlighted in black is the 
extracellular domain with predicted transmembrane domains in yellow.  
 
 
 
EPEC-EspZ          1 ----------------MEAANLS--PSGAVLPLAA--TINGNNPVDEKTG     30 
                                     |....:.  ||.| ||:..  |....|.|    | 
E.tarda-EspZ       1 MLILAALIYDLLEYSAMTTGTIGTLPSNA-LPMRPINTHESTNAV----G     45 
 
EPEC              31 VMQSEG--GTSRSVRILGGVLIGAG---VLAAIGTGIAAMCV---DDPSQ     72 
                     |:.||.  .|||:::|   |.:.:.   ||.||||||||...   .|... 
E.tarda           46 VLNSESSTNTSRTIKI---VTLASSLTLVLGAIGTGIAAKVTGDNGDADS     92 
 
EPEC              73 RLGLGIAAGVLGGVTTVAGGLAMKYA-----------     98 
                     .:.||::|||||.|...||.|....|            
E.tarda           93 SMALGVSAGVLGFVGLGAGVLGSIVAKKLDNNSSNNS    129 
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 Protein EPEC E. tarda Identity    similarity Protein function Reported 
1 rOrf1  Missing   Unknown function  
2 EspG 398aa Missing   Effector  
3 Ler 129aa 129aa 38.6% 54.5% LEE encoded the master regulator   
4 EscE /Orf2 72aa 76aa 35.1% 51.9% Class II chaperone for EscF   
5 CesAB 107aa 104aa 35.3% 54.6% Class II chaperone for EspA & EspB   
6 EscK /Orf4 199aa 121aa 12.6% 21.4% A sorting platform protein   
7 EscL /Orf5 231aa 215aa 27.3% 53.7% A negative regulator that inhibits 
EscN ATPase activity 
  
8 EscR 217aa 218aa 73.4% 88.5% T3SS core proteins (T3SS export 
apparatus) contribute to the 
recruitment and regulation of initial 
insertion of substrates into the 
injectisome. 
  
9 EscS 89aa 89aa 63.0% 82.6%   
10 EscT 258aa 259aa 56.1% 75.6%   
11 EscU 345aa 345aa 58.0% 78.8%   
12 EtgA 152aa 158aa 43.2% 62.3% A peptidoglycan lytic enzyme   
13 grlR  Missing   A negative regulator of LEE gene 
expression 
 
14 grlA  Missing   A  positive regulator of the ler 
expression 
 
15 CesD 151aa 153aa 64.3% 79.9% Class II chaperone for EspD &EspB   
16 EscC 512aa 503aa 64.6% 80.3% T3SS outer membrane ring (IM)    
17 SepD 151aa 143aa 39.6% 63.6% Molecular Switch from 
translocators to effectors 
  
18 EscJ 190aa 179aa 53.1% 72.9% T3SS inner membrane ring (IM)    
19 EscI /Orf8 142aa 130aa 46.9% 
63.3% 
The T3SS inner rod that connect  
OM and IM rings 
  
20 EspZ /SepZ 98aa 129aa 29.9% 38.0% Effector  
21 CesL/Mpc 117aa 107aa 30.1% 42.3% A class I chaperone for SepL   
22 EscV 675aa 674aa 66.3% 79.9% T3SS export apparatus   
23 EscN 466aa 458aa 62.1% 76.4% ATPase complex  T3SS component   
24 EscA/EscO/ 
Orf15 
125aa 122aa 25% 54% AATPase complex component that 
stimulates EscN ATPase activity 
  
25 EscP/Orf16 138aa 103aa 21% 39% Regulate EscI secretion/ Molecular 
ruler/ Molecular Switch (by 
interacting with EscU) 
  
26 SepQ/EscQ 305aa 297aa 21% 44.1% C-ring of T3SS that act as sorting 
platform 
  
27 EspH 168aa Missing   Effector  
28 CesF 120aa Missing   Class IA chaperone that binds EspF  
29 Map 203aa Missing   Effector  
30 Tir 550aa 529aa 24% 36.3% Translocate intimin receptor   
31 CesT 156aa 156aa 60.3% 80.1% Class IB chaperone for Tir effector 
and many LEE/non-LEE effectors  
  
32 Intimin/eae 939aa 1117aa 39.6% 51.6% Extracellular bacterial protein   
33 EscD* 406aa 416aa 43.7% 61.0% The  T3SS inner membrane ring (IM)    
34 SepL* 351aa 343aa 49.3% 74.4% Molecular Switch (gatekeeper)   
35 EspA 192aa 199aa 62.0% 74.5%  
Translocators 
  
36 EspD 380aa 385aa 50.9% 66.9%   
37 EspB 321aa 340aa 37.8% 55.7%   
38 CesD2 135aa 136aa 53.7% 66.9 % Class II chaperone for EspD   
39 EscF 73aa 74aa 67.6% 87.8% T3SS component ( needle protein)   
40 EscG/Orf29/
CesA2 
92aa 89aa 36.8% 56.8% Class III chaperone of the needle 
protein EscF and the filament 
protein EspA 
  
41 EspF 206aa Missing   Effector  
Table 8: Comparison of reported virulence proteins encoded among E. tarda and EPEC LEE 
region. E. tarda and EPEC protein sequences were aligned using the EMBOSS Needle Program 
(http://www.ebi.ac.uk/Tools/psa/emboss_needle/). Rows highlighted in green correspond to the 
missing effectors. While the blue color corresponds to the reported missing protein, red color refers to 
unreported effectors. EscD* is truncated into two proteins EscD1 (157aa) and EscD2 (259aa). SepL* 
is truncated into two proteins SepL1 (125aa) and SepL2 (218aa) where the latter beings with the rare 
codon ATT instead of ATG. 
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4.3.3 Proteins encoded over two adjacent open reading frames  
Comparing the size of predicted E. tarda LEE proteins to their EPEC homologues 
found most to share a similar number of residues with a few notable exceptions (Table 
8) i.e. EscL (146 versus 231 residues), EscD (259 versus 406 residues) and SepL (218 
versus 351 residues). Further interrogation of the escD gene region revealed an escD-
like sequence (escD2) on an adjacent open reading frame, Orf, which if placed in frame 
with the first Orf (escD1) would produce a 416 residue protein sharing good homology, 
over the entire length, with the EPEC homologue, except for a short N-terminal 
extension (Figure 43). Indeed, the ‘fused’ EscD protein shares a similar output with its 
EPEC homologue when probing for transmembrane domains (Figure 44). 
As it is was possible that the two Orfs relate to sequencing errors, oligonucleotides 
were designed to PCR amplify the out-of-frame region which, surprisingly, failed to 
define sequencing errors (Figure 45). This finding suggests that EscD is either non-
functional or, as reported for some T3SS components (Penno et al., 2006), expressed 
from two adjacent open reading frames. The latter is associated with regulating protein 
expression or function with a single polypetide generated by ribosome slippage or 
jumping (Atkins et al., 2016, Penno et al., 2006). However, it is also possible that EscD 
is expressed as two separate polypeptides that can function together and/or 
individually. 
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Figure 43: Alignment of E. tarda and EPEC EscD proteins. The E. tarda and EPEC EscD 
proteins were aligned (http://www.ebi.ac.uk/Tools/psa/emboss_needle/). The combined E. tarda 
EscD1 (1 -259AA) and EscD2 (260-449AA) sequence were combined into a single protein.  
 
 
E. tarda-EscD      1 MLTVLSSYFICLLAAIINMRSCDYKIRFLTWPCLSGRELIVPICESFSIG     50 
                                       |.| .|||:.|. ..:..|||.:|: .:.::| 
EPEC-EscD          1 ------------------MLS-SYKIKLLN-GAMRNRELQLPM-GNLTLG     29 
 
E. tarda          51 KNDDSLITYQLENPCLQNFTLSTNDCDGVWLNTPTTCFWINGIQTSNCAD    100 
                     ..|:.::.:.||.. |..|.|...: :||:|.:|.. |||:|..|...|| 
EPEC              30 TEDNDIVYFPLEQG-LNQFLLDIRE-EGVFLLSPVE-FWIDGQPTPYEAD     76 
 
E. tarda         101 SILLPLNQPIDIAGCGFICLLSADQETSLCVSLPKRKKNACHIDKKNIVV    150 
                     . .||:.:.||||||   |.:..|.:.||.:|....:.:|.:..||.::: 
EPEC              77 K-PLPVGKIIDIAGC---CFIIGDIDHSLPLSDVPERFSAKNQRKKRLIL    122 
 
E. tarda         151 ICASLLFLTLSLS-IFAFFIMIS-----CLISREDVYQSCLKKEKLFAIV    194 
                       ||::..|.:|| ....::::|     ...:|.||||. ||:.||.||. 
EPEC             123 --ASVIGATFALSGAIGSYVLLSPKAEPPTFTRADVYQQ-LKENKLHAIT    169 
 
E. tarda         195 CPVWHGSSIALCYGRCEQSSQLQTFFNFLYKNCNIRYINNIICCNDQIIS    244 
                     . ||||.:||| |||||.::.|..|||:| |..||.|.|.|| ||:|||| 
EPEC             170 L-VWHGKNIAL-YGRCESTTDLTPFFNYL-KEKNIFYYNKII-CNNQIIS    215 
 
E. tarda         245 GINDCVLVQYGYDNICDVSYGGSPGFFILSGYIQSPCLQWKKVEGQLCLT    294 
                     .||| ||.:|||.:|. ::.|..||||:||||| .|..:|.:|| .|.|. 
EPEC             216 AIND-VLTEYGYKDII-ITKGNKPGFFLLSGYI-PPSPKWSEVE-NLLLN    261 
 
E. tarda         295 MPGVRGWQCVRNKADAIINCSLVDELSKNKLINKLSIHKRCDKAIIIDGL    344 
                     .|||.||: :.|.::..|| .|..|..||||||.::|.|:.| .||:.|. 
EPEC             262 TPGVAGWE-IHNNSNNKIN-ELASEFKKNKLINYVNIFKKND-VIIVAGE    308 
 
E. tarda         345 VCSAVEEQKIINCIIDRLNNN---KICIFQNIPPYIPKNLFSGKIIRCVS    391 
                     | |...|.||: .||:.:|.|   || :||||.|||..::|.|||:| :| 
EPEC             309 V-SQQNESKIL-AIINAMNKNSNVKI-LFQNIQPYISADIFPGKILR-IS    354 
 
E. tarda         392 GTKNAPMICTLDNGSTLTVCGSALNNGYIICNEISLENGISISRENELIH    441 
                     ||...|.| .||||::|.: ||.|..||:| :.|..::||:|||.:|.|| 
EPEC             355 GTMKNPTI-ALDNGTSLGI-GSILKGGYVI-DAIDPKDGINISRPDEYIH    401 
 
E. tarda         442 ICPISYDK    449 
                     | |:||   
EPEC             402 I-PLSY--    406 
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Output from TMpred 
 
2 possible models considered, only 
significant TM-segments used 
 
-----> STRONGLY prefered model: N 
terminus inside 
 2 strong transmembrane helices, total 
score: 2798 
 # from    to    length   score    orientation 
 1- 120   142   (23)      2220        i-o 
 2- 360   382   (23)      578          o-i 
 
------> Alternative model 
 1 strong transmembrane helices, total 
score: 1975 
 # from    to   length    score    orientation 
 1- 120   141 (22)       1975        o-i  
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Output from TMpred 
 
2 possible models considered, only significant TM-
segments used 
 
 
-----> STRONGLY prefered model: N-terminus 
outside 
 6 strong transmembrane helices, total score: 
7404 
 #   from    to     length     score      orientation 
 1-       1     19     (19)       1873           o-i 
 2-    105   124    (20)       563             i-o 
 3-    148   171    (24)       2623           o-i 
 4-    190   208    (19)       932             i-o  
 5-    262   279    (18)       897             o-i 
 6-    395   422    (28)       516             i-o 
 
------> Alternative model 
 5 strong transmembrane helices, total score: 
6871 
 #    from    to    length    score      orientation 
 1-     1      17     (17)       1903           i-o 
 2-   148   171    (24)       2623           o-i 
 3-   190   208    (19)       932             i-o 
 4-   262   279    (18)       897             o-i 
 5-   395   422    (28)       516             i-o 
Figure 44: The E. tarda and EPEC EscD proteins are predicted to possess one, similarly-located, transmembrane domain.The EPEC EscD and 
E. tarda combined EscD1 (AA 1-259)/EscD2 (AA 260-449) sequence were used to predict transmembrane domains 
(http://www.ch.embnet.org/software/TMPRED_form.html) revealing one in each protein (residues ~120 to 141 in EPEC EscD; ~140 to 160 in combined 
E. tarda EscD protein). The program requires setting of minimal and maximal hydrophobic helix length, in this case it was 17 and 33 respectively. Solid 
line is the prediction for inside to outside TM helix and interrupted line is the prediction for outside to inside TM helix.  
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Closer examination of the sepL gene region revealed a premature stop codon with 
insertion of a single nucleotide restoring a single Orf for a protein similar in size and 
sequence over its complete length to its EPEC homologue (Figure 46). Indeed, a 
similar finding was evident for escL i.e. addition of extra base restored a single Orf 
encoding a protein of similar size to the EPEC counterpart with good homology over 
the whole protein (Figure 47). 
Figure 45: The E. tarda EscD protein is encoded on two adjacent open reading frames. The E. 
tarda escD gene region sequence is given with start (ATG) and stop (TAA) codons indicated by red 
underlined text. escD1 spans from the first ATG to TAA codon with escD2 from second ATG to TAA 
with intervening 14 bases highlighted by blue lettering. Sequencing data from a PCR-amplified 
fragment confirmed the presence of stop, intervening and start codons between escD1 and escD2.  
 
 
ATGCTAACCGTACTATCAAGCTACTTTATACTATTAGCAGCAATCATCAACATGCGATCTGATTATAAAATAAGATTTCT
GACTTGGCCACTGAGTGGTAGAGAGTTGATTGTACCTATAGAGTCATTTTCTATTGGTAAAAACGATGATAGTCTCATCA
CATACCAACTTGAAAATCCATTGCAAAATTTCACTCTTAGCACTAATGATGATGGTGTTTGGCTAAATACCCCCACTACA
TTTTGGATTAATGGTATTCAGACGTCTAACGCTGATTCAATTTTGCTTCCACTCAATCAACCAATTGATATTGCCGGCTG
CGGATTTATTCTACTTAGCGCAGATCAAGAAACGTCGCTAGTATCATTACCCAAACGAAAAAAAAACGCACATATAGATA
AGAAAAACATTGTAGTAATCGCATCATTGCTATTTTTAACACTTTCTTTATCGATTTTTGCTTTTTTTATATAAAAAAAC
AAGATTCTATGATTAGTCTCATCAGCAGAGAAGACGTTTATCAATCACTAAAAAAAGAAAAGCTTTTTGCTATTGTACCC
GTCTGGCATGGGAGTAGCATTGCTTTATACGGTCGATGCGAGCAATCATCTCAATTGCAGACTTTCTTTAATTTTCTTTA
TAAAAATAACATAAGATATATAAATAATATTATTTGTAATGACCAAATAATCAGTGGAATTAATGATGTTTTAGTTCAGT
ATGGCTATGACAATATAGATGTATCTTATGGTGGTAGCCCCGGATTCTTCATCCTATCGGGTTACATTCAGTCACCGCTA
CAGTGGAAAAAAGTAGAAGGCCAGCTCTTAACTATGCCAGGCGTCAGAGGATGGCAAGTACGAAACAAAGCCGACGCCAT
CATCAATTCATTAGTTGATGAACTATCGAAAAACAAATTAATCAACAAGTTAAGCATTCATAAGCGTGATAAAGCAATAA
TCATTGACGGCTTAGTTTCAGCAGTAGAAGAGCAAAAAATAATAAATATTATCGACAGGCTAAATAACAATAAAATAATT
TTTCAAAATATACCACCCTATATTCCCAAAAACCTATTTTCAGGAAAGATCATCAGAGTGAGTGGAACAAAAAATGCGCC
AATGATTACATTAGATAATGGGAGCACTCTCACTGTCGGCAGCGCCCTAAACAATGGCTACATAATCAACGAAATCAGCC
TAGAAAATGGTATTAGTATCTCGAGGGAAAATGAATTAATCCATATCCCAATCTCTTATGATAAGTAA  
E.tarda-escD   GCATCATTGCTATTTTTAACACTTTCTTTATCGATTTTTGCTTTTTTTATATAAAAAAAC 
Sequencing     GCATCATTGCTATTTTTAACACTTTCTTTATCGATTTTTGCTTTTTTTATATAAAAAAAC 
               ************************************************************ 
 
E.tarda-escD   AAGATTCTATGATTAGTCTCATCAGCAGAGAAGACGTTTATCAATCACTAAAAAAAGAAA 
Sequencing     AAGATTCTATGATTAGTCTCATCAGCAGAGAAGACGTTTATCAATCACTAAAAAAAGAAA 
               ************************************************************ 
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E.tarda-SepL       1 MASGIDFNVSVIPVFNDIN-DFSNK-----QNNNLSLNTPLANMQNELAI     44 
                     ||:||:||.:...|||..: ||..:     |.|:.:.::||.|:|||||: 
EPEC-SepL          1 MANGIEFNQNPASVFNSNSLDFELESQQLTQKNSSNTSSPLINLQNELAM     50 
 
E.tarda           45 INAASMAETAEGISLGFRRPTGRRVEEDGGNDNIINKMQDIINLAGEDAL     94 
                     |.::|::||.||:|||:|:.:.|:.||....:.::|:||:::.|...|.: 
EPEC              51 ITSSSLSETIEGLSLGYRKGSARKEEEGTTIEKLLNEMQELLTLTDSDKI    100 
 
E.tarda           95 QDIALHTAIQLDQHDPQLAMFGAMPKGEIIAINIVPTAFEYDYLSAKKKY    144 
                     ::::|..:..|:||||.|||||.||||||:|:.......::..:..|||| 
EPEC             101 KELSLKNSGLLEQHDPTLAMFGNMPKGEIVALISSLLQSKFVKIELKKKY    150 
 
E.tarda          145 AKLLLELLGEEEWELALLAWLGVGGITHEKLKKIKNLYQKAKDQEDYEGS    194 
                     |||||:||||::||||||:|||||.:..|.::|||.||:||||::...|: 
EPEC             151 AKLLLDLLGEDDWELALLSWLGVGELNQEGIQKIKKLYEKAKDEDSENGA    200 
 
E.tarda          195 TLLTWFLEIKDLPDRDNYLKVIIRALSFELSYLPQVEDRERTSSVITDLY    244 
                     :||.||:||||||:|:.:||||||||||:|||:...||:.||||:|:||. 
EPEC             201 SLLDWFMEIKDLPEREKHLKVIIRALSFDLSYMSSFEDKVRTSSIISDLC    250 
 
E.tarda          245 RIIVFLSLNNYSEIVSLSLKKDADIILSELISTLEQTWLTEEWFAGSPSR    294 
                     |||:|||||||::|:::|:|||.|:||:|::|.:|..||||:|...|||| 
EPEC             251 RIIIFLSLNNYTDIIAISIKKDKDVILNEMLSIIEHVWLTEDWLLESPSR    300 
 
E.tarda          295 VGVIDGQKLYYYHLIKDFYQTLPHSCFMTEEQRESIINGISDVIDRDSE-    343 
                     |.:::.:.:||:||:|:|:.:||.:||:..|||.:.:..|..|||...:  
EPEC             301 VSIVEDKHVYYFHLLKEFFASLPDACFIDNEQRSNTLLMIGKVIDYKEDV    350 
 
E.tarda          344 -    343 
                       
EPEC             351 M    351 
 
 
 
 
 
Figure 46: The E. tarda SepL protein is interrupted by a stop codon. The E. tarda sepL gene 
region sequence is given with start (ATG and, rare, ATT) and stop (TAA) codons indicated by red 
underlined text. A rare start codon (ATT) is part of the premature TAA stop (T in red; AA in black). 
The two SepL-related open reading frames were spliced together for alignment 
(http://www.ebi.ac.uk/Tools/psa/emboss_needle/) against the EPEC homologue.  
 
 
ATGGCTTCTGGTATTGATTTTAATGTATCTGTAATTCCAGTGTTTAACGATATAAATGATTTTTCGAATAAACAAAATAA
TAATTTATCGTTAAATACACCATTAGCTAATATGCAAAATGAGTTAGCAATAATCAATGCAGCCTCTATGGCTGAAACGG
CTGAGGGGATCAGCTTAGGGTTCCGTCGACCTACGGGACGTAGGGTGGAGGAAGATGGGGGTAATGATAATATAATCAAT
AAAATGCAAGATATCATTAACTTAGCTGGTGAGGATGCGTTGCAGGATATTGCGTTGCACACCGCTATTCAGCTGGATCA
GCATGACCCCCAGTTGGCGATGTTTGGCGCAATGCCGAAAGGCGAGATTATTGCCATTAATATCGTCCCTACTGCATTTG
AATACGATTACCTTAGCGCAAAAAAAAAGTACGCCAAATTGCTCTTGGAACTACTCGGTGAAGAGGAATGGGAGCTGGCT
TTGCTGGCCTGGTTGGGGGTCGGTGGGATAACGCATGAAAAACTAAAGAAAATAAAAAACCTCTATCAGAAGGCAAAAGA
TCAGGAGGATTATGAAGGAAGTACACTGCTTACATGGTTCTTAGAGATAAAGGATTTGCCTGATAGAGATAACTACCTTA
AAGTAATAATTCGTGCATTGTCATTTGAGCTATCTTATTTACCACAGGTCGAGGATAGAGAAAGAACGTCATCTGTCATT
ACTGATCTGTATAGAATTATAGTTTTTTTATCATTAAATAATTATAGCGAAATAGTTTCTTTATCCTTAAAAAAGGATGC
TGATATTATTCTTAGTGAGCTGATTAGCACGTTGGAACAAACTTGGTTGACCGAAGAGTGGTTTGCGGGGAGTCCAAGCC
GGGTTGGTGTTATTGATGGACAGAAACTATATTATTATCATTTAATAAAAGATTTTTATCAAACGTTGCCCCACTCTTGT
TTTATGACTGAAGAACAGCGAGAAAGTATTATTAATGGTATTTCAGATGTTATAGATAGAGACTCGGAGTAA 
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EPEC EscL          1 MIYFLTDLIKFYCLMKLYEFKNIEIDLVLTEDIIPEDKLQEIIQSDDIIK     50 
                                   ||...::.|::.....:..:...::..:...::.|| 
E.tarda EscL       1 --------------MKTTRYRKIKLSNFNEKKHLSASEISILNIENNNIK     36 
 
EPEC              51 LARKKTYEHLLRARRKSKELKIESRKKIARKMIAMRERIRKNNKIKLDKE    100 
                     .:|:.....||.||:|..::|...|:::|.::...|..|..:.:::.::: 
E.tarda           37 ESRETACNILLSARKKKHQIKANIRRRLAIRLWRYRNNINTHYQMRFNEK     86 
 
EPEC             101 VNQSIKWVKDIQAIELVLMQDIMNKVHLSLTNALHSLDTSSRINWDDLLN    150 
                     :||||:.:.|.|..|..|....:.:..|||:.||..| .:.||:|..:|: 
E.tarda           87 INQSIQLLLDTQNAERYLFLKAIEQAQLSLSRALPEL-LAKRIDWPQILS    135 
 
EPEC             151 EVVRETLSNNNIVGAIKITKNPDIKLDPGEANNIQLINDANTPHNKIIIE    200 
                     |::.:.:..|.:.|.|:||||.::.::. ::.|..:.||:|...:.|::| 
E.tarda          136 EIISDKIKKNKLNGDIEITKNENLIINT-DSINATITNDSNMDIDTIVME    184 
 
EPEC             201 NEYIRITLDPLEQISILLNSFKDNYLSIIQE    231 
                     |:||||||.|.:||...|.:||..|.:::.| 
E.tarda          185 NQYIRITLSPKKQIENALANFKLKYNTLLDE    215 
ATGAAAACAACACGCTACAGAAAAATAAAATTGAGTAATTTTAATGAAAAAAAACACTTAAGCGCCAGTGAGATCAGT
ATATTAAATATTGAAAATAACAACATTAAAGAATCTAGAGAAACAGCATGCAATATATTATTATCAGCAAGAAAAAAG
AAACATCAGATAAAAGCAAACATTCGCAGAAGACTCGCAATTAGACTATGGAGATATCGTAACAATATTAACACGCAT
TATCAAATGAGATTTAATGAAAAAATAAACCAATCCATTCAACTACTACTCGATACTCAGAATGCTGAGCGTTATCTT
TTTCTAAAAGCCATAGAGCAGGCGCAGTTATCATTGAGCCGCGCACTCCCTGAACTTTTGGCTAAACGCATCGACTGG
CCACAAATTCTATCAGAAATAATTAGTGACAAAATTAAAAAAAaCAAGTTAAATGGAGATATAGAAATAACAAAGAAC
GAAAATCTCATAATTAATACAGATAGTATTAATGCAACGATTACTAATGATAGCAACATGGACATCGATACCATAGTA
ATGGAAAATCAATATATAAGAATAACACTATCGCCCAAAAAACAAATAGAAAACGCGTTAGCAAACTTCAAACTAAAA
TATAACACTTTATTAGACGAATAA 
Figure 47: The E. tarda EscL protein is interrupted by a stop codon. The E. tarda escL gene 
region sequence is given highlighting start (ATG) and stop (TAA) codons with red underlined text. 
Indicated is position of added base (underlined) upstream of the premature TAA stop to restore an 
Orf for a full length EscL protein. The protein sequence of the full length EscL and EPEC 
homologues were aligned (http://www.ebi.ac.uk/Tools/psa/emboss_needle/). 
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4.3.4 The E. tarda escD gene can functionally substitute for EPEC escD 
EscD is required for T3SS apparatus functionality and substrate secretion (Ogino et 
al., 2006). To investigate whether the escDEt region encodes a functional protein 
studies interrogated its ability to functionally replace the EPEC escD gene. Thus, the 
escDEt gene region was PCR amplified, from provided E. tarda genome DNA (kindly 
by Dr Yoji Nakamura), and ligated into the AT cloning vector generating pCR-2.1- 
escDEt. The cloned fragment was excised, by digesting BamHI and SalI restriction 
enzymes (cut at oligonucleotide-introduced restriction enzyme recognition sites 
flanking escD), and ligated in pACYC184 (digested with same restriction enzymes) to 
generate pACYC-escDEt (Figure 48), The presence of the escDEt insert was supported 
by restriction enzyme and PCR analyses (Figure 48). An EPEC escD mutant was 
generated, using kindly provided suicide vector (see Chapter 2; Table 6) before 
introducing, via electroporation, the pACYC-escDEt plasmid (Figure 48).  
To examine if escDEt could functionally replace EPEC escD, HeLa cells were infected 
for 3 and 6h with the escD mutant or two clones of the escD mutant complemented 
with pACYC-escDEt plasmid. Following the infection period, the Triton X-100 soluble 
(containing host cytoplasm and membrane proteins plus delivered effectors) and 
insoluble (containing host nuclei and cytoskeletal proteins plus adherent bacterial 
proteins) fractions were isolated for Western blot analysis. 
Interestingly, the ΔescD complemented strain, unlike the EscD deficient mutant 
(supporting strain genotype), delivered Tir as evidenced by shifts in apparent molecular 
mass (Figure 49); latter due to host kinase modification. This work suggests that the 
E. tarda escD region encodes a functional EscD protein. Importantly, using unique 
restriction sites in the E. tarda DNA to delete most of the escD1 sequence produced a 
plasmid that failed to rescue the EPEC ΔescD mutant defect (not shown). 
A similar approach was undertaken, under my supervision, by undergraduate students 
(Joe Frost and Shaz Malook), to generate pACYC-sepLEt and pACYC-escLEt plasmids 
which both failed to complement the T3SS defect of provided ∆sepL (Monjaras Feria 
et al., 2012) and ∆escL mutants (Soto et al., 2017), respectively, unlike plasmids 
carrying EPEC sepL and escL genes (not shown).  
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Figure 48: Cloning E. tarda escD region into pACYC184 and generating EPEC escD mutant. 
Schematic of pACYC184 plasmid carrying E. tarda escD gene region with (A-G) agarose gel data 
illustrating steps in generating and confirming of pACYC-escDEt  and EPEC escD mutant. A) PCR 
amplification of a single band of expected size for escD1/escD2 gene, B) ligation of PCR fragment into 
AT vector (pCR-2.1), C) PCR support for generating pCR2.1-escDEt, D) restriction enzyme release of 
escDEt  fragment, E)  restriction enzyme digestion support for escDEt  gene insertion into pACYC184, 
F) PCR screening supports generation of EPEC escD mutant [clones 1, 2, 4, 5, 7, 9-11] and G) PCR 
support for introduction of pACYC-escDEt  into EPEC escD mutant.  
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Figure 49: Rescuing the EPEC escD mutant T3SS defect by introducing pACYC-escDEt. HeLa 
cells were left uninfected or infected 3 and/or 6h with indicated strains before isolating Triton X-100 
soluble (containing host cytoplasm and membrane proteins plus delivered effectors) and insoluble 
fractions (containing host nuclei and cytoskeletal proteins plus adherent bacterial proteins) fractions 
for western blot analysis (10% SDS-PAGE) probing for Tir. The position of Tir unmodified (T
o
) and 
host kinase fully modified (T”) forms, as well as protein markers, are indicated. Strains used were 
EscD deficient EPEC (∆escD) or ∆escD complemented with pACYC-escDEt (two clones). 
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4.3.5 The E. tarda eae gene encodes for a larger Intimin protein 
While bioinformatics revealed the E.tarda Intimin-encoding gene (eaeEt) to encode a 
protein with a similar number of residues to the EPEC variant (929 versus 937), blast 
searches revealed an Intimin-like C-terminal domain on an adjacent Orf (not shown). 
To examine the possibility of a frame-shifting sequencing error, the region of interest 
was PCR amplified with the sequencing data revealing an additional base (G; Figure 
50). Adding this base to the E. tarda LEE eae sequence restored a single Orf of 1117 
residues sharing 39.6% identity (51.6% similarity) to the EPEC homologue (Figure 51). 
While the EPEC and EHEC homologues are similar sized and highly homology, the E. 
tarda variant has additional sequences throughout its C-terminal domain helping to 
explain why it shares less homology to the EPEC/EHEC homologues. The cell and Tir 
binding activity of Intimin maps to the C-terminal 280 amino acids (Frankel et al., 1994) 
with E. tarda Intimin sharing 35.7% identity (51.2% similarity) in this region. Four C-
terminal residues (S890, T909, N916 and N927) play critical roles for Intimin binding 
of Tir (Yi et al., 2010) with Cys937 critical for cell binding (Adu-Bobie et al., 1998). 
Interestingly, these residues are relatively well conserved between the homologues 
(Figure 51), suggesting that E. tarda Intimin may be able to bind EPEC Tir.  
 
 
 
 
 
 
 
 
 
E.tarda           83 TGTGACTACGGAGGCTGATGGTACCGCCCGGGTCATTCTGACCAGCGTGA    132 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Sequenced         59 TGTGACTACGGAGGCTGATGGTACCGCCCGGGTCATTCTGACCAGCGTGA    108 
 
E.tarda          133 CTGCAGGTCAGGCGACCGTGTCCGCCACTACGGC-GGGGGGACGCCAGCG    181 
                     |||||||||||||||||||||||||||||||||| ||||||||||||||| 
Sequenced        109 CTGCAGGTCAGGCGACCGTGTCCGCCACTACGGCGGGGGGGACGCCAGCG    158 
 
E.tarda          182 ACGAAGACGGTGACATTTAACGCGGTTCTGGAGATCACCGGCGTATTGAT    231 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Sequenced        159 ACGAAGACGGTGACATTTAACGCGGTTCTGGAGATCACCGGCGTATTGAT    208 
 
Figure 50: Sequence error in E. tarda LEE eae gene. The nucleotide sequence of the PCR 
amplified fragment aligned (http://www.ebi.ac.uk/Tools/psa/emboss_needle/) to the corresponding 
region of the provided E. tarda eae gene sequence revealed a guanine (G) base is missing in the 
provided DNA sequence.  
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E.tarda      MSEYSFMSGGVLKSKIKNILFFIFI----LLSFVCVAYAGQTNYYTLYQDSKLIPNSNIN 56 
EHEC         MITHGCYTRTRHKHKLKKTLIMLSAGLGLFFYVNQNSFANGENYFKLGSDSKLLTHDS-- 58 
EPEC         MITHGFYARTRHKHKLKKTFIMLSAGLGLFFYVNQNSFANGENYFKLGSDSKLLTHNS-- 58 
             *  :.  :    * *:*: ::::      :: .   ::*   **:.* .****: ...   
 
E.tarda      SGNIIYYTLKKGENAAYIAKKNGISIDAIWSINKSYYSSRQSMLSAGSGDILRLPLKSLG 116 
EHEC         YQNRLFYTLKTGETVADLSKSQDINLSTIWSLNKHLYSSESEMMKAAPGQQIILPLKKLP 118 
EPEC         YQNRLFYTLKTGETVADLSKSQDINLSTIWSLNKHLYSSESEMMKAAPGQQIILPLKKLP 118 
               * ::****.**..* ::*.: *.:.:***:**  ***...*:.*. *: : ****.*  
 
E.tarda      A-LDGLPALGSIEMTDNFQTVRQGMPGERSVL--WQPSEVGSTVSADRLYG-------GR 166 
EHEC         FEYSALPLLGSAPLVAA-----GGVAGHTNKLTKMSPDVTKSNMTDDKALNYAAQQAASL 173 
EPEC         FEYSALPLLGSAPLVAA-----GGVAGHTNKLTKMSPDVTKSNMTDDKALNYAAQQAASL 173 
                ..** ***  :.        *: *. . *   .*. . *.:: *:          .  
 
E.tarda      AQPTSAQTLNGQQTGSMALAMASGQASGALQAWMSQFGTAEVNLQAGNGWDGSSLDWLLP 226 
EHEC         GSQLQSRSLNGDYAKDTALGIAGNQASSQLQAWLQHYGTAEVNLQSGNNFDGSSLDFLLP 233 
EPEC         GSQLQSRSLNGDYAKDTALGIAGNQASSQLQAWLQHYGTAEVNLQSGNNFDGSSLDFLLP 233 
             ..  .:::***: : . **.:*. ***. ****:.::********:** :******:*** 
 
E.tarda      FYDTPAMLAFSQVGARYINSRFTANVGGGQRFFFDHGMVGYNTFIDQDISGNNSRLGVGI 286 
EHEC         FYDSEKMLAFGQVGARYIDSRFTANLGAGQRFFLPANMLGYNVFIDQDFSGDNTRLGIGG 293 
EPEC         FYDSEKMLAFGQVGARYIDSRFTANLGAGQRFFLPENMLGYNVFIDQDFSGDNTRLGIGG 293 
             ***:  ****.*******:******:*.*****:   *:***.*****:**:*:***:*  
E.tarda      EYWRDYLKTSLNTYFRLSGWHQSYDQSDYYERPANGFDLRVNAYLPSYPALGTKLIFEQY 346 
EHEC         EYWRDYFKSSVNGYFRMSGWHESYNKKDYDERPANGFDIRFNGYLPSYPALGAKLIYEQY 353 
EPEC         EYWRDYFKSSVNGYFRMSGWHESYNKKDYDERPANGFDIRFNGYLPSYPALGAKLMYEQY 353 
             ******:*:*:* ***:****:**::.** ********:*.*.*********:**::*** 
 
E.tarda      YGNNVALFDRDSKQSNPSAFTMGVNYTPIPLVTFGADYRLGAGGRNDTLYSLQFNYRFGD 406 
EHEC         YGDNVALFNSDKLQSNPGAATVGVNYTPIPLVTMGIDYRHGTGNENDLLYSMQFRYQFDK 413 
EPEC         YGDNVALFNSDKLQSNPGAATVGVNYTPIPLVTMGIDYRHGTGNENDLLYSMQFRYQFDK 413 
             **:*****: *. ****.* *:***********:* *** *:* .** ***:**.*:* . 
 
E.tarda      SWQQQISPQNVANLRSLQGSRYDLVQRNNNIVLDYKKQDVISLTIPDGMSGLEGTVRSIT 466 
EHEC         SWSQQIEPQYVNELRTLSGSRYDLVQRNNNIILEYKKQDILSLNIPHDINGTEHSTQKIQ 473 
EPEC         PWSQQIEPQYVNELRTLSGSRYDLVQRNNNIILEYKKQDILSLNIPHDINGTERSTQKIQ 473 
              *.***.** * :**:*.*************:*:*****::**.**. :.* * :.:.*  
 
E.TARDA      YSVKSKHAVSRIDWHDVELVRYGGKINKVG----EGYQLEFPKYIKNGNNTYQVNARAID 522 
EHEC         LIVKSKYGLDRIVWDDSALRSQGGQIQHSGSQSAQDYQAILPAYVQGGSNIYKVTARAYD 533 
EPEC         LIVKSKYGLDRIVWDDSALRSQGGQIQHSGSQSAQDYQAILPAYVQGGSNVYKVTARAYD 533 
               ****:.:.** *.*  *   **:*:: *    : **  :* *:: *.* *:*.*** * 
 
E.tarda      SQGNISNVAVLLVTVLSDSGSG-GTIVDTLTANKISAIADGTDEITYTALVQSGGKPQAN 581 
EHEC         RNGNSSNNVQLTITVLSNGQVVDQVGVTDFTADKTSAKADNADTITYTATVKKNGVAQAN 593 
EPEC         RNGNSSNNVLLTITVLSNGQVVDQVGVTDFTADKTSAKADGTEAITYTATVKKNGVAQAN 593 
              :** ** . * :****:.     . *  :**:* ** ** :: ***** *:. *  *** 
 
E.tarda      VDVDFSIQRGVGTLSTVQAKSDAQGRAMVRLTATEVGEVVVAAKTADMSAPLAAAPVNFI 641 
EHEC         VPVSFNIVSGTATLGANSAKTDANGKATVTLKSSTPGQVVVSAKTAEMTSALNASAVIFF 653 
EPEC         VPVSFNIVSGTAVLSANSANTNGSGKATVTLKSDKPGQVVVSAKTAEMTSALNANAVIFV 653 
             * *.*.*  *...*.: .*:::..*:* * *.:   *:***:****:*:: * *  * *. 
 
E.tarda      AGGAIVVHEITADKSTALANGTDAISYTIRVSKNGVSQANTDVDVTTTAGSLSSPRVTTG 701 
EHEC         DQTKASITEIKADKTTAVANGKDAIKYTVKVMKNGQPVNNQSVTFSTNFGMFNGKSQT-- 711 
EPEC         DQTKASITEIKADKTTAVANGQDAITYTVKVMKGDKPVSNQEVTFTTTLGKLSNSTEK-- 711 
                   : **.***:**:*** ***.**::* *      * .* .:*. * :.    .   
 
E.tarda      ADGVATVKLTSNAVANNVIVSAKTAEMTTALDASPVNFVNVEPTVVSSITADKTQALADG 761 
EHEC         ------------------------------------------------------------ 711 
EPEC         ------------------------------------------------------------ 711                                                                 
 
E.tarda      AKTAEMTTALDASPVNFSNNPSVATLTADNEFAVANGTSGVTFTATVMRDGAPAAGIPVT 881 
EHEC         ATVSDG-AEVKATEVT--------------------------FFDE-------------- 755 
EPEC         ARVSDVAVDVKAPEVE--------------------------FFTT-------------- 753 
             * .::  . :.*  *                           *                  
 
E.tarda      FATSGGTLSATDVTTEADGTARVILTSVTAGQATVSATTAGGTPATKTVTFNAVLEITGV 941 
EHEC         ---------------------------LK--------------------IDN-KVDIIG- 766 
EPEC         ---------------------------LT--------------------IDDGNIEIVG- 765 
                                        :.                      :  ::* *  
 
E.tarda      LIPGSGGTSVPSVWLEGGQIQLVVRGGGAGLQYASSAASAT--VNDSGLITLDSAGDATI 999 
EHEC         ---NNVRGELPNIWLQYGQFKLKASGGDGTYSWYSENTSIATVDA-SGKVTLNGKGSVVI 822 
EPEC         ---TGVKGKLPTVWLQYGQVNLKASGGNGKYTWRSANPAIASVDASSGQVTLKEKGTTTI 822 
                     .:*.:**: **.:* . ** .   : *   : :     ** :**.  * ..* 
 
E.tarda      QVTSPEDGQTASYTLNTPAVFVRPEFATQRNYSAARTYCIAQGGALAADQSVLQNVRMLW 1059 
EHEC         KATS-GDKQTVSYTIKAPSYMIK--VDKQAYYADAMSICKNL---LPSTQTVLSDIYDSW     876 
EPEC         SVIS-SDNQTATYTIATPNSLIVPNMSKRVTYNDAVNTCKNFGGKLPSSQNELENVFKAW     881   
             .. *  * **.:**: :*  ::   . .:  *  * . *      * : *. *.::   * 
 
E.tarda      GDANRYPAYAGLVARQAWVEQTPTDIAGGVGKTYDLIRGNPQSNVNVSTANVYAVCIH 1117  
EHEC         GAANKYSHYSSMNSITAWIKQTSSEQRSGVSSTYNLITQNPLPGVNVNTPNVYAVCVE 934 
EPEC         GAANKYEYYKSSQTIISWVQQTAQDAKSGVASTYDLVKQNPLNNIKASESNAYATCVK 939 
             * **:*  * .  :  :*::**  :  .**..**:*:  **   ::..  *.**.*:. 
 
 
 
 
 
Figure 51: E. tarda Intimin shares residues critical for EPEC/EHEC Intimin binding to Tir. E. 
tarda, EPEC (E2348/69) and EHEC (O157:H7) Intimin sequences were aligned 
(http://www.ebi.ac.uk/Tools/psa/emboss_needle/) revealing high levels of overall size, 
identity/similarity between EPEC/EHEC homologues with the E.tarda variant having additional 
sequences in the C-terminal region. The N-terminal half shows highest homology to EPEC/EHEC 
homologues. Red boxes highlight important residues in Intimin binding to Tir and host receptors. 
 
 
Chapter 4 Results II 
112 
  
4.3.5.1 E. tarda Intimin can bind EPEC Tir triggering its actin nucleation activity  
To interrogate functional interchangeability, the eaeEt gene was PCR amplified, using 
E. tarda genomic DNA as a template, and ligated into pACYC184 (pre-digested with 
BamHI/SalI restriction enzymes) using the Gibson Assembly protocol (see Chapter 2; 
section 2.2.8) generating pACYC-eaeEt (Figure 52). PCR analysis was used to support 
pACYC-eaeEt construction and introduction in the Intimin-deficient (Δeae) mutant 
(Figure 52).  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 52: Cloning E. tarda eae gene into pACYC184 and introduction into EPEC eae mutant. 
Agarose gel data illustrating steps in generating and/or confirming presence of pACYC-eaeEt plasmid 
A) PCR amplification of a single band of expected size of eae gene, B) Digestion of pACYC184 to 
obtained vector fragment for C) use with PCR eae gene fragment in Gibson Assembly protocol to 
generate pACYC-eaeEt, D) supported by PCR detecting the eae fragment in examined clones (#1, 
#3) with E) providing PCR support for a disrupted eae gene in the EPEC eae mutant (4 colonies 
examined) and pACYC-eaeEt introduction into EPEC eae mutant (3, of 4, examined colonies). 
 
Chapter 4 Results II 
113 
  
HeLa cells were then infected to confirm Tir delivery - linked with kinase modification 
to T’’ form - and determine if there was an Intimin-dependent migration of the T’’ form 
into the insoluble fraction. As expected, EPEC and eae mutant delivered Tir which was 
modified to T’’ form and detected in the soluble fraction but only the insoluble fraction 
of cells infected with EPEC, not the eae mutant (Figure 53). However, introducing a 
plasmid carrying the EPEC or E. tarda eae genes rescued this defect (Figure 53). 
Importantly, probing insoluble fractions (contains proteins from adherent bacteria) with 
antibodies raised against EPEC Intimin detected Intimin in samples from cells infected 
with EPEC or eae mutant carrying the plasmid encoding the EPEC, but not E. tarda, 
eae gene (Figure 53). These findings show that the E. tarda eae gene encode a 
functional Intimin protein that can bind the membrane-inserted EPEC Tir effector. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 53: Rescuing the EPEC eae mutant defect in binding membrane-inserted Tir by 
introducing E. tarda eae gene.  HeLa cells were left uninfected or infected 3 and/or 6h with indicated 
strains before isolating Triton X-100 soluble (containing host cytoplasm and membrane proteins plus 
delivered effectors) and insoluble fractions (containing host nuclei and cytoskeletal proteins plus 
adherent bacterial proteins) fractions for western blot analysis (10% SDS-PA gels) probing for EspB, 
EspF, Tir and/or Intimin. The position of Tir unmodified (T
o
) and host kinase fully modified (T’/T”) 
forms are indicated as well as, Intimin, EspF, EspB and protein markers. Strains used were EPEC, 
Intimin deficient EPEC mutant (eae) or eae mutant complemented with plasmid carrying EPEC 
(eaeEPEC) or E. tarda (eaeEt) eae genes.  
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4.3.6 E. tarda LEE proteins of highest, medium and lowest homology to EPEC 
counterparts 
Interrogating the ‘identify/similarity’ data (Table 8) revealed great variability between 
homologues with 9 proteins (27%) sharing the highest level (60-73% identity); 15 (45%) 
the lowest level (~12-39% identity) with the remaining 8 (24%) intermediate levels 
(~40-59% identity) compared to their corresponding EPEC homologue. 
 Members of the ‘highest level’ homology (60-73% identity) group are four core 
T3SS components (EscR, EscS, EscC, EscV), the needle protein (EscF), ATPase 
(EscN), a chaperone of middle (CesD) and late (CesT) substrates and the translocator 
(EspA) which failed (Chapter 3; section 3.3.8) to functionally replace its EPEC 
homologue, unless co-expressed with E.tarda EspD and EspB (Chapter 3; section 
3.3.9).   
The ‘intermediate level’ homology (40-59% identity) group members are five 
core T3SS components (EscT, EscU, EscJ, EscI, EscD), the peptidoglycan lytic 
enzyme (EtgA), molecular switch protein (SepL), a translocator (EspD) and chaperone 
for a middle (CesD2) substrate. Interestingly, the previous functional interchangeability 
studies included two of these proteins with one (EscD unlike SepL) functionally 
interchangeable for its EPEC homologue.  
The final group (lowest level homology[(12-39% identity)]) contains the master 
regulator (Ler), sorting platform/molecular switch proteins (EscK, EscL, SepD, EscQ), 
chaperones for early (EscG, CesL, EscE) and middle (CesAB, EscA) substrates, ruler 
protein (EscP), a translocator (EspB), two effectors (Tir, EspZ) plus Intimin. Two 
members of this group (EspB and Intimin) have already been shown to functionally 
interchangeable in contrast to the third examined protein, EscL 
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4.3.7 E. tarda Ler protein replaces EPEC Ler regulatory activity  
As it was not feasible to examine the functional interchangeability of all E. tarda LEE 
proteins, studies focused on those proteins in the lowest homology group focusing on 
proteins linked to delivering effectors i.e. Ler, EscK, EscP and Tir.  
The E. tarda ler gene (lerEt) was PCR amplified, using E.tarda genomic DNA as a 
template, and inserted into pACYC184 (pre-digested with BamHI/SalI) using the 
Gibson Assembly protocol (Figure 54). Construction of pACYC-lerEt, and its 
introduction into the provided Ler deficient EPEC, ∆ler (Mellies et al., 2007) was 
supported by PCR analysis (Figure 54) before HeLa cell infection. Western blot 
analysis on isolated Triton X-100 soluble and insoluble fractions confirmed that the ler 
mutant does not express Tir, EspB or EspF proteins (Figure 55) (Yerushalmi et al., 
2008). Crucially, introducing pACYC-lerEt led to Tir, EspB and EspF expression and 
delivery as evidenced by host kinase modification of Tir to T’/T” forms (Figure 55). 
Thus, the E. tarda ler gene encodes a protein which can functionally replace the EPEC 
Ler protein to induce EPEC LEE protein expression and produce a functional effector 
delivery system. 
 
 
 
 
 
Figure 54: Cloning E. tarda ler gene into pACYC184 and introduction into EPEC ler mutant. 
Agarose gel data illustrating steps in generating and/or confirming presence of pACYC-lerEt plasmid A) 
PCR amplification of a single band of expected size of lerEt gene, B) Digestion of pACYC184 to obtained 
vector fragment for C) use with PCR eae gene fragment in Gibson Assembly protocol to generate 
pACYC-lerEt, D) supported by PCR detecting the ler fragment in all examined clones with E) providing 
PCR support for pACYC-lerEt introduction into EPEC ler mutant. 
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Figure 55: The E. tarda ler genes restores the ability of the EPEC ler mutant to express and 
deliver LEE effector proteins. HeLa cells were infected 3 and/or 6h with indicated strains prior to 
isolating Triton X-100 soluble (containing host cytoplasm and membrane proteins plus delivered 
effectors) and insoluble (containing host nuclei and cytoskeletal proteins plus adherent bacterial 
proteins) fractions for western blot analysis (10% SDS-PA gels) probing for Tir, EspB and EspF. The 
position of Tir unmodified (T
o
) and host kinase fully modified (T”) forms and indicated as are the 
EspB, EspF and protein markers. Strains used were EPEC ∆ler mutant and ler mutant carrying the 
pACYC-lerEt plasmid (carries E. tarda ler gene) 
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4.3.8 E.tarda Tir protein lacks key EPEC Tir-related subversive features can be 
delivered by EPEC in a CesT/T3SS-dependent manner without evidence of 
modification to T’’ form. 
While the predicted E. tarda Tir protein is similar in size to EPEC Tir, aligning the 
sequences revealed many unexpected differences (Figure 56) that helps explain the 
low homology (24% identity; 36% similarity [Table 8]). Thus, the N-terminus (19.7% 
identity/34.6% similarity) contains some small deletions and several large insertions in 
contrast to high similarity (66.7%) between the transmembrane domains and Intimin 
binding region (Figure 56). The shared presence of residues K289, G305 and N306 
(Figure 56) required for EPEC Tir-Intimin binding (Ross & Miller, 2007) suggests that 
the E. tarda Tir variant may interact with EPEC Intimin. As expected, examining E. 
tarda Tir for transmembrane spanning regions found ones flanking the Intimin binding 
region (Figure 57) supporting that, like EPEC Tir (Kenny, 1999, Kenny et al., 1997b), 
it is inserted into the host plasma membrane in a hairpin-like conformation. A 
polyproline rich region is one of the few N-terminal features with a defined role in EPEC 
Tir’s subversive activities - recruits host tyrosine kinases to modify Tir residues 
(Bommarius et al., 2007) - with this feature highly degraded in E. tarda Tir (Figure 56). 
Surprisingly, the C-terminal domain (10% identity; 17% similarity) which contains most 
features linked to EPEC Tir’s subversive activities (Kenny, 1999, Kenny & Warawa, 
2001, Allen-Vercoe et al., 2006, Yan et al., 2013) is truncated in E tarda Tir and thus 
lacks all these important EPEC Tir features (Figure 56). 
The absence of residues that are substrates for host kinase phosphorylation predicted 
that E. tarda Tir, if delivered, may not undergo shifts in apparently molecular mass and, 
if inserted into the plasma membrane, would interact with EPEC Intimin without 
triggering actin nucleation (depends on kinase modification of Tir tyrosine residues).  
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Figure 56: Comparison of E. tarda and EPEC Tir proteins. E. tarda and EPEC Tir sequences were 
aligned (http://www.ebi.ac.uk/Tools/psa/emboss_needle/). Key features linked to EPEC Tir 
functionality are highlighted: polyproline rich motif (Red), Intimin binding area (Green), residues 
important for Intimin binding (Blue), kinase modified residues (single residues; dark green) and 
arginine finger motif (Yellow). 
 
E.tarda Tir   1 MKLESAAN----SPLINPYAPSESGTQNTA---------NLGRLGDRAI-     36 
                |.:.:..|    :.||.|..|..|.|...|         :.|.||.|::  
EPEC Tir      1 MPIGNLGNNVNGNHLIPPAPPLPSQTDGAARGGTGHLISSTGALGSRSLF     50 
 
E.tarda      37 --AVNADSSARDGGQLPGLPSSPVALQPSRGSDPVYRHTNVYTAQDSFEA     84 
                  ..|:.:.:.|...:||||::|..|..:         |:.......||. 
EPEC         51 SPLRNSMADSVDSRDIPGLPTNPSRLAAA---------TSETCLLGGFEV     91 
 
E.tarda      85 I--KGMSLNMLFERVGNATFSRRTTPEGNVEAVSTRGQHEMAVLLPQDEQ    132 
                :  || .|::|..::|.:.|......:|...|:..:...|::|.|...|. 
EPEC         92 LHDKG-PLDILNTQIGPSAFRVEVQADGTHAAIGEKNGLEVSVTLSPQEW    140 
 
E.tarda     133 YALNSLSPDPEANFVFIG--GSRSHPLVSLAGESSEV-ISVRQTLERGQG    179 
                .:|.|:..:.:..|||.|  |...||:|::|.:.:|. ..:...|:     
EPEC        141 SSLQSIDTEGKNRFVFTGGRGGSGHPMVTVASDIAEARTKILAKLD----    186 
 
E.tarda     180 LSDRPGGVSPLDSSLFRGQLEHSLGNRTGVDREMTGGTGFLHSSHSELGA    229 
                .|..||..|.|                 ||....|               
EPEC        187 -PDNHGGRQPKD-----------------VDTRSVG--------------    204 
 
E.tarda     230 TGQTDMRGSATTQALAGQADTINQGPQIDGGERLRELTHPQLVEINNYIA    279 
                               .|.|..|:.|                :|...:... 
EPEC        205 ---------------VGSASGIDDG----------------VVSETHTST    223 
 
E.tarda     280 VNPPAMSRSHLYVALGTAAAVGLTAL-ATGLSQAFAITPAPDDALVVDPN    328 
                .|....|....:|::| |.|.||..| |||::||.|:||.|||....||: 
EPEC        224 TNSSVRSDPKFWVSVG-AIAAGLAGLAATGIAQALALTPEPDDPTTTDPD    272 
 
E.tarda     329 QAQQDAVTNTRNELTSEALKDPANQKVEVDEMGNQRPTGILLDNVAAEIE    378 
                ||...|.:.|:::||.||.|:|.||||.:|..||..|:|.|.|::..:|. 
EPEC        273 QAANAAESATKDQLTQEAFKNPENQKVNIDANGNAIPSGELKDDIVEQIA    322 
 
E.tarda     379 VKAQEAGEAAKQQAITDNAVAQERHDTQQEKRDKELAISGGAGYG-AAAL    427 
                .:|:||||.|:|||:..||.||:|::.|..:|.:||.:|.|.||| ::|| 
EPEC        323 QQAKEAGEVARQQAVESNAQAQQRYEDQHARRQEELQLSSGIGYGLSSAL    372 
 
E.tarda     428 IGAGGFTAAGV---LYRRNKETHEEAMELHRALPQAEPPVGNRTETG---    471 
                |.|||. .|||   |:|||:...:........:.|.:.. ||....|    
EPEC        373 IVAGGI-GAGVTTALHRRNQPAEQTTTTTTHTVVQQQTG-GNTPAQGGTD    420 
 
E.tarda     472 -TRSERFTFPRAVVLDQPPREPGAVGGIYQGLQRGEWSAASSTW-DSASQ    519 
                ||:|..:..|                     :..:.|.||:.| ||:|: 
EPEC        421 ATRAEDASLNR---------------------RDSQGSVASTHWSDSSSE    449 
 
E.tarda     520 TSLAGNVTLV----------------------------------------    529 
                        :|                                         
EPEC        450 --------VVNPYAEVGGARNSLSAHQPEEHIYDEVAADPGYSVIQNFSG    491 
 
E.tarda     530 --------------------------------------------------    529 
                                                                        
EPEC        492 SGPVTGRLIGTPGQGIQSTYALLANSGGLRLGMGGLTSGGESAVSSVNAA    541 
 
E.tarda     530 ---------    529 
                               
EPEC        542 PTPGPVRFV    550 
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Output from TMpred 
2 possible models considered, only significant 
TM-segments used 
-----> STRONGLY prefered model: N-terminus 
inside 
 2 strong transmembrane helices, total score: 
3875 
 #     from    to      length     score       orientation 
1-  234    253     (20)         1981            i-o 
2-  364    386     (23)         1894            o-i 
------> Alternative model 
 2 strong transmembrane helices, total score: 
3779 
 #     from    to     length   score     orientation 
1- 234     253    (20)       2104        o-i 
2- 363     382    (20)       1675        i-o 
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Output from TMpred 
2 possible models considered, only significant TM-
segments used 
-----> STRONGLY prefered model: N-terminus inside 
 2 strong transmembrane helices, total score: 
3678 
 #    from      to    length   score    orientation 
1-    290     309     (20)    1722          i-o 
2-    418     440    (23)    1956           o-i 
 ------> Alternative model 
 2 strong transmembrane helices, total score: 
3304 
 #    from     to    length     score     orientation 
1-  290   309   (20)       1659          o-i 
2-  421   440   (20)       1645          i-o 
Figure 57: The E. tarda and EPEC Tir proteins have two putative transmembrane domains.  The E. tarda and EPEC Tir protein sequences were 
examined for the presence of transmembrane domains (http://www.ch.embnet.org/software/TMPRED_form.html)  and found to possess two in similar 
locations (234-253 & 363-382 EPEC Tir; 290-309 & 421-440 E. tarda Tir) flanking the Intimin binding region. The program requires setting of minimal and 
maximal hydrophobic helix length, in this case it was 17 and 33 respectively. Solid line is the prediction for inside to outside TM helix and interrupted line 
is the prediction for outside to inside TM helix. 
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4.3.8.1 Generating an E. tarda Tir-HA fusion protein  
Given the low degree of Tir homology, it was not surprising that plasmids carrying the 
E. tarda gene failed to produce a protein that could be detected with antibodies raised 
against EPEC Tir. Adding epitope tags, including HA, to the C-terminus of EPEC Tir 
does not interfere with its known subversive functions (Kenny et al., 1997b). Thus, a 
plasmid encoding an E. tarda Tir-HA fusion protein (TirHAEt) was generated (see 
Chapter 2; Section 2.2.8). Briefly, tirEt was amplified with flanking unique restriction 
enzyme sites and inserted into the TA cloning vector (pCR-2.1) prior to subcloning into 
a pSK-based plasmid (carrying EPEC tirHA and cesT genes) replacing the EPEC tir 
fragment (Figure 58). PCR analysis supported the generation of pSK-tirHAEt cesTEPEC 
(Figure 58). 
To assess TirHAEt fusion protein expression and delivery, Hela cells were infected with 
EPEC or the tir mutant carrying no plasmid or a plasmid encoding EPEC or E. tarda 
TirHA fusion proteins prior to isolating Triton X-100 soluble and insoluble fractions for 
Western blot probing for HA tagged proteins. This analysis confirmed expression and 
delivery of EPEC TirHA into host cells (kinase modified T’’ form in soluble and insoluble 
fractions; not shown) but only a very weak band of the expected molecular mass for 
the E. tarda TirHA protein was evident in the insoluble, but not soluble, fraction (data 
not shown).  
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Figure 58: Construction of pSK-tirHAEt cesTEPEC.  Agarose gel data illustrating steps in generating 
and/or confirming presence of pSK-tirHAEt cesTEPEC A) PCR amplification of a single band of expected 
size of tirEt gene and support for introduction into pCR-2.1 plasmid (B&C) Restriction digestion release 
of tirEt from pCR-2.1 tirHAEt and tirEPEC from pSKtirHA cesT to isolated fragments for D) ligation to 
generate pSK-tirHAEt cesTEPEC E) supported by PCR detecting tirEt in two of 4 screened clones (#3, 
#4) 
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4.3.8.2 Generating pACYC-tirHAEt  
It was possible that this expression problem may relate to cloning the E. tarda gene 
into a high copy number plasmid and/or co-expression with CesTEPEC, so it was 
decided to subclone E. tarda tirHA gene to pACYC184 as used in previous 
complementation studies (and medium copy number).  
Briefly, pSK-tirHAEt cesTEPEC was digested Xbal/BglII - releases E.tarda tirHA fragment 
and 5’ end of EPEC cesT gene - and ligated into Xbal/BamHI sites of pACYC184. 
Generation of pACYC-tirHAEt and its introduction into the EPEC ∆tir mutant strain was 
supported by PCR analyses (Figure 59). Studies also examined whether CesTEPEC is 
needed for E. tarda Tir stability and/or T3SS-dependent delivery into cells by 
introducing the plasmid into the CesT/Tir-negative ∆go3core mutant and EspB/Tir-
negative ∆tir_espB mutant (see Chapter 2; Table 1). 
Western blot analysis of Triton X-100 insoluble fractions from infected HeLa cells 
revealed TirHAEt to be expressed by all the Tir negative (∆tir, ∆tir_espB and ∆go3core) 
strains with reduced levels in the CesT-deficient (∆go3core) mutant indicative of 
CesTEPEC-dependent stability (Figure 60). Probing for EspB confirmed its expected 
absence from the ∆tir_espB mutant. Crucially, probing soluble fractions for HA proteins 
failed to detect a HA protein in ∆tir_espB mutant infected cells in contrast to low and 
high levels of a band of TirET expected molecular mass in ∆go3core and ∆tir mutant-
infected cells, respectively (Figure 60). This data is consistent with EspB/T3SS-
dependent delivery of E. tarda Tir by EPEC with efficient transfer requiring CesTEPEC 
expression. Crucially, detecting only a single band suggests that, as predicted, E. tarda 
Tir does not undergo host kinase modifications that trigger shifts in apparent molecular 
mass.  
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Figure 59: Schematic of pACYC-tirHAET and PCR support for introduction into EPEC strains. 
Plasmid map of pACYC-tirHAET with PCR data A) supporting E.tarda tir gene in pACYC184 and B) 
introduction into EPEC ∆tir (lacks functional Tir protein); EPEC∆tir_espB (lacks functional Tir and 
EspB [translocator/effector] proteins) and ∆go3core (missing genes for 5 effectors [LEE EspG, Tir, 
Map, EspH, Orf3/EspG2], Intimin and 2 chaperones CesT/CesF) mutants. 
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Figure 60: EPEC T3SS-dependent delivery of E. tarda Tir into HeLa cells promoted by EPEC 
CesT. HeLa cells were infected for 3, 6 and/or 9h with indicated strains before isolating Triton X-
100 soluble (containing host cytoplasm and membrane proteins plus delivered effector proteins) 
and insoluble (containing host nuclei and cytoskeletal proteins plus adherent bacterial proteins) 
fractions for western blot analysis (10% SDS-PA gel) probing for EspB or HA proteins. The positions 
of Tir-HA, EspB and protein markers are indicated. Strains used lacked Tir (∆tir), Tir and EspB 
(∆tir_espB) or the CesT/CesF chaperones, Intimin, EspG, EspG2, EspH, Map, Tir (∆go3core). 
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4.3.9 The E. tarda cesT gene produced a protein that weakly substitutes for 
CesTEPEC in promoting TirEPEC delivery into HeLa cells  
CesTEPEC promoting E. tarda TirHA stability in EPEC and efficient delivery into HeLa 
cells made it likely that the E. tarda CesT homologue (~60% identity; ~80% similarity) 
would be functionally interchangeable. To interrogate this prediction cesTEt  was cloned 
into pACYC184 (see Chapter 2; Section 2.2.8). Briefly, cesTEt was amplified, using 
E.tarda genomic DNA as a template, and ligated into pACYC184 (predigested 
BamHI/SalI) using the Gibson Assembly protocol (Figure 61). Generation of pACYC-
cesTEt was supported by PCR analyses (Figure 61). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Probing western blots of fractions isolated from HeLa-infected cells revealed the 
expected ∆cesT mutant phenotype – i.e. little Tir expression/no detectable delivery - 
with introduction of cesTEPEC rescuing the defect as evidenced by detecting kinase 
modified T’’ from in soluble and insoluble fractions (Figure 62). Interestingly, 
introducing the cesTET plasmid also rescued the ΔcesT mutant defect but to a much 
less extent, especially in the soluble fractions. Thus, the Tir level in the insoluble 
fraction was reduced - relative to samples from cells infected with the cesTEPEC 
Figure 61: Construction of pACYC-cesTEt. Agarose gel data illustrating steps in generating and/or 
confirming presence in strains A) The E.tarda cesT gene was amplified as a single band at most 
assessed temperatures for use with B) pACYC184 digested with BamHI and SalI restriction enzymes. 
C) for linking together using the Gibson Assembly protocol with introduction of the generated pACYC-
cesTET D) confirmed in all 3 examined clones. 
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complemented strain - at 3, not 6, hour post-infection time point in contrast to both time 
points for the soluble fraction samples  (Figure 62). The presented data implies that E. 
tarda CesT is less capable than EPEC CesT at chaperoning EPEC Tir to the EPEC 
T3SS for transfer into host cells. It was also noted that plasmid expressing E. tarda 
CesT was associated with higher EspB protein levels in the insoluble fractions (Figure 
62).  
Examining the CesT alignment data (Figure 63) revealed differences in features linked 
to EPEC CesT chaperone activity. The N-terminal region (65% identity) of EPEC CesT 
is linked to chaperone dimerization (Delahay et al., 2002) while the C-terminal domain 
(51% identity) has an amphipathic α-helical regions; linked to EPEC CesT substrate 
binding (Delahay et al., 2002). Residues E142, V116, V126, H128, N129 and S147, 
along with the final 11 amino acids, are important for EPEC CesT functionality in 
secreting NleA and Tir (Ramu, 2013). Interestingly, there are residues differences in 
the amphipathic α-helical with the E. tarda variant lacking E142 and S147 and 4 of the 
last 11 residues are different to the EPEC homologue. 
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Figure 62: The E. tarda CesT protein is less effective than EPEC CesT in promoting EPEC Tir 
stability and delivery into host cells. HeLa cells were infected for 3 and/or 6 h with indicated 
strains before isolating Triton X-100 and soluble (containing host cytoplasm and membrane proteins 
plus delivered effectors) and insoluble (containing host nuclei and cytoskeletal proteins plus 
adherent bacterial proteins) fractions for western blot analysis (10% SDS-PA gel) probing for Tir, 
EspB and EspF. The position of Tir unmodified (T
o
) and host kinase modified forms (T’/T”), EspB, 
EspF and protein markers are indicated. Strains used were the ∆cesT mutant carrying no (-) 
plasmids or plasmids carrying the EPEC or E. tarda cesT (pCesTEPEC and pCesTEt respectively) 
genes. 
 
 
 
 
EPEC-CesT          1 MSSRSELLLDRFAEKIGVGSISFNENRLCSFAIDEIYYISLSDANDEYMM     50 
                     ||||:::||:..::::|:..:.|||.:||||.||::|.:|||||:||:|| 
E.tarda-CesT       1 MSSRAQVLLESLSKRVGIDGLCFNEYKLCSFFIDDLYCVSLSDASDEHMM     50 
 
EPEC              51 IYGVCGKFPTDNPNFALEILNANLWFAENGGPYLCYESGAQSLLLALRFP    100 
                     |||||||||.:...||||||||||||||:|||:||||||::|||||||.. 
E.tarda           51 IYGVCGKFPINEQGFALEILNANLWFAESGGPHLCYESGSESLLLALRVN    100 
 
EPEC             101 LDDATPEKLENEIEVVVKSMENLYLVLHNQGITLENEHMKIEEISSSDNK    150 
                     ||..|.:|||||||.||.:|||||||.|||||.|:|:.:.:......:.| 
E.tarda          101 LDHCTTDKLENEIEHVVNAMENLYLVFHNQGIELKNDLLNVSPFEKMEIK    150 
 
EPEC             151 HYYAGR    156 
                     :|::.| 
E.tarda          151 NYFSAR    156 
Figure 63: Comparison of E. tarda and EPEC CesT proteins. E. tarda and EPEC CesT 
sequences were aligned (http://www.ebi.ac.uk/Tools/psa/emboss_needle/). Highlighted are 
features linked to EPEC CesT functionality: amphipathic -helical region associated with substrate 
binding (Yellow) plus individual (Red) and run of residues (Green) linked to efficient effector 
secretion. 
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4.4  Discussion  
Type III secretion systems (T3SS) play a critical role in the pathogenesis of many 
bacterial pathogens that infect humans, animals and plants (Galán et al., 2014, Buttner 
& He, 2009). Thus, it is important to understand the functionality of the ~20 proteins that 
make up T3SSs which serves to deliver effector proteins into infected host cells (Buttner, 
2012, Cornelis, 2006, Cardenal-Munoz et al., 2014). The T3SS components of A/E 
pathogens, including EPEC, EHEC, Citrobacter rodentium, are highly homologous with 
many displaying much more diversity to corresponding proteins from other pathogens 
such as Yersinia, Salmonella and Shigella species (Diepold & Wagner, 2014). Recently, 
a fish pathogen, Edwardsiella tarda (E. tarda), was reported to carry a LEE region 
(Nakamura et al., 2013) – key virulence determinant of A/E pathogens – encoding 
proteins for a T3SS, transcriptional regulator, Intimin surface protein and one effector, 
Tir. Here, we report on our bioinformatics analysis of the E. tarda LEE region and ability 
of E. tarda proteins to functionally replace their EPEC homologues. The work reveals 
issues with the original bioinformatics analysis and argues that E. tarda encodes a 
functional T3SS to deliver, under specific conditions, two LEE (Tir, EspZ) and, probably, 
non-LEE-encoded effectors into fish cells. Importantly, finding little or no functional 
interchangeability between some components provides an opportunity to gain insights 
on the structure and/or function of T3SS proteins from A/E, and possibly other, 
pathogens. 
 
Although E. tarda was reported to share 29 out of 42 EPEC LEE open reading frames, 
Orfs (Nakamura et al., 2013), EPEC only has 41 recognised Orfs (Elliott et al., 1998, 
Deng et al., 2004) with the additional one - between ler and espG genes – not considered 
to produce a functional protein. Interestingly, the E. tarda LEE region appears to have 
37 Orfs and thus 8 proteins with no EPEC homologous. However, six of these new Orfs 
are in regions where E. tarda LEE genes (escD, sepL, escL) are significantly smaller 
than their EPEC homologues or replacing the escE, escA and escS genes while the final 
two are in a region where the ‘missing’ EPEC effector genes would be expected to be 
located. However, most of these new genes appear to encode very small proteins with 
our analysis revealing the E. tarda escE, escA and escS genes in the same area as that 
they might be there with another three likely not to be expressed as our bioinformatics 
analyses revealed ‘missing’ portions of the escD, sepL and escL genes on open reading 
frames in the regions that encode these non-EPEC LEE proteins. 
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Sequencing the ‘out of frame’ region for three genes (escD, sepL, escL) revealed the 
two escD Orfs to be separated by a 14bp gap while the SepL and EscL Orfs are distinct 
due to the apparent absence of a single base. While such finding are suggestive of these 
T3SS critical proteins no longer being functional, this was not supported, at least for 
EscD, by finding that the effector delivery defect of an EPEC escD mutant (Ogino et al., 
2006) could be rescued by introducing both, not one, E. tarda escD Orfs. The two EscD 
Orfs produce a protein of similar size to EPEC EscD, 10 residues larger, but with many 
differences (~44% identity/61% similarity). This finding suggests that E tarda EscD is 
expressed either as i) two independent polypeptides or ii) as one Orf - via, for example, 
ribosome hopping; a process linked to expressing T3SS proteins, from two Orfs, in other 
pathogens in relation to specific environmental signals such as stress (Penno et al., 
2006, Atkins et al., 2016, Namy et al., 2004). The latter mechanism is supported by the 
presence of a hungry Ile (AUA) codon (Gallant & Lindsley, 1998) – linked to ribosome 
stalling (Keiler, 2015) and hopping (Lovett & Rogers, 1996) - prior to the stop codon of 
the first escDEt orf. EscDEt functionally interchangeable, but only when both Orfs were 
introduced, supports a critical role for each domain in accordance to the finding that 
T3SS functionality depends on the N-terminal domain interacting with EscJ while the C-
terminal domain interacts with EscC and EscF proteins (Ogino et al., 2006). Crucially, 
EscD functional interchangeability supports the idea that the E. tarda LEE region might 
produce a functional effector delivery system. Further studies will be needed to elucidate 
the exact mechanism that underpins the functional interchangeability of E tarda EscD 
encoded over two adjacent, but non-overlapping Orfs. 
 
By contrast, similar complementation studies with the E. tarda SepL and EscL proteins 
failed to rescue the effector delivery defect of EPEC espL and escL mutants, 
respectively, though the E. tarda SepL protein appeared to partially rescue T3SS 
functionality (data not shown). It is predicted that these T3SS critical proteins, like EscD, 
are under some form of regulatory control at the protein translation level (i.e. ribosome 
frame-shifting to generate a single Orf) with the failure to functionally replace the EPEC 
homologue likely to reflect differences in protein sequences (~49% identity/~74% 
similarity between SepL proteins and ~27% identity/~54% similarity between EscL 
proteins). SepL and EscL are components of a sorting platform with SepD, EscP, EscK, 
EscA and EscN. It is possible that co-expressing these proteins with each other or other 
sorting platform proteins could restore functionality in line with our findings with 
translocator proteins i.e E. tarda EspA and EspD proteins had little functional 
Chapter 4 Results II 
131 
  
interchangeability until co-expressed. Moreover, complementation studies with two other 
platform proteins, EscK (~13% identity/~21% similarity) and EscP (~21% identity/~39% 
similarity), found that only the latter could substitute for its EPEC homologue. Further 
studies should examine the functional interchangeability of other platform proteins: SepD 
(~40% identity/~64% similarity), EscA (~25% identity/~54% similarity) and EscN (~62% 
identity/~76% similarity) with the definition of features/residues differences that hinder 
complementation, perhaps, providing important new insights on how these proteins 
contribute to T3SS functionality.  
 
It is worth pointing out that T3SS components from different A/E pathogens are usually 
highly homologous while proteins exposed to the host immune system (i.e. translocators, 
effectors and Intimin proteins) are generally more divergent - due to selective pressure 
to avoid immune recognition (Perna et al., 1998). However, T3SS components of 
different pathogens can either have low or high levels of conservation (Diepold & 
Wagner, 2014) with the former presumably reflecting species specific alterations that 
promote the pathogen’s lifecycle. Indeed, the E. tarda T3SS proteins, in general, have a 
low degree of conservation to homologues of other A/E pathogens suggesting that E. 
tarda has been undergoing a distinct evolutionary pathway that presumably reflects its 
role in aiding the lifecycle of this invasive fish pathogen. 
 
Crucially, while our data supports (Nakamura et al., 2013) E. tarda LEE lacking genes 
for multiple effectors (Map, EspF, EspG, EspH), a chaperone (CesF; needed for efficient 
EspF delivery) (Elliott et al., 2002) and two transcriptional regulators (GrlA, GrlR), it 
uncovered genes for proteins critical for i) T3SS functionality (i.e. EscA [ATPase complex 
component], EscS [T3SS core protein] plus, as mentioned, EscE [EscF chaperone]) and 
ii) A/E pathogen virulence i.e. the EspZ effector (Deng et al., 2004, Shames et al., 2010). 
It is not obvious why these small proteins (122, 89, 78,129AA for EscA EscS, EscE and 
EspZ respectively) were missed and why the authors did not comment on the 
implications of this (as well as truncated EscD, SepL, EscL proteins) on T3SS 
functionality. By contrast, our findings provide further support for the E. tarda LEE region 
encoding a functional T3SS that serves to deliver EspZ and Tir into host cells to promote 
cell survival (EspZ) and provide a receptor (Tir) for the Intimin surface protein to promote 
pathogen-fish cell interaction. Interestingly, our analysis revealed a region flanking LEE 
to carry genes for an effector - 25.7% identical (39.4% similar) to the Yersinia tyrosine 
phosphatase YopH (Guan & Dixon, 1990, Rosqvist et al., 1988) – and a chaperone, 
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SycH ~30% identical (~54% similar) (Woestyn et al., 1996). This finding raises the 
possibility that the LEE T3SS may also deliver other, non-LEE-encoded, effectors into 
fish cells. However, it must be noted that this LEE carrying E. tarda strain (FPC503) is 
an atypical family member, as carries an additional T3SS and two T6SS (Nakamura et 
al., 2013). Further studies are needed to determine which system transfers which, if any, 
identified effectors into host cells. By contrast, the absence of GrlR and GrlA regulators 
should have no impact on T3SS functionality as they are linked to regulating the activity 
of the LEE encoded master regulator, Ler, to environmental cues (Barba et al., 2005, 
Jimenez et al., 2010) while a recently published non-pathogenic E.coli strain (SIEC), 
lacking grlR and grlA genes, produced a functional T3SS when transcriptional activation 
was no longer under their control (Ruano-Gallego et al., 2015). Interestingly, while the 
Ler proteins are only ~39% identical (~59% similar) the E. tarda variant could functionally 
replace the EPEC homologue to induce T3SS expression and effector delivery. Thus, 
the E. tarda LEE region is undoubtedly under transcriptional control of the Ler protein 
which is presumably controlled through the activity of non-LEE encoded proteins, 
equivalent to the plasmid-encoded regulator (Per) in EPEC, to induce T3SS production 
under a specific set of environmental conditions (Gomez-Duarte & Kaper, 1995).   
 
Interestingly, while the initial analysis suggested that the E. tarda Intimin protein is larger 
than the EPEC homologue our analysis uncovered a slightly smaller protein (929 versus 
939 residues) with an Intimin-like sequence on an overlapping reading frame. Moreover, 
DNA sequencing revealing an error which, when corrected, provides a gene encoding 
an 1117 residue protein that is quite dissimilar to its EPEC homologue (~40% identity; 
52% similarity). Importantly, the E. tarda protein could functionally substitute for EPEC 
Intimin, at least in binding the EPEC delivered Tir protein and triggering Tir’s actin 
nucleating activity. The latter result was, perhaps, not too unexpected as E. tarda Intimin 
has residues reported to be critical for binding Tir (Yi et al., 2010). 
 
Perhaps not too surprisingly, the E. tarda LEE Tir and EspZ effectors shared low 
homology with their EPEC counterparts (~24-30% identity/~36-38% similarity) though 
this is greater than some E. tarda T3SS components such as EscK (~13% identity/~21% 
similarity). Tir from another A/E pathogen, enterohemorrhagic E.coli O157:H7 (EDL993 
strain), shares one of the lowest level of identity (66%) with its EPEC homologue linked 
to divergent evolution and EHEC Tir nucleating actin by a different, Intimin-dependent, 
mechanism (Perna et al., 1998, Diepold & Wagner, 2014, DeVinney et al., 1999, 
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Campellone et al., 2004b). The corresponding EPEC/EHEC EspZ proteins share 70% 
identity (Perna et al., 1998) and thus E. tarda provides the best example of a LEE 
carrying pathogen with strain-specific divergence in effector (and other T3SS-related 
proteins). Interestingly, much of the EspZ variance relates to N- and C-terminal 
extensions with highest homology between two predicted transmembrane domains and 
the small, possibly extended (10-14 residue) extracellular domain. It would be interesting 
to examine the functional interchangeability of E. tarda EspZ protein for the EPEC 
homologue both in vitro and in vivo models. By contrast, Tir divergence was linked to a 
smaller E. tarda protein (529 versus 550 residues) with absence of features linked to 
EPEC Tir’s known subversive activities (through residues differences, insertions and 
deletions; latter includes loss of most of C-terminal domain) with, as per EspZ, the most 
homology related to the two predicted transmembrane regions and extracellular (Intimin 
binding) domain. Indeed, these differences are presumably responsible for the failure of 
the anti-EPEC Tir polyclonal antibodies from recognising E. tarda Tir - a finding in line 
with the failure of anti-EPEC EspB polyclonal antibodies detecting E. tarda EspB – 
prompting studies with a HA tagged Tir variant. Interestingly, this variant was expressed 
by EPEC and, apparently, delivered into HeLa cells (expression/delivery were reduced 
when the EPEC Tir chaperone, CesT, was absent) but there was no evidence for host 
kinase modification-induced shifts in molecular mass. However, the latter was not 
surprising given that E. tarda Tir lacks serine and tyrosine-related motifs linked to host 
kinase modification-induced shifts in molecular mass and, following Intimin binding, actin 
nucleation respectively. The latter findings, makes it very difficult to assess whether E. 
tarda Tir is truly delivered into cells and/or becomes inserted into the plasma membrane 
and, if the latter occurs, whether during the transfer process or via a cytoplasmic 
intermediate. Future studies are needed to address these questions. By contrast, 
preliminary studies to determine whether E. tarda can deliver EPEC Tir (as a TirHA 
fusion protein) into cells for host kinase modification, insertion into the plasma membrane 
and Intimin binding are suggestive of low level delivery and kinase modification (but 
apparently not Intimin binding). However, the transfer process may relate to the second 
T3, or either T6 secretion systems. The low deliver levels may relate to issues including 
failure to define conditions that maximally induce E. tarda LEE T3SS expression and/or 
functionality and the finding that the E. tarda CesT protein could only weakly substitute 
for the EPEC homologue (despite being ~60% identical/~80% similarity). Interestingly, 
the E. tarda CesT variant did not appear to have a defect in promoting Tir stability within 
EPEC but was associated with reduced delivery levels suggesting that differences 
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between these variants either i) impact on CesT docking with the T3SS, ii) Tir release 
from CesT and/or iii) Tir transfer through the T3SS/translocon systems. Interestingly, 
there are differences in residues linked to transfer efficiency so, undoubtedly, domains 
swaps and residue substitutions experiments would identify the responsible 
residues/features and promote studies to define how they impact on Tir deliver levels. 
 
It should be noted that we only tested the functional interchangeability of 12 (~36%) of 
E. tarda LEE proteins with six (EscD; Ler; Intimin; EspA; EspD and EspB) appeared to 
fully substitute for their homologues (though two [EspA and EspD need to be co-
expressed]) while 3 displayed low levels of functional interchangeability (SepL; CesT 
and EscP) with the remaining three (EscL; EscK and Tir) not able to replace their EPEC 
homologues. It is possible that the complementation defects related to issues in the 
expression (i.e codon usage), stability (i.e defects in binding chaperones) or sequence 
divergence of E. tarda proteins, with the latter group the most important for future studies 
to provide insights on their roles in T3SS functionality and/or pathogen virulence. 
Undoubtedly, the remaining 21 E. tarda LEE proteins should also be examined for 
functional interchangeability, and the E. tarda LEE region cloned into non-pathogenic E. 
coli to define conditions to induce expression and test its ability to deliver EPEC, E. tarda 
and/or hybrid Tir proteins into host cells to investigate the direct or indirect membrane 
insertion mechanisms.
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Chapter 5: The enteropathogenic E. coli (EPEC) delivered EspZ 
effector prevents host cells cytotoxicity in response  
to the Tir-Intimin interaction 
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5.1  Introduction  
The virulence of enteropathogenic Escherichia coli (EPEC) depends on a functional 
T3SS, Tir, Intimin and EspZ proteins (Wilbur et al., 2015, Marchès et al., 2000, Coburn 
et al., 2007). While Tir and Intimin’s virulence critical role is linked to their interacting 
together to mediate intimate host-pathogen interaction (Kenny et al., 1997b, Kenny, 
1999) that of EspZ is associated with preventing infected cells from undergoing a 
cytotoxic response (Shames et al., 2011, Berger et al., 2012, Roxas et al., 2012). EspZ, 
is a small (9kDa) effector predicted to be integrated, like Tir, in the host cell plasma 
membrane in a hairpin-loop topology, via two transmembrane domains, with a small 
(10AA) extracellular loop (Kanack et al., 2005). EspZ is reported to be, after Tir, the 
next most-abundantly delivered effector with some localising to mitochondria (Shames 
et al., 2011, Mills et al., 2008). 
The ability of EspZ to stop cells cytotoxicity was initially linked to its interacting with a 
transmembrane glycoprotein, CD98 (Shames et al., 2010) triggering increased focal 
adhesion kinase (FAK) activity to enhance pro-survival signalling (Shames et al., 
2010). However, this hypothesis was questioned by deletion of CD98 not promoting 
cell cytotoxicity (Roxas et al., 2012). A second hypothesis stemmed from finding EspZ 
interacts with translocase of inner mitochondrial membrane 17b (TIM17b) promoting 
maintenance of mitochondrial membrane potential and thus protecting against cell 
death during EPEC infection (Shames et al., 2011). However, depletion of TIM17b also 
decreased survival of uninfected cells (Garabedian et al., 2011, Sinha et al., 2014). As 
two EPEC effectors (Map and EspF) target the mitochondria, via mitochondrial 
targeting sequences [MTS], linked to loss of mitochondrial membrane potential (Nagai 
et al., 2005, Kenny & Jepson, 2000, Papatheodorou et al., 2006), it has been 
suggested that EspZ may protect against cell death by inhibiting the deleterious impact 
of these effectors on mitochondrial function (Shames et al., 2011, Roxas et al., 2012). 
A third possibility relates to finding that EspZ also interacts with a translocator protein, 
EspD (Creasey et al., 2003a), suggesting that the EspZ might regulate translocation of 
EPEC effectors into the host cells (Berger et al., 2012). Thus, it is proposed that when 
EspZ is absence there is continuous translocation of subversive effectors which 
overloads the cells, leading to permeabilization of plasma membrane and, thus, 
cytotoxicity (Berger et al., 2012). It is also worth mentioning that EspZ is also reported 
to interfere with apoptosis – programmed cell death (not cytotoxic) - by inhibiting the 
intrinsic apoptotic pathway as espZ mutant infected cells had higher levels of cytosolic 
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cytochrome c and increased activation of caspases 9, 7, and 3 (Roxas et al., 2012). 
Interestingly, EPEC infection of epithelial cells activates the epidermal growth factor 
receptor; EGFR, which induces cell survival signalling (Roxas et al., 2007) with EspZ 
found to regulate EGFR stability by protecting against EspF-dependent cleavage 
thereby promoting host cell survival (Roxas et al., 2014). 
 
Our previous work (Chapter 3) revealed that a mfz(81)go3 mutant (lacks LEE Map, 
EspF, EspZ & EspG effectors plus the non-LEE-encoded Orf3/EspG2 effector) could 
deliver Tir into HeLa cells where it was modified to the T’’ form and could be bound by 
Intimin. However, extending the infection time (from 3 to 6hr) revealed a number of 
phenotypes: loss of i) Tir T” form, ii) host and Tir tyrosine phosphorylated proteins and 
iii) host cytoplasmic tubulin and actin proteins (not shown but see below). These 
phenotypes were, presumably, due to cell cytotoxicity as the strain does not express 
the pro-survival EspZ effector. Surprisingly, these phenotypes were not observed 
following infection with a similar multi-mutant, mfz(81)go3e, which differs only by the 
additional absence of the Intimin encoding gene, eae. This observation questioned the 
idea about EspZ’s anti-cytotoxicty activity relates to it limiting the level of effector 
delivery, counteracting Map/EspF’s deleterious impact on mitochondrial function or 
preventing EspF cleavage of EGFR unless these are Intimin-dependent events. 
 
5.2 Aim  
The aim of this chapter was to investigate the hypothesis that EspZ protects infected 
cells from Intimin-dependent cytotoxicity and, if true, to provide insight on the process.  
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5.3 Results  
5.3.1 mfz(81)go3 mutant phenotypes linked to absence of EspZ delivery  
To investigate whether loss of i) T” form, ii) tyrosine dephosphorylated Tir and host 
proteins and iii) cytoplasmic tubulin and actin proteins were due to EPEC failing to 
deliver EspZ, HeLa cells were infected over a 9h period with EPEC, espZ and T3SS 
mutant strains before Triton X-100 soluble (contains host cytoplasm and membrane 
proteins plus delivered effectors) and insoluble (contains host nuclei and cytoskeletal 
proteins plus adherent bacterial proteins) fractions were isolated for Western blot 
analyses. 
The T3SS mutant strain expressed Tir (Figure 64A, insoluble fraction) but did not, as 
expected, deliver it (or EspB or EspF) into host cells (Figure 64A, soluble fraction). 
Similar gel loadings and absence of cytotoxicity over the first 7 hours of infection was 
supported by probing for tubulin (mostly in soluble fraction) and actin (~70% in soluble 
fraction) with the 9h infection period linked to tubulin/actin signal loss (Figure 64A). 
Probing for tyrosine phosphorylated proteins revealed a single prominent band in the 
insoluble fraction linked to the EPEC protein Ep85 (also known as Etk) (Rosenshine et 
al., 1992, Kenny & Finlay, 1997, Ilan et al., 1999) with infection linked to 
dephosphorylation of host tyrosine phosphorylated proteins in the soluble fraction by 
7h post-infection. The latter findings reveals a T3SS-independent mechanism that 
induces dephosphorylation of HeLa cytoplasmic/membrane proteins and precedes a 
cell cytotoxicity response. These changes were linked to bacterial overgrowth - 
associated media acidification - which could be avoided by changing the media every 
3hrs or decreasing the infection time (to 6hr; not shown but see below).  
By contrast, EPEC and espZ(81) strains delivered Tir, as evidenced by detecting T’’ 
form in the soluble fractions (Figure 64C), but whereas the T’’ form was evident in the 
soluble fractions of EPEC infected cells at all, but not the 9hr time, point, it was absent 
from most of the corresponding samples from espZ(81)-infected cells linked to 
increasing T’ and/or unmodified Tir forms (Figure 64C). This change in Tir signal was 
associated with tubulin/actin signal loss linking it to cell cytotoxicity (Figure 64C); latter 
supported by absence of most cells (~70%) at final (9h) infection time point. 
Interestingly, no corresponding loss of EspB and EspF signals was evident from the 
soluble fractions suggesting that they are mainly membrane inserted/associated and/or  
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Figure 64: T3SS-independent and -dependent loss of Tir T’’, phosphotyrosine proteins and 
tubulin/actin signals in espZ(81)-infected cells. HeLa cells were left uninfected or infected with 
indicated strains, for indicated times, prior to isolating Triton X-100 soluble (contains host cytoplasm 
and membrane proteins plus delivered effector proteins) and insoluble (contains host nuclei and 
cytoskeletal proteins plus adherent bacterial proteins) fractions for Western blot analysis probing 
for phosphotyrosine proteins (PY), Tir, EspB, EspF, tubulin and actin. The position of unmodified 
(To) and host kinase modified Tir (T” and PY [TY]) forms are indicated as are Ep85 (EPEC tyrosine-
phosphorylated cytoplasmic protein), EspF, EspB, tubulin, actin and protein markers bands. Strains 
used were EPEC, T3SS-deficient (T3SS/cfm-14) and EspZ-deficient (espZ(81)). Note, data is 
representative of that from two or more independent experiments. 
 
  
C) 
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within organelles, for example, EspF accumulates within mitochondria (Nagai et al., 
2005). As expected, the phosphotyrosine antibodies detected Tir and host proteins in 
the soluble fractions from espZ and EPEC-infected cells but with a rapid dramatic loss 
in these signals, over time, from espZ(81)-infected cells (Figure 64C). Interestingly, 
while the Tir T’’ modified form migrated (due to binding Intimin) into the insoluble 
fraction of EPEC-infected cells at each time point, there was little evidence of this for 
espZ-infected cells suggesting that Tir is no longer available to, or cannot stably, 
interact with Intimin (Figure 64B). It should be noted that strain binding levels are 
reflected by Ep85, EspB, EspF and unmodified Tir (within bacteria) signals in insoluble 
fractions, with Ep85 in samples from EPEC-infected cells obscured by strong 
phosphotyrosine Tir band (Figure 64B). This work links the T3SS-dependent loss of i) 
T” form, ii) tyrosine dephosphorylated Tir and host proteins and iii) cytoplasmic 
tubulin/actin proteins to the failure of EPEC to deliver EspZ in cells leading to a 
cytotoxic response. 
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5.3.2 Critical role for Intimin, Map and EspF proteins in the espZ(81)-associated 
phenotypes  
As our previous work suggested that the, above described, espZ(81)-associated 
phenotypes could be prevented by inactivating the Intimin gene, with most Intimin 
subversive activities relating to it binding Tir (Kenny & Finlay, 1997, Kenny et al., 
1997b, Kenny et al., 2002b, Rosenshine et al., 1996), studies examined the impact on 
infecting cells with EspZ-deficient strains unable to express other effectors and/or 
Intimin. These studies were restricted to a 6 h period; which is sufficient to reveal the 
T3SS-dependent cytotoxicity-associated phenotypes linked to espZ(81) infection 
(Figure 64). The screened strains and resulting western blot data (representative blots 
shown in Figure 65A-D) are summarised in Table 9. HeLa cells were infected with 
control strains, EPEC and Intimin-deficient (eae) mutant, for only 3 and/or 6 hr with 3, 
4, 5 and 6hr infections for strains lacking EspZ alone (espZ(81)) or with other effectors 
(Tir, Map, EspH, EspF, EspG/Orf3) and/or Intimin proteins.  
 
 
Strain Figure # 3h 4h 5h 6h Notes 
EPEC 64, 65A/C/D E E E E  T” is stable, No pTyr nor tub/actin loss 
espZ
(81)
 64, 65A/C E ∆*●○ ∆*●○ ∆*●○  
fz:km   65A E Z Z Z Slower T’’ and tub/actin loss 
mz:km   65A E Z Z Z Faster pTyr proteins loss; slower tub/actin loss 
go3z:km    65A E Z Z Z Faster pTyr proteins and tub/actin loss 
hz:km   65A E Z Z Z Faster pTyr proteins and tub/actin loss 
ez:km 65B E E E E Loss  pTyr proteins at 5/6h 
mfz:km    65B E E Z Z Loss pTyr proteins & Tir T’’ at 5/6h & tub/act 6h  
mfz:kmgo3 65C E E Z Z Loss tub/actin 5/6h and pTyr proteins 5/6h 
mez:km 65D E E E E Loss of  pTyr proteins & some Tir T’’ at 6h 
fz:kme  69 E E E E Loss of  pTyr proteins at 6h 
mfez:km 65B/D E E E E  
mfz:kmgo3e 65C E E E E  
Table 9: Summary of differences between cells infected with EspZ-deficient and EPEC strains. 
Summary of western blot data from HeLa cells infected with indicated strains after 3, 4, 5 and 6h. 
Strains used were EPEC or those unable to express EspZ alone (espZ(81)) or EspZ plus one or more 
of indicated effectors – EspF (f), Map (m), EspH (h), EspG/EspG2 (go3) – and/or Intimin (e) proteins. 
E indicates normal T3SS dependent changes at indicated time point, while Z indicates data similar to 
that obtained with the espZ(81)-infected samples at that time point with, when present, some 
differences in probed signals (∆ reveals dephosphorylation of Tir and host tyrosine phosphoproteins; 
* loss to Tir T’’ band, ● loss of tubulin (tub) signal, and ○ loss of actin signal). Orange highlights espZ 
multi-mutants associated with minor phenotypic changes at later time points. Yellow highlights espZ 
multi-mutants that behave like EPEC. The espZ gene was inactivated by deleting 81 (of 98) residues 
or introducing kanamycin-encoding gene indicated by (81) and :km respectively.  
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Interestingly, most espZ multiple mutants behaved like the espZ(81) single mutant 
(Table 9; Figure 65) but there were some notable, subtle and dramatic differences. The 
former include an apparent delay in Tir T’’ and tubulin/actin signal loss by the fz and, 
to a lesser extent, hz mutants suggestive of EspF and EspH roles in promoting these 
changes. By contrast, the mz and go3z mutants were linked to a more rapid loss of the 
Tir T’’ form and slower tubulin/actin loss suggestive of roles for Map and the EspG 
homologues in hindering and promoting these events respectively (Table 9; Figure 
65A). A more dramatic difference was evident with the remaining strains (ez, mfz, mez, 
fze mfez, mfzgo3 and mfzgo3e multi-mutants) which behaved like EPEC though three 
(ez, fze and mez) were associated with one or more minor phenotypes at later time 
points (Table 9; Figure 65B-D). The EPEC-like profile for the ez double mutant is 
suggestive of a central role for Intimin functionality in all the phenotype, except tyrosine 
protein dephosphorylation where it appears to play a suppressive role. The latter is 
presumably mediated by Map and EspF activities as no tyrosine protein 
dephosphorylation is apparent with the mfez mutant in contrast to some for triple 
mutant-infected cells mez and fze (Table 9; Figure 65BD and 69). Interestingly, the 
mfz triple mutant is only associated with little loss of the Tir T’’ form linked to some loss 
in tyrosine phosphorylated protein and tubulin/actin signals (5/6h time point). The latter 
suggests that Map and EspF promote loss of the Tir T’’ form with roles for other 
effectors, presumably the EspG homologues as the mfzgo3 mutant does not induce 
Tir T’’ loss (Table 9; Figure 65C). Crucially, two EspZ-deficient strains (mfez and 
mfzgo3e) failed to display any espZ mutant-associated phenotypes revealing key 
cooperative roles for Intimin, Map and EspF activities.  
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Figure 65: Assessment of espZ multi-mutants. HeLa cells were left uninfected or infected with 
indicated strains, for indicated times, prior to isolating Triton X-100 soluble (contains host cytoplasm 
and membrane proteins plus delivered effector proteins) and insoluble (contains host nuclei and 
cytoskeletal proteins plus adherent bacterial proteins) fractions for Western blot analysis probing for 
phosphotyrosine proteins (PY), Tir, EspB, EspF, tubulin and actin. The position of unmodified (To) and 
host kinase modified Tir (T” and PY [TY]) forms are indicated as are Ep85 (EPEC tyrosine-
phosphorylated cytoplasmic protein), EspF, EspB, tubulin, actin and protein markers. Strains used 
were EPEC strains lacking EspZ (espZ(81) or z) alone and one or more of the indicated proteins: Map 
(m); EspF (f), Tir (t), EspH (h), EspG/EspG2 (go3) or Intimin (e). Below the strain name (note indicates 
order genes were inactivated) is the identity of proteins of interest (Tir, Map [M], EspH, EspZ, EspF 
[F], EspG/EspG2 [G], EspB [B] effector and/or Intimin [Int] proteins) expressed by the strain. The espZ 
gene was inactivated by deleting 81 (of 98) residues or introducing kanamycin-encoding gene 
indicated by (81) and :km respectively. Note, data is representative of that from two or more 
independent experiments. 
NOTE in some write Tr instead of Tir and don’t see fze mutant data 
D) 
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5.3.3 Restoring espZ associated-phenotypes of mfez:km mutant by complementing 
with Map, EspF or Intimin-expressing plasmids 
The previous work suggested possible roles for EspF, Map and/or Intimin proteins in 
the espZ(81)-associated phenotypes. To support this premise, plasmids carrying genes 
for Map, EspF or Intimin were, individually, introduced into the mfez:km (lacks Map, 
EspF, Intimin and EspZ proteins) mutant (see Chapter 2; Section 2.2.2 & Table 5) to 
determine if ‘rescued’ the defect to a level found for the respective triple mutants (Table 
9). PCR analyses supported mfez:km mutant genotype and plasmid introduction of the 
appropriate gene (Figure 66).  
 
 
 
 
 
 
 
 
Western blot analysis of Triton X-100 soluble and insoluble fractions from HeLa cells 
infected with the Intimin complemented strain (mfez/p-eae) confirmed an EPEC-like 
phenotype for the mfez:km mutant (though some loss of host/Tir phosphotyrosine 
protein signal was evident at 6hr time point in this experiment) with plasmid expression 
of Intimin - supported by Western blot analysis – linked to a much more prominent 
impact on the T” form, host/Tir phosphotyrosine protein and tubulin/actin profiles (4-
6hr; Figure 67). Tir (T’’ or T’’pY forms) were not evident, due to the absence of Intimin, 
in the insoluble fractions (Figure 67). This data supports a key role for Intimin in the 
espZ(81)-associated phenotypes. 
 
 
 
 
Figure 66: Absence of eae, espF and map genes 
from the mfez:km mutant and plasmid 
reintroduction of individual genes. Primers specific 
for the eae, map and espF genes were used to 
amplify DNA from the indicated strains or, as a 
control, purified plasmids (used to transforming 
strains) encoding Intimin (pCVD-eae), Map (pACYC-
map) or EspF (pBR-espF). Strains examined were 
EPEC, the mfez:km mutant (missing map, espF, eae 
and espZ genes; Km indicated antibiotic cassette 
within espZ gene). PCR products were run on 1% Gel 
with molecular weight makers (2 log DNA ladder) 
visualized using Red Nucleic Acid Stain.   
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Figure 67: Critical role for Intimin to trigger Tir T” to T’ shift and Tir tyrosine 
dephosphorylation by EspZ-deficient strains. HeLa cells were left uninfected or infected with 
indicated strains (for indicated times) prior to isolating Triton X-100 soluble (contains host cytoplasm 
and membrane proteins plus delivered effector proteins) and insoluble (contains host nuclei and 
cytoskeletal proteins plus adherent bacterial proteins) fractions. The samples were processed for 
Western blot analysis (10% SDS-PA gels) and probed for phosphotyrosine proteins (PY), Intimin, Tir, 
EspB, EspF, tubulin and actin. The position of unmodified (To) and host kinase modified (T” and T’’pY 
[TY]) Tir forms are indicated as are the positions of Ep85 (EPEC tyrosine-phosphorylated protein), 
Intimin, EspB, EspF, tubulin, actin and protein markers. Strains used were EPEC, espZ(81) and strains 
lacking 3 or 4 of the genes encoding Map (m), EspF (f), EspZ (z) and Intimin (e) with, when 
appropriate, strains carrying an Intimin-expressing plasmid (pCVD-eae). Note tyrosine 
dephosphorylation with mfez:km mutant at 6hr is unusual (see Figure 68 and 69).  
 
 
A) 
 
 
 
 
 
 
 
 
 
 
 
 
B) 
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Studies with the EspF complemented strains confirmed an EPEC-like phenotype for 
the mfez:km mutant with the mfez/p-F equivalent triple mutant (mez:km) linked to loss 
of host and Tir phosphotyrosine protein signals at 6h time point (Figure 68). 
Importantly, the complemented (mfez/pF) strain mimicked, as predicted, the mez:km 
mutant supporting a role for EspF in promoting host and Tir phosphoprotein signal loss. 
Strain genotype was supported by EspF absence in samples from only the mfez:km 
infected cells (Figure 68). It should be noted that the timing and, perhaps, level of EspB 
and (when expressed) EspF signals was different between mfez:km (evident by 3hr in 
soluble fraction), mez:km (evident by 4hr) and mfez/pF (evident by 5hr; Figure 68).  
 
EspF and Map proteins target the mitochondria, via mitochondrial targeting 
sequences [MTS], leading to loss of mitochondrial dysfunction hence host cell death 
(Nagai et al., 2005, Kenny & Jepson, 2000, Papatheodorou et al., 2006) and EspZ is 
proposed to inhibit the impact of these effectors on mitochondrial function (Shames 
et al., 2011, Roxas et al., 2012). In an attempted to examine whether EspF and Map 
associated phenotypes (in the absence of EspZ) are linked to their import to the 
mitochondria, the mfez:km mutant was complemented with plasmids encoding EspF 
variants unable to target mitochondria, due a single substitution; L16E (Nagai et al., 
2005) or replacing the N-terminal 101 residues  - contains mitochondrial targeting 
sequence – with N-terminal 101 Tir residues (Quitard et al., 2006). However, no 
defects were evident (data not shown) implicating dependence on other features.   
 
Consistent with our previous findings, introducing the Map-encoding plasmid into the 
mfez:km mutant, generating an equivalent triple mutant (fz:kme), was linked to loss of 
host and Tir phosphotyrosine proteins at later (4-6hr) time points (Figure 69). Strain 
genotype was supported by absence of EspF and Intimin protein signals (antibodies 
against EPEC Map were not available). Interestingly, the EspB levels in samples from 
cells infected with the complemented strain were greater than that from control 
mfez:km-infected cells (Figure 69), but similar to that in the fz:kme infected cells. 
Complementation studies were also undertaken with Map variants known to have 
subversive defects i.e. don’t target mitochondria as N-terminal 41 residues - contains 
mitochondrial targeting sequence - replaced by N-terminal 101 Tir residues 
(mapΔMTS), can’t activate Cdc42 (mapE78A) and can’t sustain Map-triggered Cdc42 
activity (mapΔTLR or mapHA); latter also enables antibody detection of Map (Kenny & 
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Jepson, 2000, Papatheodorou et al., 2006, Wong et al., 2012a, Dean et al., 2013). 
These studies revealed a significant defect for one variant, mapΔMTS, implicating a 
key role for Map targeting mitochondria or another N-terminal feature, though it is 
possible that the Tir domain prevents the responsible Map activity (Figure 70). 
Interestingly, expressing the other variants were linked to a faster and greater level of 
phosphotyrosine protein loss than the native, plasmid encoded, Map (Figure 70) 
suggesting that these features may hinder Map activity that promotes loss of 
phosphotyrosine protein signal.  Probing for HA and Tir epitopes supported expression 
and delivery of MapHA and Tir_ΔMTSMap proteins, respectively (Figure 71). 
 
Collectively, these data support a major role for Intimin in the cytotoxicity-associated 
phenotypes of EspZ-deficient strains with Map and EspF proteins promoting 
dephosphorylation of host/Tir phosphotyrosine proteins dependent on the N-terminal, 
MTS containing, domain of Map but not EspF effector protein. 
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Figure 68: Minor role for EspF in the dephosphorylation of host and Tir tyrosine 
phosphorylated proteins following infection by EspZ-deficient strains. HeLa cells were left 
uninfected or infected with indicated strains (for indicated times) prior to isolating Triton X-100 
soluble (contains host cytoplasm and membrane proteins plus delivered effector proteins) and 
insoluble (contains host nuclei and cytoskeletal proteins plus adherent bacterial proteins) 
fractions. The samples were processed for Western blot analysis (10% SDS-PA gels) and probed 
for phosphotyrosine proteins (PY), Tir, EspB, EspF, tubulin and actin. The position of unmodified 
(To) and host kinase modified (T” and T’’pY [TY]) Tir forms are indicated as are the positions of 
Ep85 (EPEC tyrosine-phosphorylated protein), EspB, EspF, tubulin, actin and protein markers. 
Strains used were EPEC and strains lacking 3 or 4 of the genes encoding Map (m), EspF (f), 
EspZ (z and Intimin (e) with, when appropriate, strains carrying a plasmid encoding for EspF 
(pBR-espF).  
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Figure 69: Prominent role for Map in triggering tyrosine dephosphorylation of host 
proteins of EspZ/Intimin-deficient strains. HeLa cells were left uninfected or infected with 
indicated strains (for indicated times) prior to isolating Triton X-100 soluble (contains host 
cytoplasm and membrane proteins plus delivered effector proteins) and insoluble (contains host 
nuclei and cytoskeletal proteins plus adherent bacterial proteins) fractions. The samples were 
processed for Western blot analysis (10% SDS-PA gels) and probed for phosphotyrosine 
proteins (PY), Intimin, Tir, EspB, EspF, tubulin and actin. The position of unmodified (To) and 
host kinase modified (T” and T’’pY [TY]) Tir forms are indicated as are the positions of Ep85 
(EPEC tyrosine-phosphorylated protein), Intimin, EspB, EspF, tubulin, actin and protein markers. 
Strains used were EPEC, espZ(81) mutant and strains lacking 3 or 4 of the genes encoding Map 
(m), EspF (f), EspZ (z) and Intimin (e) with, when appropriate, strains carrying a plasmid 
encoding for Map (pACYC-map)  
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Figure 70: Map triggered espZ associated Tir/host protein tyrosine dephosphorylation 
phenotypes is N-terminal dependent. HeLa cells were infected with indicated strains (for indicated 
times) prior to isolating Triton X-100 soluble (contains host cytoplasm and membrane proteins plus 
delivered effector proteins) and insoluble (contains host nuclei and cytoskeletal proteins plus adherent 
bacterial proteins) fractions. The samples were processed for Western blot analysis (10% SDS-PA 
gels) and probed for phosphotyrosine proteins (PY), Tir, EspB, EspF, tubulin and actin. The position 
of unmodified (To) and host kinase modified (T” and T’’pY [TY]) Tir forms are indicated as are the 
positions of Ep85 (EPEC tyrosine-phosphorylated protein), EspB, EspF, tubulin, actin and protein 
markers. Strains used were espZ quadruple (mfez) mutant (lacking genes encoding Map (m), EspF 
(f), EspZ (z) and Intimin (e) carrying a plasmid encoding for Map (pSK-map, pSK-map-HA) or Map 
variant that is missing mitochondrial targeting sequence (mapΔMTS), as N-terminal 41 residues - 
contains mitochondrial targeting sequence - replaced by N-terminal 101 Tir residues, (mapΔE78A) 
can’t activate Cdc42  and (mapΔTLR) can’t sustain Map-triggered Cdc42 activity. The immunoblots 
(where appropriate) cropped and moved for presentation purposes. Note, data is representative of 
that from two or more independent experiments. 
 
A) 
 
 
 
 
 
 
 
 
 
 
B) 
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Figure 71: Expression and delivery of MapHA and Tir-∆MTS-Map fusion proteins. Sample from 
previous experiment were processed for Western blot analysis (10% SDS-PA gels) and probed for A) 
HA-tagged or B) Tir protein. The position of Tir, HA-tag or Tir_ΔMTSMap (Map-MTS is swapped with 
N-terminal domain of Tir effector protein) are indicated as are the position of the protein markers. 
Strains used were as described in Figure 69. 
 
 
 
A) 
 
 
 
 
 
 
B) 
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5.3.4 Critical role for Tir in triggering espZ(81) associated phenotypes  
Intimin subverts host cellular process through binding mammalian receptors, such as 
beta Integrin and nucleolin, or Tir (Frankel et al., 1996, Sinclair et al., 2006, Kenny & 
Finlay, 1997, Kenny et al., 1997b). Thus, we decided to examine whether Tir has a 
possible role in triggering or suppressing espZ(81) phenotypes. Therefore, a z(81)t 
double mutant strain was generated (see Chapter 2; Section 2.2.7), PCR confirmed 
(data not shown) and HeLa cells were then infected with espZ(81) and z(81)t mutant 
strains for indicated time course with Triton X-100 soluble and insoluble fractions 
isolated for analyses. It should be noted that, since all espZ(81) phenotypes have been 
detected between 3 and 6hrs post infection with no real differences observed between 
4 and 5hr, thus, this strain was examined at only 3, 4.5 and 6hrs post-infection time 
points. 
Western blot analysis showed, as expected, no evidence for Tir expression nor delivery 
for cells infected with the z(81)t mutant strain (Figure 72), supporting strain genotype.  
Interestingly, probing with anti-tubulin and actin showed no change in the amount of 
proteins in cells infected with z(81)t mutant at all-time points. Similarly, probing with anti-
phosphotyrosine revealed no tyrosine dephosphorylation event (noting Tir is missing 
in this strain) was evident in z(81)t mutant infected cells (3hr) with >3hr, a slight host 
proteins dephosphorylated was observed, confirming a possible role for other effector 
proteins, Map and/or EspF, to induce this phenotype (Figure 72). 
Collectively, these data suggested that Tir seems to have an important role in triggering 
espZ(81) phenotypes, via/or with not Intimin, with cooperative roles for other EPEC 
effector proteins (presumably Map and EspF).   
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Figure 72: Tir is critical for espZ(81) associated phenotypes. HeLa cells were left uninfected or 
infected with indicated strains, for indicated times, prior to isolating Triton X-100 soluble (contains 
host cytoplasm and membrane proteins plus delivered effector proteins) and insoluble (contains 
host nuclei and cytoskeletal proteins plus adherent bacterial proteins) fractions for Western blot 
analysis probing for phosphotyrosine proteins (PY), Tir, EspB, EspF, tubulin and actin. The position 
of unmodified (To) and host kinase modified Tir (T” and PY [TY]) forms are indicated as are Ep85 
(EPEC tyrosine-phosphorylated protein), EspF, EspB, tubulin, actin and protein markers bands. 
Strains used were EspZ-deficient (espZ(81)) mutants and Tir/EspZ-deficient strain (z(81)t). The espZ 
gene was inactivated by deleting 81 (of 98) residues and indicated by (81), while tir was inactivated 
by deleting the whole gene. Note, data is representative of that from two or more independent 
experiments. 
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5.3.5 Supporting roles for Map and EspF in z(81)t mutant associated phenotypes  
To test the hypothesis that dephosphorylation events detected at latest time point 
infection with the z(81)t mutant (Figure 72) are linked to other EPEC effectors, 
presumably Map and/or EspF, we examined z(81)t multiple mutant strains missing one 
or more EPEC LEE effector proteins. The screened strains and resulting western blot 
data (representative blots shown in Figure 72&73) are summarised in Table 10.  
 
As expected, Western blot analysis showed no evidence for Tir expression in the 
soluble/insoluble fractions of all infected strains, as these strains are missing Tir 
(Figure 73). Interestingly, while no evidence for tubulin and actin proteins loss in the 
soluble/insoluble fractions of all infected strains, >4h infection with mtz:km led to some 
tubulin loss (Figure 73AB).  Probing with anti-phosphotyrosine revealed that infection 
for >4hr with etz:km, emtz:km or mtz:km mutant strains (lacking Tir and EspZ with Map 
or Intimin or both) led to host proteins being dephosphorylated at later time points 
(Figure 73A). Interestingly, deleting EspF from tz mutant (tfz:km, etfz:km and tmfz:km) 
showed little if any host proteins dephosphorylation (Figure 73B). The latter suggest 
that EspF promote loss of the host protein phosphorylation with possible role for other 
effectors, presumably the EspG homologues, as the mfz(81)go3t mutant does not 
induce this phenotype (Table 10; Figure 74). While a similar EspB profile was observed 
Strain Figure # 3h 4h 5h 6h Notes 
EPEC 64, 65A/C/D E E E E     T” is stable, No pTyr nor tub/actin loss 
espZ
(81)
 72 E ∆*●○   ∆*●○ ∆*●○    
z81)t 72 tE tE tE Z       Slower pTyr proteins loss at 5/6h 
etz:km    73B tE tE tE Z         Slower pTyr loss at 5/6h 
mtz:km 73A tE tE tE Z       Slower pTyr  and tub loss at 5/6h 
emtz:km 73A tE tE tE Z Slower pTyr  loss at 5/6h  
etfz:km 73A tE tE tE    Z Slower pTyr  loss at 6h 
tfz:km 73A tE tE tE    tE  
tmfz:km   73B tE tE tE tE        
mfz
(81)
go3t 74 tE tE tE tE  
Table 10: Summary of differences between cells infected with EspZ-deficient and Tir/EspZ 
negative mutants strains. Summary of western blot data from HeLa cells infected with indicated 
strains after 3, 4, 5 and 6h. Strains used were espZ(81) mutant or those unable to express EspZ alone 
(espZ(81) mutant) or EspZ plus Tir with one or more of indicated effectors – EspF (f), Map (m), 
EspG/EspG2 (go3) – and/or Intimin (e) proteins. E indicates normal T3SS dependent changes at 
indicated time point. While tE indicates normal T3SS dependent changes, except Tir data, as these 
mutants lack Tir, Z indicates data similar to that obtained with the espZ(81)-infected samples at that 
time point with, when present, some differences in probed signals (∆ reveals dephosphorylation of 
Tir and host tyrosine phosphoproteins; * loss to Tir T’’ band, ● loss of tubulin (tub) signal, and ○ loss 
of actin signal). Orange highlights espZ multi-mutants associated with minor phenotypic changes at 
later time points. Yellow highlights espZ multi-mutants that behave like EPEC. The espZ gene was 
inactivated by deleting 81 (of 98) residues or introducing kanamycin-encoding gene indicated by (81) 
and :km respectively.  
tE and Z revealing data similar to corresponding EPEC and espZ(81) mutant-infected samples, 
respectively with, when present, some differences in probed signals (∆ reveals dephosphorylation of 
Tir and host tyrosine phosphoproteins; * loss to Tir T’’ band, ● loss of tubulin (tub) signal, and ○ loss 
of actin signal). Orange highlighting indicate Tir/EspZ-deficient-mutants that associated with minor 
phenotypes at later time points. Yellow highlighting indicate Tir-EspZ-deficient-mutants that behave 
like EPEC (note, no data linked to Tir protein as th se strains are missing Tir). The espZ gene was 
inactivated by deleting 81 (of 98) residues or introducing kanamycin-encoding gene indicated by (81) 
and :km respectively.  
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in all soluble and insoluble fractions, EspF was only detected in cells infected with EspF 
positive strains (Figure 73AB).  
Collectively, these data (with our previous work findings) support a critical role for Tir 
and/or Intimin (via or not Tir-Intimin interactions) in triggering espZ(81) phenotypes and 
suggested a cooperative role for EspF and Map in the absence of Intimin and/or Tir, to 
induce espZ(81) associated dephosphorylation event. 
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Figure 73: Assessment of Tir/EspZ-deficient mutant strains. HeLa cells were infected with 
indicated strains (for indicated times) prior to isolating Triton X-100 soluble (contains host cytoplasm 
and membrane proteins plus delivered effector proteins) and insoluble (contains host nuclei and 
cytoskeletal proteins plus adherent bacterial proteins) fractions. The samples were processed for 
Western blot analysis (10% SDS-PA gels) and probed for phosphotyrosine proteins (PY), Tir, EspB, 
EspF, tubulin and actin. The position of Ep85 (EPEC tyrosine-phosphorylated protein), EspB, EspF, 
tubulin, actin and protein markers are indicated. Strains used were EPEC strains lacking EspZ 
(espZ(81) or z) and Tir with one or more of the indicated proteins: Map (m); EspF (f) or Intimin (e). 
Below the strain is the identity of proteins of interest (Map [M], EspH, EspF [F], EspG/EspG2 [G], 
EspB [B] effector and/or Intimin [Int] proteins) expressed by the strain. The espZ gene was 
inactivated by introducing kanamycin-encoding gene indicated by :km. 
 
. 
A) 
 
 
 
 
 
 
 
 
 
 
 
B) 
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5.3.6 espZ(81) cytotoxicity-associated phenotypes depend on Tir with critical role for 
kinase modified residues 
To examine the role of Tir features in the espZ(81) associated phenotypes, 
complementation studies were undertaken with the mfz(81)go3t mutant which showed 
no espZ(81) associated phenotypes, in contrast to the mfz(81)go3 mutant (doesn’t 
express EspZ, Map, EspF, EspG or EspG2 effectors) (Table 9; Figure 65).  
Western blot analysis showed that mfz(81)go3 mutant infection was linked to loss of 
tubulin (didn’t assess actin) and phosphotyrosine protein signals (at late time points; 
Figure 74) In contrast, the Tir-deficient variant (mfz(81)go3t) appeared not to induce 
these alterations indicating a critical role for Tir for these events. Strain genotype was 
supported by absence of Tir bands in samples from mfz(81)go3t, unlike mfz(81)go3, 
mutant-infected cells (Figure 74). To gain insight on how Tir may be contributing to this 
process, complementation studies were undertaken with variants that were i) unable 
to interact with Intimin (TirHAinto; p3gtHAinto) as HA epitope tag within Intimin binding 
domain, ii) carrying a HA tag C-terminus with no known impact on Tir functionality or 
iii) kinase substrate residues serine (434 and 463) and tyrosine (454 and 474) 
substituted to alanine/phenylalanine (TirΔSY; p3gtΔSY). Interestingly, only the TirHA 
variant rescued the mfz(81)go3t mutant defect with complementation supported by 
Western detecting Tir  (increased molecular mass when HA epitope tagged) and failure 
to detect TirΔSY variant with anti-phosphotyrosine antibodies (Figure 74). This data is 
suggestive of a key role for Tir-Intimin interaction and one or more of the examined Tir 
kinase phosphorylation substrates in the ability of EspZ-deficient strains to induce 
tubulin (and presumably actin) loss i.e. cytotoxicity and loss of tyrosine phosphorylated 
proteins.  
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Figure 74: Intimin induced espZ(81) phenotypes is Tir dependent with critical role for serine 
and/or tyrosine residues. HeLa cells were infected with indicated strains (for indicated times) prior 
to isolating Triton X-100 soluble (contains host cytoplasm and membrane proteins plus delivered 
effector proteins) and insoluble (contains host nuclei and cytoskeletal proteins plus adherent 
bacterial proteins) fractions. The samples were processed for Western blot analysis (10% SDS-PA 
gels) and probed for phosphotyrosine proteins (PY), Tir, EspB, EspF, tubulin and actin. The position 
of unmodified (To) and host kinase modified (T” and T’’pY [TY]) Tir forms are indicated as are the 
positions of Ep85 (EPEC tyrosine-phosphorylated protein), EspB, EspF, tubulin and protein markers. 
Strains used were mfz(81)go3 lacking EspZ (espZ(81) or z) with other indicated proteins: Map (m); 
EspF (f) and EspG/EspG2 (go3), mfz(81)go3t as mfz(81)go3 but lacks Tir, and  mfz(81)go3t 
complemented with pACYC- tir (expressing Tir), pACYC-3gtHAinto, (expressing Tir with HA-taq 
inserted in the Intimin binding area (IBA) to prevent Tir-Intimin interaction), pACYC-3gtHAo 
(expressing Tir with HA-taq inserted in the C-terminal of Tir), or tir∆SY (kinase phosphorylated serine 
(434 and 463) and tyrosine (454 and 474) residues substituted to alanine/phenylalanine). Note, data 
is representative of that from two or more independent experiments. 
A) 
 
 
 
 
 
 
 
 
 
 
 
B) 
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5.3.7 Additional complexity in the espZ(81) mutant phenotypes 
Although our study with the mfz(81)go3e and mfz(81)go3t mutant strains (Figure 65 & 74) 
implicated a key role for Tir via Intimin in triggering espZ(81)  associated phenotypes 
with contribution from EspF, Map and EspG, additional complexity was evident by an 
earlier observation that the espZ multiple mutant; mfz(81)go3eh:km (As mfz(81)go3e but 
lacks EspH [h]) behaved like the espZ(81) (Figure 75).  
While Western blot analysis showed no evidence of the espZ(81) associated 
phenotypes was observed in cells infected with either EPEC or mfz(81)go3e mutant 
(Figure 75), the mfz(81)go3eh:km infection linked to a slower loss of Tir T’’ form and 
tubulin/actin were detected at latter time point of infection (Figure 75). Furthermore, 
while EspB was detected in all loaded samples (Figure 75), EspF was absent from 
soluble and insoluble fractions of cells infected with either mfz(81)go3eh:km or 
mfz(81)go3e mutant, contrasting to an EPEC strain, which support strains’ genotype 
(Figure 75).  
This data suggestive of a possible suppressive role for EspH against other EPEC 
protein(s), presumably Tir or a non-LEE effector protein(s). 
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Figure 75: Multiple mutant strain mfz(81)go3eh:km, unlike mfz(81)go3e,  triggers espZ(81) 
phenotypes. HeLa cells were infected with indicated strains (for indicated times) prior to isolating 
Triton X-100 soluble (contains host cytoplasm and membrane proteins plus delivered effector 
proteins) and insoluble (contains host nuclei and cytoskeletal proteins plus adherent bacterial 
proteins) fractions. The samples were processed for Western blot analysis (10% SDS-PA gels) and 
probed for phosphotyrosine proteins (PY), Tir, EspB, EspF, tubulin and actin. The position of 
unmodified (To) and host kinase modified (T” and T’’pY [TY]) Tir forms are indicated as are the 
positions of Ep85 (EPEC tyrosine-phosphorylated protein), EspB, EspF, tubulin, actin and protein 
markers. Strains used were EPEC, mfz(81)go3e (lacking EspZ (espZ(81) or z) with other indicated 
proteins: Map (m); EspF (f), EspG/EspG2 (go3) and Intimin (e), mfz(81)go3eh:km as mfz(81)go3e but 
also lacks EspH (h). The espZ gene was inactivated by deleting 81 (of 98) residues while espH was 
inactivated by introducing kanamycin-encoding gene indicated by (81) and :Km respectively. The 
immunoblots (where appropriate) cropped and moved for presentation purposes. Note, data is 
representative of that from two or more independent experiments. 
 
A) 
 
 
 
 
 
 
 
 
 
 
 
B) 
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5.3.8 LDH release depends on espZ mutants expressing Tir or Intimin 
Our previous results (Figure 65 & 72) revealed Intimin and Tir proteins are essential 
for triggering the espZ(81) associated phenotypes. To support this proposition, we 
quantified cellular cytotoxicity mediated by different espZ(81)  strains (express or not Tir 
and/or Intimin proteins) using the Lactate dehydrogenase (LDH) assay. Thus, HeLa 
cells were infected with EPEC, T3SS mutant (cfm-14), espZ single or multiple mutants 
(lacking Tir and/or Intimin with or without other EPEC LEE effector proteins) before cell 
culture supernatants were isolated to quantify the level of released LDH. The finding 
are summarised in Table 11 and Figure 76.  
As reported (Shames et al., 2010), the T3SS mutant strain induced minimal host cell 
cytotoxicity, with ~10% of LDH enzyme released into the cell culture media by 6hr post 
infection (Figure 76). In contrast, cells infected with the EPEC strain was linked to more 
LDH release with ~18% of LDH enzyme released by 6hr post-infection (Table 11; 
Figure 76). In contrast, espZ(81) infection led to the greatest release of LDH enzyme 
with 20, 65 and ~90% of LDH enzyme being released after 3, 4.5 and 6hr infection 
periods, respectively (Table 11; Figure 76). Similar results were obtained with only one 
strain, mfz(81)go3 mutant (lacks four EPEC LEE effector proteins and EspG2, but has 
both Tir and Intimin) (Table 11; Figure 76). Interestingly, deleting either Tir or Intimin 
from all examined EspZ deficient, including mfz(81)go3 led to an EPEC-like profile 
(Table 11; Figure 76). This finding illustrates a critical role for Tir and Intimin proteins 
to induce espZ(81)  associated cytotoxicity. 
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Strain Figure # 3h 4h 5h 6h Notes   Mean value of 
%LDH released (6h) 
EPEC 64&65 E E E E     17.9 
cfm (T3SS) 64 E E E E  10 
espZ
(81)
 64&65A/C E ∆*●○   ∆*●○ ∆*●○    88.8 
ez:km 65B E E E  E  Loss  pTyr proteins at 5/6h 20.2 
z(81)t 72 tE tE tE Z      Slower pTyr proteins loss at 6h 19.2 
etz:km 73B tE tE tE Z     Loss pTyr loss at 5/6h 13.3 
mfz:kmgo3 65C E E Z Z Loss Tub/actin 6h and pTyr 
proteins 5/6h 
76.5 
etfz:km    73A tE tE tE Z           Slower pTyr proteins loss at 6h  16.9 
mfez:km 65B/D E E E E  17.5 
mfz
(81)
go3t 74 tE tE tE tE  14.5 
mfz:kmgo3e 65C E E E E  15.3 
mfz(81)go3eh 75 E E Z Z Loss pTyr proteins/Tir T’’ at 
4.5/6h & tub/act 6h 
22.8 
Table 11: Summary of differences between cells infected with EspZ-deficient and EPEC 
strains. Summary of western blot and LDH data (6h only) from HeLa cells infected with indicated 
strains after 3, 4, 5 and 6h. Strains used were EPEC, cfm (T3SS mutant) or those unable to express 
EspZ alone (espZ(81) mutant) or EspZ plus one or more of indicated effectors – Tir (t) EspF (f), Map 
(m), EspH (h), EspG/EspG2 (go3) – and/or Intimin (e) proteins. E indicates normal T3SS dependent 
changes at indicated time point. While tE indicates normal T3SS dependent changes, except Tir data, 
as these mutants lack Tir, Z indicates data similar to that obtained with the espZ(81)-infected samples 
at that time point with, when present, some differences in probed signals (∆ reveals dephosphorylation 
of Tir and host tyrosine phosphoproteins; * loss to Tir T’’ band, ● loss of tubulin (tub) signal, and ○ 
loss of actin signal). Yellow highlighting indicate espZ multi-mutants that release the higher 
percentage of LDH enzyme. The espZ gene was inactivated by deleting 81 (of 98) residues or 
introducing kanamycin-encoding gene indicated by (81) and :km respectively.  
 
 
Figure 76: LDH release depends on espZ mutant expressing Tir or Intimin proteins. HeLa cells 
were infected with indicated strains (for indicated times) prior to processing extracellular media for 
LDH release as a measure for cell cytotoxicity. Strains used were EPEC, cfm-14 (T3SS mutant) or 
espZ single or multiple mutants (lacking Tir (t) and/or Intimin (e) with or without one or more of 
indicated LEE effectors – EspF (f), Map (m), EspG/EspG2 (go3) and EspH (h). LDH releases was 
measured and data expressed as means ±S.D. from four independent experiments with asterisk 
indicating when only involved three independent experiments. 
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5.3.9 Ruling out any possible role for non-LEE effector proteins in espZ(81) 
phenotypes    
Finding that, deleting the espH gene from mfz(81)go3e mutant revealed its ability to 
trigger espZ(81)  associated phenotypes (Figure 75; mfz(81)go3eh:km), implicated 
additional complexity in which EspH may suppress cytotoxicity inducing activity of, 
presumably, non-LEE encoded effector protein(s). In EPEC (strain E2348/69), 24 non-
LEE putative effectors have been identified (Dean & Kenny, 2009, Iguchi et al., 2009, 
Deng et al., 2004b). Thus, we decided to examine the putative role for these effector 
proteins in the espZ(81)  phenotypes by generating a strain lacking the espZ gene and 
as many LEE and non-LEE-encoded effectors as possible with the prediction that it 
would have little if any espZ(81) phenotypes. Thus, I took an advantage of an available 
mutant TOE-A7 (Yen et al., 2010) that lacks 14 non-LEE effectors and EspG, from 
which espZ, espF, map espH, eae, tir and/or espB genes were deleted using available 
suicide vectors and developed strategies (see Chapter 2; Section 2.2.7). This led to 
the generation of ten strains (Table 12) with PCR analysis confirming disruption of 
espZ, espF, map, espH, eae, tir and/or espB genes (data not shown). The screened 
strains and resulting Western blot data (shown in Figure 77A-D) are summarised in 
Table 12.  
Western blot analysis of isolated fractions revealed that TOE-A7, as expected, 
behaved like EPEC with no evidence for any espZ(81) associated phenotypes (Table 
12; Figure 77A). In contrast, TOE-A7 mutants, ∆fz, ∆fzm and ∆fzmh (lacking EspZ with 
one or more of the LEE effectors EspF, Map and EspH) behaved like espZ(81) (Table 
12; Figure 77AB). Interestingly, while ∆fzmth (lacks all classical LEE effectors [but not 
EspB] and the 14 non-LEE effectors) was associated with one or more minor 
phenotypes at later time points (Table 12; Figure 77D), ∆fzmthe (as ∆fzmth but lacks 
Intimin) was linked to a more rapid loss of the proteins tyrosine phosphorylation and 
tubulin/actin proteins, with, of course, no information about Tir modification as strains 
are tir-negative strains (Table 12; Figure 77C). Similarity, TOE-A7∆core (lacks the 14 
non-LEE effectors and loss of LEE region genes encoding the EspH, CesF, Map, Tir, 
CesT and Intimin) also behaved like espZ(81), suggestive of a role for Tir and Intimin in 
promoting and a suppressing these events, respectively (Table 12; Figure 77D). 
Noticeably, the cytoplasmic tubulin protein, was detected in the insoluble fractions of 
most EspZ deficient TOE-A7 mutants, suggesting a putative role for EspZ with other 
14 non-LEE effectors to protect against that. In addition, EspB was detected in all 
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infected cells (soluble and insoluble fractions) with a gradual increase in HeLa cells 
infected over 3hr with espZ(81) deficient strains, suggested that  EspB might be 
regulated by EspZ or other missing effectors. In contrast, EspF was only detected in 
EspF positive strain (EPEC, TOE-A7 and espZ(81)) which is a further support for strains 
genotype.  
These findings suggested that Tir, but not Intimin, is responsible for triggering the 
espZ(81)  associated phenotypes in the TOE-A7 genetic background. 
 
 
 
Strain Figure  3h 4h 5h 6h Notes Mean value of 
%LDH released (6h) 
EPEC 64/77 E E E E T” is stable, No pTyr nor 
tub/actin loss 
17.9 
espZ
(81)
 77A/B E ∆*●○ ∆*●○ ∆*●○ Slower tub/actin 6h 88.8 
TOE-A7 77A/C E E E E As EPEC 12.5 
TOE-A7b N/A _ _ _ _  11.1 
TOE-A7∆fz 77A E Z Z Z As  espZ
(81)
 28.2 
TOE-A7∆fzm 77B E Z Z Z As  espZ
(81)
 36.0 
TOE-A7∆fzmh 77B E Z Z Z As  espZ
(81)
 38.6 
TOE-A7∆fzme N/A _ _ _ _  29.2 
TOE-A7∆fzmeh 77C E Z  (4.5h) Z Slower T’’ and pTyr loss; Faster 
tub/actin 4h 
37.4 
TOE-A7∆fzmt N/A _ _ _  9.7 
TOE-A7∆fzmth 77C tE tE  (4.5h) Z Slower loss pTyr proteins at 6h 
& tub/act 6h 
11.4  
TOE-A7∆fzmthe 77C tE Z  (4.5h) Z Faster pTyr and tub/actin loss 
4.5h 
9.8 
TOE-A7∆core 77C tE tE  (4.5h) Z Slower loss pTyr proteins at 6h 
& tub 6h 
16.3 
TOE-A7∆fzmehb N/A _ _ _  6.0 
Table 12: Summary of differences between cells infected with EspZ-deficient TOE-A7 strains. 
Summary of western blot and LDH (only 6hr) data from HeLa cells infected with indicated strains and 
time. Strains used were TOE-A7 (lacks 14 non-LEE effectors and one LEE effector, EspG) or those 
(TOE-A7 mutants) unable to express EspZ plus one or more of indicated LEE effectors – EspF (f), 
Map (m), EspH (h), Tir (t) – and/or Intimin (e) proteins and core region (loss of LEE region genes 
encoding the EspH, CesF, Map, Tir, CesT and Intimin). E indicates normal T3SS dependent changes 
at indicated time point. While tE indicates normal T3SS dependent changes, except Tir data, as these 
mutants lack Tir, Z indicates data similar to that obtained with the espZ(81)-infected samples at that 
time point with, when present, some differences in probed signals (∆ reveals dephosphorylation of Tir 
and host tyrosine phosphoproteins; * loss to Tir T’’ band, ● loss of tubulin (tub) signal, and ○ loss of 
actin signal). N/A indicate that this strain was not assisted. Yellow highlighting indicates espZ multi-
mutants that release the higher percentage of LDH enzyme.  
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Figure 77: Assessment of EspZ deficient TOE-A7 multi-mutants. HeLa cells were left uninfected 
or infected with indicated strains, for indicated times, prior to isolating Triton X-100 soluble (contains 
host cytoplasm and membrane proteins plus delivered effector proteins) and insoluble (contains 
host nuclei and cytoskeletal proteins plus adherent bacterial proteins) for Western blot analysis 
probing for phosphotyrosine proteins (PY), Intimin, Tir, EspB, EspF, tubulin and actin. The position 
of unmodified (To) and host kinase modified Tir (T” and PY [TY]) forms are indicated as are Ep85 
(EPEC tyrosine-phosphorylated protein), Intimin, EspF, EspB, tubulin, actin and protein markers. 
Strains used were EPEC, TOE-A7 strains lacking EspZ (espZ(81) or z) with one or more of the 
indicated proteins: Map (m); EspF (f), Tir (t), EspH (h) or Intimin (e), or  core region (loss of LEE 
region genes encoding the EspH, CesF, Map, Tir, CesT, EspG and Intimin protein). Below the strain 
name (note indicates order genes were inactivated) is the identity of proteins of interest (Tir, Map 
[M], EspH, EspZ, EspF [F], EspB [B] effector and/or Intimin [Int] proteins) expressed by the strain. 
The espZ gene was inactivated by deleting 81 (of 98) residues while espH by introducing 
kanamycin-encoding gene indicated by (81) and :km respectively. The immunoblots (where 
appropriate) cropped and moved for presentation purposes. Note, data is representative of that from 
two or more independent experiments. 
 
 
NOTE in some write Tr instead of Tir and don’t see fze mutant data 
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The cellular cytotoxicity mediated by EspZ deficient TOE-A7 mutants (express or not 
Tir and/or Intimin proteins) was also quantified using the Lactate dehydrogenase (LDH) 
assay and data are summarised in Table 12. As before, the espZ(81) infection lead to 
the greatest release of LDH enzyme with 20, 65 and ~90% of LDH enzyme being 
released after 3, 4.5 and 6hr infection periods, respectively (Figure 78). In contrast, 
cells infected with the TOE-A7 strain was linked to ~18% LDH released by 6hr post-
infection with less in cells infected with T3SS mutant strain (TOE-A7∆espB; ~11%) 
(Figure 78). Interestingly, TOE-A7 mutants, ∆fz, ∆fzm and ∆fzmh (lacking EspZ with 
one or more LEE effectors EspF, Map and EspH) were linked to more LDH enzyme 
released ~30% compared to TOE-A7 (Figure 78). Importantly, deleting Tir, but not 
Intimin, (∆fzmt and ∆fzmth) linked to a great reduction in the amount of LDH enzyme 
release (~10%) (Figure 78).  
Collectively, these data suggested that the LDH release, in the TOE-A7 genetic 
background, is Tir but not Intimin dependent. 
 
 
  
Figure 78: LDH release depends on EspZ deficient TOE-A7 mutants expressing Tir but not 
Intimin. HeLa cells were infected with indicated strains (for indicated times) prior to processing 
extracellular media for LDH release as a measure for cell cytotoxicity Strains used were the espZ(81), 
TOE-A7, TOE-A7∆b (T3SS mutant), EspZ deficient TOE-A7 multiple-mutant strains (lacking EspZ 
plus one or more of indicated effectors EspF (f), Map (m), EspH (h) and/or –Tir (t) /Intimin (e) proteins) 
or lacking the core region (loss of LEE region genes encoding the EspH, CesF, Map, Tir, CesT and 
Intimin), LDH releases was measured and data expressed as means ±S.D. from four independent 
experiments with asterisk indicating when only involved three independent experiments. 
. 
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5.3.10 K12 ‘mini-LEE’ strain behaves like espZ(81) mutant 
In an effort to avoid the above-mentioned complexities, studies explore the possibility 
that a recently published non-pathogenic E.coli strain (SIEC-eLEE5; genes introduced 
to express EPEC’s effector delivery system, Intimin and only one classical LEE 
effector, Tir) would be cytotoxic to HeLa cells as lacks the espZ gene product. The 
EPEC T3SS-associated genes in are under the control of an IPTG-inducible promoter 
(Ruano-Gallego et al., 2015). Initial HeLa cell infection studies revealed that, as 
expected, SIEC-eLEE5 could deliver Tir into cells where modified to the T” form and 
interacts with Intimin (Figure 79); latter evidenced by presence in insoluble fraction. By 
contrast, no Tir or EspB bands were evident in cells infected with the negative control 
strain SIEC∆p1-eLEE5 which cannot express a T3SS as lacks promoter to drive 
expression of T3SS components (Ruano-Gallego et al., 2015). It should be noted that 
there appears to be ‘leaky’ expression of EspB and Tir, but not the T3SS delivery 
system, as Tir is not modified to T’’ form (Figure 79) with no evidence of cell cytotoxicity. 
Thus, the infection time was extended and carried out at two MOI’s. 
 
 
 
 
 
 
 
 
 
 
Figure 79: SIEC-eLEE5 delivers Tir where modified to T”-like form and interacts with Intimin. 
HeLa cells were left uninfected or infected with indicated strains for 3hr, prior to isolating Triton X-
100 soluble (contains host cytoplasm and membrane proteins plus delivered effector proteins) and 
insoluble (contains host nuclei and cytoskeletal proteins plus adherent bacterial proteins) for 
Western blot analysis probing for Tir, EspB and EspF. The position of unmodified (To) and host 
kinase modified Tir (T”) forms are indicated as are EspF and EspB. Strains used were EPEC, SIEC-
eLEE5 (expresses T3SS/Esp translocons, effector delivery system, Intimin, Tir and its chaperone 
CesT) or SIEC∆p1-eLEE5 (same as SIEC-eLEE5 but lacks promoter to drive expression of T3SS 
components needed for the effector-delivery process). 
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Interestingly, the Western blot profile obtained with the SIEC-eLEE5 strain, at both 
MOI’s (Figure 80), was similar to that with extended espZ(81) mutant infections (Chapter 
5; Figure 64) i.e. loss of Tir T’’ form over the extended infection period linked to 
decreasing levels of host and Tir phosphotyrosine proteins as well as tubulin and actin  
proteins. Crucially, these phenotypes were not evident with the negative control, 
SIEC∆p1-eLEE5, strain linked to very poor expression of effectors (Tir and EspB) with 
absence of functional T3SS as no Tir modification (Figure 80). It should be noted that 
probing for tyrosine phosphorylated proteins did not reveal Ep85 (insoluble fraction) as 
this protein is not expressed by K12 E. coli (Ilan et al., 1999).  
Collectively, this work illustrated that SIEC-eLEE5 strain behaves like the espZ(81) 
despite lacking all known EPEC effectors except Tir and EspB providing a simple 
model to examining the hypothesis that EspZ protects infected cells from a cytotoxic 
outcome in response to Tir-Intimin interactions.  
5.3.11 The SIEC-eLEE5 associated phenotypes are CesT dependent  
To examine the predicted key roles for Tir and Intimin in the cytotoxic-associated 
phenotype of the SIEC-eLEE5 strain, we wanted to inactivate the Tir and Intimin genes. 
However, this was not possible with available suicide vectors due to how the tir, cesT 
eae (encodes Intimin) operon was inserted into the K12 genome as this provided little 
homology (<200bp) for crossover events. Indeed, numerous attempts to disrupt the 
genes, via, the small degree of homology, were unsuccessful. Therefore, it was 
decided to disrupt the gene encoding the Tir chaperone, CesT, as it is critical for Tir 
delivery (Thomas et al., 2005) using an available suicide vector and developed 
strategies (see Chapter 2; Section 2.2.7). PCR analysis confirmed disruption of the 
cesT gene (Figure 81A) as evidenced by a larger fragment reflecting insertion of 
Kanamycin resistance encoding gene in the 5’ end of cesT.  
Next, HeLa cells were infected with the new strain to determine its ability to induce 
cytotoxicity-associated alterations after an extended (9h) infection period. However, 
data interpretation was hindered by apparent inability of the SIEC-eLEE5∆cesT mutant 
to bind to the infected cells suggested by absence of EspB-related bands detected in 
the soluble or insoluble fractions in contrast to cells infected with the SIEC-eLEE5 or 
SIEC∆p1-eLEE5 strains (Figure 81B).  
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Figure 80: Cell cytotoxic responses following infection with SIEC-eLEE5.  HeLa cells were left 
uninfected or infected with indicated strains, for indicated times and MOI, prior to isolating Triton X-
100 soluble (contains host cytoplasm and membrane proteins plus delivered effector proteins) and 
insoluble (contains host nuclei and cytoskeletal proteins plus adherent bacterial proteins) fractions 
for Western blot analysis probing for phosphotyrosine proteins (PY), Tir, EspB, EspF, tubulin and 
actin. The position of unmodified (To) and host kinase modified Tir (T” and PY [TY]) forms are indicated 
as are EspF, EspB, tubulin, actin and protein markers. Strains used were EPEC, SIEC-eLEE5 
(expresses T3SS/Esp translocons, effector delivery system, Intimin, Tir and its chaperone CesT) or 
SIEC∆p1-eLEE5 (same as SIEC-eLEE5 but lacks promoter to drive expression of T3SS components 
needed for the effector-delivery process).  
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Figure 81: The SIEC-eLEE5∆cesT strain does not deliver EspB. A) Confirmation of the disruption 
of the cesT gene in the SIEC-eLEE5 strain. Primers designed to amplify cesT gene was used to 
interrogate the absence or presence of cesT gene in the SIEC-eLEE5∆cesT with EPEC, SIEC-eLEE5 
were used as a positive control. PCR products and 2 Log DNA ladder marker (100ng-BioLabs) were 
run on a 1% agarose gel containing Gel Red Nucleic Acid Stain. B) HeLa cells were left uninfected or 
infected with indicated strains, for indicated times, prior to isolating Triton X-100 soluble (contains host 
cytoplasm and membrane proteins plus delivered effector proteins) and insoluble (contains host nuclei 
and cytoskeletal proteins plus adherent bacterial proteins) fractions for Western blot analysis probing 
for, Tir and EspB. The position of unmodified (To) and host kinase modified Tir (T”) forms are indicated 
as are EspB and protein markers. Strains used were SIEC (expresses T3SS/Esp translocons, effector 
delivery system but not Intimin, Tir or CesT), SIEC-eLEE5 (as SIEC but also expresses Intimin, Tir 
and CesT) and SIEC-eLEE5∆cesT (as SIEC-eLEE5 but lacks functional cesT gene) 
 
 
A) B) 
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Therefore, we attempted to promote strain binding by introducing a plasmid, pIL14, 
which encoding an afimbrial adhesin (Labigne-Roussel et al., 1984) in each of the 
SIEC-related strains. Indeed, a similar (9h) infection with the three strains resulted in 
similar levels of EspB proteins in the Triton X-100 soluble and insoluble fractions 
(Figure 82) support the idea that disruption of CesT hinders SIEC-eLEE5 interaction 
with HeLa cells. As expected, only the SIEC-eLEE5 strain delivered Tir into cells as 
evidenced by T’’ form in both fractions (Figure 82).  
 
 
 
 
 
 
 
 
 
Crucially, a time course infection with these afimbrial adhesin-expressing strains 
revealed that only the SIEC-eLEE5 strain induced espZ mutant-associated phenotypes 
despite all three strains displaying similar EspB signals in the soluble and insoluble 
fractions (Figure 83). This finding demonstrates a critical role for CesT, again 
presumably via Tir, in driving cytotoxicity-associated events that are normally 
prevented by the T3SS-dependent delivery of EspZ.  
 
Figure 82: EspB delivery defect of the CesT-deficient SIEC-eLEE5 strain is rescued by plasmid 
expressing an afimbrial adhesin. HeLa cells were left uninfected (0) or infected for 9 h with indicated 
strains prior to isolating Triton X-100 soluble (contains host cytoplasm and membrane proteins plus 
delivered effector proteins) and insoluble (contains host nuclei and cytoskeletal proteins plus adherent 
bacterial proteins) fractions for Western blot analysis probing for Tir and EspB. The position of 
unmodified (To) and host kinase modified Tir (T”) forms are indicated as are EspB and protein 
markers. Strains used were SIEC (expresses T3SS/Esp translocons, effector delivery system but not 
Intimin, Tir or CesT), SIEC-eLEE5 (as SIEC but also expresses Intimin, Tir and CesT) and SIEC-
eLEE5∆cesT (as SIEC-eLEE5 but lacks functional cesT gene). Each strain either carried no additional 
plasmid (-) or the pIL14 plasmid (+) that encodes an afimbrial adhesin. 
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Figure 83: CesT activity is critical for SIEC-eLEE5 to induce espZ mutant-associated 
phenotypes. HeLa cells were left uninfected (0) or infected for 6 or 9 h with indicated strains 
prior to isolating Triton X-100 soluble (contains host cytoplasm and membrane proteins plus 
delivered effector proteins) and insoluble (contains host nuclei and cytoskeletal proteins plus 
adherent bacterial proteins) fractions for Western blot analysis probing for phosphotyrosine 
proteins (PY), Intimin, Tir, EspB, EspF, tubulin and actin. The position of unmodified (To) and 
host kinase modified Tir (T” and PY [TY]) forms are indicated as are Intimin, EspB, tubulin, actin 
and protein markers. Strains used were SIEC (expresses T3SS/Esp translocons, effector 
delivery system but not Intimin, Tir or CesT), SIEC-eLEE5 (as SIEC but also expresses Intimin, 
Tir and CesT) and SIEC-eLEE5∆cesT (as SIEC-eLEE5 but lacks functional cesT gene). Each 
strain carried the pIL14 plasmid which encodes an afimbrial adhesin. It should be noted that 
phosphotyrosine protein signal is unusually weak (eg compare to Figure 80) in the soluble 
fraction of uninfected cells. 
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5.4  Discussion 
The aim of the described work was to explore the idea, based on data from Chapter 3, 
that the delivered EspZ effector protects cells from Intimin-dependent activities that 
trigger a cytotoxicity response. Indeed, studies with available and newly generated 
EspZ multi-mutants supported a key role not only for Intimin but also its receptor Tir 
with contributory, minor, roles for other examined effectors. However, additional 
complexity was evidenced by unexpected results with some multi-mutants but crucially 
a simple model supports the idea of a new protective mechanism, whereby EspZ 
prevents cells undergoing a cytotoxic response initiated as a consequence of Tir-
Intimin interaction.   
 
Studies on the role of LEE effectors in the Tir modification and insertion process led to 
data questioning EspZ’s proposed role in protecting cells from cytotoxicity by different 
mechanisms (Shames et al., 2011, Berger et al., 2012, Roxas et al., 2012). However, 
our data argues that EspZ protects against the cell cytotoxicity response stemming 
from Tir-Intimin interaction, to perhaps explaining why EspZ, Tir and intimin, unlike 
other classical effectors, are critical for the virulence of EPEC (Wilbur et al., 2015, 
Marchès et al., 2000). The key roles for Tir and Intimin were suggested by a dramatic 
reduction in espZ(81) associated phenotypes when either tir or eae gene was inactivated 
(z(81)t or ez:km. respectively). However, there are residential minor phenotypes at later 
time points which can be prevented through the deletion of other effectors (Map, espF 
and EspG), suggesting a cooperative role for these effectors in triggering the espZ(81) 
associated phenotypes. Unexpectedly, multiple mutant strain revealed an additional 
complexity. For example, inactivation of the esph gene from the mfz(81)go3e mutant 
(which behaves like EPEC) led to the generation of a  mfz(81)go3eh:km mutant and the 
restoration of espZ(81) activities. This implies a possible suppressive role for EspH 
against, (presumably) Tir or other non-LEE effectors. In addition, inactivation of the 
eae gene from a TOE-A7Δfzmh mutant (lacking 14 non-LEE effectors and LEE Map, 
EspF, EspZ, EspH &EspG2/Orf3) did not prevent the appearance of espZ(81) 
associated phenotypes, suggests that these phenotypes are intimin independent in the 
TOE-A7 genetic background. However, the ability of TOE-A7Δfzmhe (lacking 14 non-
LEE effectors and LEE Map, EspF, EspZ, EspH, EspG2/Orf3 and Intimin) mutant to 
trigger these phenotypes might be attributed to the remaining protein(s), particularly 
Tir or other non-LEE effectors, EspC, LifA and EspJ (Deng et al., 2012, Vidal & 
Navarro-Garcia, 2008). The EspJ is localized to mitochondria (Kurushima et al., 2010) 
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and may cause mitochondrial dysfunction in the absence of the EspZ. The EspC, 
however, regulates the secretion levels of EspD and EspA with an espC mutant 
showing increased levels of cell-associated EspA and EspD, as well as increased pore 
formation activity associated with cytotoxicity (Guignot et al., 2015). 
 
Thus, to avoid the previous complexity and to support the key role for Tir and/or Intimin 
in triggering the espZ(81) associated phenotypes, we have used a simple model, E. coli 
K-12 (SIEC-eLEE5) strain (Ruano-Gallego et al., 2015). This strain encodes Intimin 
and the effector delivery system, but lacks all EPEC LEE effectors, except Tir and 
EspB (Ruano-Gallego et al., 2015). Conclusively, the ability of SIEC-eLEE5 strain to 
behave like espZ(81) discounted any possible role for all LEE and non-LEE effectors 
and implicated a crucial role for Tir, its chaperone CesT, and/or Intimin, in triggering 
the espZ(81) phenotypes, though it is possible that these phenotypes may be linked to 
the translocators (EspA/D/B). However, the inability of SIEC (which encodes a 
functional T3SS) and eLEE5∆cesT/pIL14 (as SIEC-eLEE5 but lacks CesT, Tir 
chaperone) to trigger the espZ(81) phenotypes discounted a possible role for the 
translocator proteins and implicated a key role for the CesT dependent effector, Tir, 
with or without Intimin interaction. It is possible that CesT has an unknown function that 
helps to bring about these phenotypes, but that is unlikely as we have implicated a key 
role for Tir in triggering these phenotypes, and CesT is required for Tir delivery 
(Thomas et al., 2005). Taken together, these findings provide further arguments 
against the balancing hypothesis, in which EspZ is thought to regulate the translocation 
of EPEC effectors into host cells (Berger et al., 2012) and instead support a key role 
for Tir/Intimin in triggering the espZ(81) associated phenotypes. Further work is required 
to inactivate tir and/or the eae gene from SIEC to further confirm these results. 
 
Intimin interacts with Tir to i) mediate an intimate attachment to the host cells, ii) 
promote pedestal formation, iii) stimulate host phospholipase C-γ1 phosphorylation 
and iv) trigger actin rearrangements (Kenny & Finlay, 1997, Kenny et al., 1997b, Kenny 
et al., 2002b, Rosenshine et al., 1996). Thus, the inability of the ez:km or z(81)t mutant 
to trigger the espZ(81) phenotypes might be due to a weaker interaction between the 
mutant strain bacteria and host cells. However, the binding capacity of ez:km and z(81)t 
mutants are reflected by Ep85, EspB or unmodified Tir (within bacteria) signals in 
insoluble fractions which argues against any binding issue. Thus, it is more likely that 
Intimin interacts with Tir or other receptors such as β integrin and nucleolin (Strong et 
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al., 2011), and subverts a signal leading to the espZ(81) phenotypes, while EspZ 
protects against that. It was reported that Td92, a surface protein of the periodontal 
pathogen Treponema denticola, interacts with the cell membrane integrin α5β1 and 
activates NOD-leucine-rich repeat protein (NLRP3) mediated cytokine and caspase-1 
processing, leading to cell death (Jun et al., 2012, Eldridge & Shenoy, 2015), and so 
Tir/Intimin might function via a similar pathway while EspZ protect against that. 
 
Interestingly, the key role filled by Tir and Intimin was further supported by re-
introducing a gene encoding Intimin or Tir in the espZ multiple mutant (mfez:km or 
mfz(81)go3t respectively) which restored their capacity to trigger the espZ(81) 
phenotypes. Importantly, preventing the Tir-Intimin interaction led to a dramatic 
reduction in the ability of complemented strain (p3gtHAinto-mfz(81)go3t) to trigger these 
phenotypes, in contrast to (ptir-mfz(81)go3t), suggesting that the Tir-Intimin interaction 
is critical in triggering these events. Tir serine (S363/S343) and tyrosine (Y454/Y474) 
residues are linked to EPEC Tir’s subversive activities (Kenny, 1999, Kenny & Warawa, 
2001, Allen-Vercoe et al., 2006, Yan et al., 2013). Crucially, the inability of TirΔSY 
(Y45/Y474 and S363/S343 residues were substituted to alanine/phenylalanine, 
respectively), to complement mfz(81)go3t and restore the espZ(81) phenotypes, 
supported a key role for these residues in triggering the espZ(81) phenotype. Further 
studies are needed to investigate which residue is necessary for triggering the espZ(81) 
phenotype and how these residues contribute to the espZ(81) phenotype.  
 
Although many studies reported the cytotoxicity of the espZ mutant (Shames et al., 
2011, Berger et al., 2012, Roxas et al., 2012), here we have demonstrated other espZ 
mutant associated phenotypes: the modification of  Tir T” to the T’ and To-like forms, 
Tir/host protein tyrosine dephosphorylation, and tubulin/actin loss. Perhaps it is not 
surprising  that the cytoplasmic host proteins tubulin/actin were lost, as espZ(81) 
infection led to rapid membrane permeabilization (Berger et al., 2012). This was not 
evident for Tir (To), EspF or EspB, as they are membrane proteins or within organelles 
and thus were not lost following the plasma membrane permeabilization event. 
Noticeably, the distinguishable level of EspB, which is linked to the espZ(81)  infection, 
but not the EPEC infected cells, could implicate a possible role for EspZ in the 
regulation of EspB and pore formation. Crucially, the espZ(81) phenotypes are promoted 
or suppressed by one or more EPEC proteins. While modification of Tir T” to the T’ and 
To-like form is an Intimin dependent event and Tir/host protein tyrosine 
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dephosphorylation appears to be attributed to the Map and EspF effectors, the 
tubulin/actin loss is a Tir/Intimin dependent event. It should be noted that, the 
tubulin/actin loss is unlikely to be linked to cytotoxicity as the TOE-A7Δfzmthe and 
TOE-A7Δcore mutants showed approximately the same levels of released LDH as 
TOE-A7, though these strains were correlated with tubulin/actin loss. 
 
The contribution role of Map, at least in the mfez:km background, can be attributed to 
its import into the mitochondria, as a map-ΔMTS complemented strain was not able to 
trigger espZ(81) phenotypes compared to Map or other Map variants. This is consistent 
with the idea that Map and EspF target mitochondria and induce cytotoxic signals 
suppressed by EspZ (Nagai et al., 2005, Papatheodorou et al., 2006, Shames et al., 
2011). However, in our model, EspF’s contribution role could not be prevented by 
blocking targeting to mitochondria (L16E-EspF and ΔMTS-EspF; latter equivalent to 
ΔMTS-Map as MTS region was swapped for the 1st 101 AA of Tir). Indeed, the Map’s 
role is to remain unaltered when known subversive activities were abolished 
(mapE78A can’t activate Cdc42 and mapΔTLR can’t sustain Map-triggered Cdc42 
activity), implied there is no role for these motifs in triggering the espZ(81) associated 
phenotypes. However, it should be noted that the high degree of Tir/host protein 
dephosphorylation observed with the map-complemented strain is likely to be 
attributed to the overexpression of Map by the map-complemented strain. This allows 
large amounts of Map to translocate to the mitochondria, resulting in mitochondrial 
dysfunction, release of cytochrome c and hence host cell death. 
 
In summary, while EPEC showed a key role for Tir via Intimin, TOE-A7 revealed these 
phenotypes are Tir, but not Intimin dependent, suggesting a complexity behind 
different effectors activities and espZ(81) phenotypes that can be triggered by different 
pathways. However, this study provided a simple model, the SIEC strain, to investigate 
EspZ associated cytotoxicity and our results confirmed, using SIEC strain, a key role 
for Tir/Intimin in triggering the espZ(81) phenotypes. Importantly, this work argued 
against the suggested alternate mechanisms by which EspZ protects against cell death 
and discounted any putative role for all known LEE/non-LEE effectors and the 
translocators. Crucially, this data also confirmed that the Tir-Intimin interaction is 
critical in triggering the espZ(81) phenotypes. Thus, we speculated that Intimin interacts 
with a functional Tir and EspZ to trigger a signal leading to the espZ(81) associated 
phenotypes, while EspZ protects against this process. Therefore, immunoprecipitation 
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experiments are required to examine whether Intimin-Tir-EspZ interact with each other 
and further studies are needed to investigate how the Tir-Intimin interaction can lead 
to cell cytotoxicity while EspZ provides a protection against it.
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Final Discussion 
The pathogenesis of enteropathogenic Escherichia coli (EPEC) depends on a 
functional T3SS to deliver two virulence proteins Tir and EspZ into the host cells 
(Wilbur et al., 2015, Marchès et al., 2000, Coburn et al., 2007). Upon delivery into the 
host cytosol, Tir acts as a substrate for the host kinase that phosphorylate Tir at two 
different serine residues, leading to an increased apparent Tir molecular mass by a 
total of 7kD (to T”-like form). The T”-like form Tir then inserts into the host cell’s 
membrane and binds Intimin. Although the LEE region was shown to be sufficient to 
aid Tir modification to T” form, this study discounted a role for the classical LEE 
encoded protein effectors (EspG, Map, EspF, EspH and EspZ) and Intimin protein in 
the modification of Tir to the T” form and instead implicated roles for other T3SS-
dependent substrates - i.e translocators or a non- delivered effector, SepL. The N-
terminus of SepL carries the secretion signal and binds to the CesL chaperone, while 
the carboxy terminus binds to the Tir effector (Wang et al., 2008, Younis et al., 2010).  
Evaluation of translocators (EspA, EspD and EspB) and SepL protein in effector 
functionality is not possible using a gene deletion strategy, as these proteins are 
essential for the functionality of T3SS. However, an EspB variant (EspB-mid) lacks 60 
residues (residues 159-218) and cannot bind host myosin proteins to inhibit 
phagocytosis (Iizumi et al., 2007), and E. tarda EspB (37.8%; identity to EPEC one) 
restored the functionality of T3SS and revealed no role for missing and homologous 
motifs, respectively, in the Tir modification and insertion mechanisms. However, the 
possible role for other, non-homologous EspB motifs cannot be discounted. It is well 
recognised how toxins and translocators are inserted directly into the host cell’s 
membrane (Dal Peraro & van der Goot, 2016), but conceptually, it is still very difficult 
to understand how proteins like Tir and EspZ are delivered with two transmembrane 
domains and inserted in the hairpin like structure into the host cells membrane.  
Importantly, the E. tarda LEE-like region is missing all known EPEC LEE effector 
homologues, except Tir and   EspZ (Nakamura et al., 2013), and E. tarda Tir lacks all 
EPEC Tir residues that are linked to EPEC Tir’s subversive activities (Kenny, 1999, 
Kenny & Warawa, 2001, Allen-Vercoe et al., 2006, Yan et al., 2013). Thus, we 
speculated that E. tarda Tir is no longer required to manipulate any effector function 
and would be inserted directly into the host cells membrane to act as a receptor for E. 
tarda Intimin (Tir-Intimin interaction) (Kenny et al., 1997b). Further studies are needed 
to investigate the direct or indirect insertion mechanism of Tir.  This can be investigated 
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via making an MTS-Tir fusion protein where Tir can only be imported to the 
mitochondria if it is present in the host cytoplasm. In addition, expressing CesT (Tir 
chaperone) or EspB (cytoplasmic and membrane forms that are potential candidates 
factor aiding Tir insertion) within the host cells to see if they can interact and inhibit the 
Tir insertion into host cells membrane thus accumulation in the host cells cytoplasm. 
These strategies will support a cytoplasmic intermediate form of Tir. 
Interestingly, our work revealed an unexpected role for EspA and EspD, not in aiding 
Tir modification to T” form, but actually in facilitating the Tir T”-Intimin interaction. This 
suggested that these translocators (EspA/D) might interact with Intimin in order to 
stabilise its interaction with the Tir T” form. Further work needs to be done to i) examine 
whether these proteins interact with each other (immunoprecipitation) and ii) examine 
whether the detected T”-like form is inserted in the host cells membrane (looking the 
topology of Tir by detecting the inserted tag in the cytoplasmic or extracellular domain). 
In addition, by swapping either the N- or C- terminal domains, or individual amino acids, 
of the EPEC and E. tarda strains, acritical features linked to the Tir-Intimin interaction 
and insertion into the host cells membrane might be revealed. A previous study (Luo 
& Donnenberg, 2011) suggested that EspA interacts with EspD while EspD interacts 
with EspB. Our study confirmed that E. tarda EspA and EspD proteins are only 
functional interchangeable when co-expressed, suggesting species-specific protein-
protein interactions. This observation also provides a possible explanation for the lack 
of interchangeability of some E. tarda proteins (SepL, EscL and EscK; components of 
a sorting platform) as these proteins might be expressed and functional but lack the 
specific motif(s) required to mediate interact with their partner homologue. Thus, the 
expression of these non-interchangeable E. tarda proteins needs to be examined by, 
for example, generating a tagged fusion protein to enable their detection. These 
proteins (for example components of a sorting platform), if expressed, should be co-
expressed to interrogate their functionality. Indeed, this work provides a good model, 
E. tarda T3SS, for investigating different T3SS components as these components are 
highly different to the EPEC one. Thus, further work needs to be done to investigate 
different T3SS components motifs that might be responsible for interaction and 
functionality of these proteins.  
Interestingly, the detection of Intimin, Tir and EspZ, but not other LEE classical 
proteins, in the LEE like region of a fish infecting bacteria strain (E. tarda), supports 
the idea of a key role for these proteins in the virulence of pathogenic strain. EspZ is 
Chapter 6 Final Discussion 
185 
  
anti-toxic protein that is protecting against cell death by different suggested 
mechanisms (Shames et al., 2011, Berger et al., 2012, Roxas et al., 2012). However, 
our study argued against all the suggested mechanisms (Shames et al., 2011, Berger 
et al., 2012, Roxas et al., 2012) and clearly illustrated that EspZ protects against the 
Tir-Intimin interaction that leads to cell death. Tir interacts with Intimin to form a pore 
in the host cell’s membrane (unpublished data). Thus, we speculate that EspZ is likely 
to interact with a translocator, in this case Tir and/or Intimin. This interaction aids EspZ 
in blocking these pores, which could be examined via immunoprecipitating these 
proteins. Crucially, the key Intimin-Tir role can also be linked to the hypothesis that this 
interaction might lead to unauthorized actin polymerization and activation of 
inflammasome-mediated cell death (MacPherson et al., 2017) which might be 
prevented by EspZ . This process is further supported by the initial data (data not 
shown) revealed that the Cytochalasin D (Cyto D), an actin polymerization inhibitor, 
prevented espZ(81) associated phenotypes. Further work will need to be done to 
examine EspZ, Tir and intimin interactions by pulling down all these proteins together 
with a translocator, presumably EspB or EspD, in order to fully investigate this 
hypothesis.
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